¥xÆW¥¼¤W¥«ªÑ²¼ °]¸gºô 

¥¼¤W¥«  

¥¼¤W¥«ªÑ²¼¦æ±¡,¿³ÂdªÑ²¼¶R½æ,¥¼¤W¥«ÂdªÑ²¼¬d¸ß,§Ö³t´x´¤¥¼¤W¥«ªÑ²¼¶R½æ¯ß°Ê

Åwªï¨Ó¨ì¥²´Iºô ¤â¾÷ª© ¥[¤J·|­û µn¤J ­º­¶
¥¼¤W¥«ÂdªÑ²¼¦æ±¡¬d¸ß,¥¼¤W¥«ªÑ²¼¶R½æ¹L¤á,¿³ÂdªÑ²¼¦æ±¡¬d¸ß¡ã§K¥I¶O±M½u¡G0800-035-178
°Q½×°Ï>¤ß®®¥ÍÂå
Åý§Ú­Ì¤@°_¬°¤ß®®¥ÍÂå¼g¤é°O     µoªí·s¸ÜÃD ¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2017/8/21 ¤U¤È 05:20:28
§N¼ö´`Àô , ¬O¥|©uªº¥²µM

º¦¶^¥æ´À , ¬OªÑ¥«ªº°¸µM

¶}³o­Óª©¤D¦³·P©ó

Cliff¤j®¦¼w¡y¤ß®®¥ÍÂå²£«~½u»PÄvª§¹ï¤â¡zªº±M·~½×­z

Åý¤p§Ìµo¨¥®É , ²`©È·\¹ï¤j®aªºµ§°O

¤]©È§j½K¤@´ò¬K¤ô , ¯}Ãa¤j®aªY½à±M·~ªº¬ü·P

©Ò¥H , ³o­Óª©

¤£¥u 543 ¥i¥H½Í 1234567890abcdef ¤]Åwªï

§Æ±æ¼ö¾x¬O­ì«h

¥»ª©¬O¦h¨¥°ó ¦h¤è¬Ý¨Æ ¦h±¡¹ï«Ý

¬ß±æ

¡y¤ß®®¥ÍÂå²£«~½u»PÄvª§¹ï¤â¡z¬O§Ú­Ìªº¦@¦Pµ§°O

¡yÅý§Ú­Ì¤@°_¬°¤ß®®¥ÍÂå¼g¤é°O¡z«h¬OÄÝ©ó¤j®aªº¦@¦P¤é°O

´Á«Ý±zªº°Ñ»P

ÁÂÁ¤j®a!

·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2020/2/3 ¤W¤È 10:40:18²Ä 1432 ½g¦^À³
¥xÆWªº·sÃÄÃþªÑ§C°g´X¦~¤F...

¦¹¦¸ªÍª¢¨Æ¥óÅý°ê»Ú¤Î¥xÆW§ó­«µø·sÃĤ½¥q...

«ü¼ÐªÑ¤¤¸Î¤µ¤é¶}§C¨«°ª..¥Ø«eÂê¦íº¦°±...·sÃÄÃþªÑ¤Ï§ð¸¹¨¤...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2020/2/2 ¤U¤È 08:16:49²Ä 1431 ½g¦^À³
¥»¦¸À³¶Ò¤H:

®]·çÂE¡Bù²±Âתѥ÷¦³­­¤½¥q¡B§õ±R¥Ã¡BªL¤ÖµÓ

ù²±Âתѥ÷¦³­­¤½¥q¥D­n¤jªÑªF:

1.¶P»ïÒ²/ 99.6305%/ µL

---------------------------------------------------------

¥»¦¸¨p¶Ò¤§°Ñ¦Ò»ù®æ46.26¤¸...¹ê»Ú»{ÁÊ»ù:52¤¸

°ª©ó¥Ø«e¥«³õ»ù®æ»{ÁÊ..¥»¦¸À³¶Ò¤H¬Ý¨ì¤ß®®ªº¥¼¨Ó¬O¤°»ò?

Ä~Äò¬Ý¤U¥h...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2020/1/30 ¤U¤È 09:46:35²Ä 1430 ½g¦^À³
ÁÙ¬O¥ýµ¹¤½¥q´xÁn...¨p¶Ò»ù®æ©¹¤W©w»ùªººA«×...¤@¼Ë¶¶§Qªº¶Ò±o¸êª÷...

¥i¨£±M·~ªº§ë¸ê¤j¤á¹ï¤½¥q¥¼¨Ó²`¨ã«H¤ß...

²Ä¤@¦¸¨p¶Òª÷ÃB¦Ü109/01/10¤é¥Ó³ø108/Q4¥¼¤ä¥Î¸êª÷¾lÃB9¤d¦h¸U..

²Ä¤G¦¸¨p¶Òª÷ÃB2»õ3¤d¦h¸U...¨Ì·Ó²{¦³¤w¨p¶Ò§¹¦¨ªº¸êª÷±À¦ô¨ì©ú¦~¤¤©|¤£¯Ê¸êª÷...

´Á«Ý·sÃĶi«×¤Î±M§Q±ÂÅv®×ºÉ³t¦³¦nªº¶i®i...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G´M³V10132258  µoªí®É¶¡:2020/1/30 ¤U¤È 05:34:25²Ä 1429 ½g¦^À³

§Ç¸¹

1

µo¨¥¤é´Á

109/01/30

µo¨¥®É¶¡

17:00:29

µo¨¥¤H

«¸§Ó¿«

µo¨¥¤H¾ºÙ

°ÆÁ`¸g²z

µo¨¥¤H¹q¸Ü

02-77422699

¥D¦®

¤½§i¥»¤½¥q108¦~«×²Ä¤G¦¸¨p¶Ò´¶³qªÑ¦¬¨¬ªÑ´Úº[¼W¸ê °ò·Ç¤é¤½§i

²Å¦X±ø´Ú

²Ä

43

´Ú

¨Æ¹êµo¥Í¤é

109/01/30

»¡©ú

1.¨Æ¹êµo¥Í¤é:109/01/30

2.¤½¥q¦WºÙ:¤ß®®¥ÍÂåªÑ¥÷¦³­­¤½¥q

3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©ÎÁpÄݤ½¥q):¥»¤½¥q

4.¬Û¤¬«ùªÑ¤ñ¨Ò(­Y«e¶µ¬°¥»¤½¥q¡A½Ð¶ñ¤£¾A¥Î):¤£¾A¥Î

5.µo¥Í½t¥Ñ:¥»¤½¥q108¦~«×²Ä¤G¦¸¨p¶Ò´¶³qªÑ4,532¥aªÑ¡A¨CªÑ»{ÁÊ»ù®æ·s¥x¹ô52¤¸¡A

À³¶Ò¤H¤w©ó109¦~1¤ë30¤éú´Ú§¹²¦¡A¥»¤½¥q¶Ò¶°¸êª÷·s¥x¹ô235,664,000¤¸¡C

6.¦]À³±¹¬I:µL¡C

7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¥»¤½¥q­q©w109¦~1¤ë30¤é¬°¼W¸ê°ò·Ç¤é¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2020/1/30 ¤W¤È 09:15:14²Ä 1428 ½g¦^À³
ª¾¦W°ê¥~ªÑ²¼§ë资¥­¥x¬ã¨s¾÷ºcsimplywall 1¤ë¤¤ªº¤ÀªR¤å..¹ï©ó¤ß®®ªº¤@¨Çµû»ù¥i°Ñ¦Ò...

Here¡¦s Why We¡¦re Not Too Worried About SyneuRx International (Taiwan)¡¦s (GTSM:6575) Cash Burn Situation

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2020/1/16 ¤U¤È 06:15:32²Ä 1427 ½g¦^À³
¤S¨£¯p¯l¯f¬r!

¡mNature¡n«á¤Ñ§K¬Ì§@¯©¡H ªü¯÷®üÀq±wªÌ¸£¤¤Å娣¤j¶q²Ó­M¬r©ÊT²Ó­M

2020.01.15Àô²y¥Í§ÞÂø»x/°OªÌ §ÅªÛ©¨ ½sĶ

www.gbimonthly.com/2020/01/61045/

³z¹L¤ñ¸ûT²Ó­M¨üÅé(TCR)§Ç¦C«á¡A¥v¤¦¦òªº¬ã¨s¹Î¶¤«ü¥X¡A¬¡¤Æ¸Ó§K¬Ì²Ó­Mªº¡A³º¬O¬Û·í±`¨£ªº¤HÃþ¯p¯l¯f¬r²Ä¥|«¬(Epstein-Barr virus, EBV)¡C

³o©M [ ¤ß®®¥ÍÂå²£«~½u»PÄvª§¹ï¤â ] ª©²Ä592½gªº«¢¦ò¤j¾Ç¬ã¨s¬O§_­^¶¯©Ò¨£²¤¦P?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2020/1/14 ¤W¤È 09:01:20²Ä 1426 ½g¦^À³
Biogen ¥H7.1»õ¬ü¤¸¦¬Áʽ÷·çªº¤¤¼Ï¯«¸gº¯³z©ÊCK1§í¨î¾¯PF-05251749 , ¥Î©óªvÀøADªº¤é¸¨²{¶H»PPDªºISWRD

www.genetinfo.com/international-news/item/33885.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GGG10148490  µoªí®É¶¡:2020/1/12 ¤U¤È 05:57:25²Ä 1425 ½g¦^À³
Á{ªÑ·|§Öº¡¤@¶g¦~

¤½¥qÄ~Äò¨IÀq

ªÑ¥«¤w¤W¸U2

³o¦~ÀY

³s®g­¸Ãð¿ïªÑ³£«ÜÃøÁ«¿ú

¥[ªo§a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/12/25 ¤W¤È 10:49:08²Ä 1424 ½g¦^À³
Intra-Cellular«äı¥¢½Õ¯g·sÃÄCAPLYTA¦b¬üÀò§å ªÑ»ù¤jº¦230%

2019.12.24 Àô²y¥Í§ÞÂø»x / °OªÌ §d°ö¦w ½sĶ

www.gbimonthly.com/2019/12/59787/

FDAªñ¦~¦b¯«¸g©Ê¯e¯fªºÃĪ«§å­ã¤W¡A¬Û¸û©ó¨ä¥L»â°ìªºÄY®æ«×¦ü¥G§ó¨ã¼u©Ê¡C¨Ò¦p¤µ¦~3¤ë¡A¼b¥Í(Johnson&Johnson)ªº§Ü¼~Æ{ÃÄSpravato (esketamine)¡A¥u¶i¦æ¤F¤@¶µµu´ÁªºÁ{§É¤T´Á¸ÕÅç·f°t°h¥X(withdrawal)³]­p§YÀò§å¡FSarepta Therapeutics¥Î©óªvÀø¸ÊÄɤó¦Ù¦×µäÁY¯g(DMD)ªº·sÃÄVyondys 53 (golodirsen)¡A¥H¥Ø«eÂàĶÂå¾ÇÀø®Ä©|¤£§¹¥þ©ú®Ôªº¥~Åã¤l¸õÅD(exon-skipping)¬°ªvÀøµ¦²¤¡A¤]¦b¥»¤ë12¤éÀò§å¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/12/23 ¤U¤È 10:46:00²Ä 1423 ½g¦^À³
«i©¹ª½«e¤j

¤£¦n·N«ä ¡A ¤p§Ì¯uªº·Q¤Ó¦h

¤£¹L¡A¤½¥qªº¸ôºt¤Û¿O¤ù´¿´£¤Î­ì­pµe¤H¼Æ¡AÀ³¬O¥Î®ÄªG¶qES=0.5 , power=85%¥[¤W§Ú­Ó¤H²q´úªº¾É¤J¶¥¬q¤ÏÀ³²v=30%¡A±¼¶¤²v=15%¨Óºâªºªº

¥H«e¡A¤p§Ì¥Î¤W¦C°Ñ¼Æ­pºâÂùª¼¶¥¬qªº¤H¼Æ¬O144¤H¡]¦¬®×¼Æ¬O348¤H¡^

§Ú­Ì¤]ª¾¹D ©Ò»Ý¼Ë¥»¼Æ¬O¥Ñ ÅãµÛ¤ô·Çalpha­È ¡A®ÄªG¶qES , ÀË©w¤Opower ¤T­Ó°Ñ¼Æ¨Ó¨M©w

¦]爲alpha , power ´X¥G©T©w¡A©Ò¥H¼Ë¥»¼Æªº¥D®_ªÌ´N¬O®ÄªG¶qES , ¤]´N¬OÀø®Ä

·íES ¶W¹L¬Y¤@¤ô·Ç«á ¡AÅý©Ò»Ý¼Ë¥»¼Æ§C©ó72¡]¦¹®É¦¬®×¼Æ¬O174¡^

©Î³\¥i¥H´Á¤¤¤ÀªR­Ý¸Ñª¼

¦ý¤½¥qªº³Wµe¦p¦ó¥[¤W­Ó¤H»{ª¾¥i¯à¦³»~

©Ò¥H¤j®a´N¤£¥Î·Q¤Ó¦h¤F

¤]½Ð§Ñ¤F¤p§Ì¦³´£³o­Ó¤£¦¨¼ôªº°²³]

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2019/12/23 ¤U¤È 08:46:56²Ä 1422 ½g¦^À³
Jerry ¤j±z¦n,

¥i±¤³o­Óºô¯¸¤£¯à«öÆg, ¤£µM§Ú¥i¯à§â±zªº¤å±À¨ìÃz! ©Ò¦³±zªº¦r¦r¥y¥y, ¦b¤U¤]¬O¤ß¦³±­±­²j

¤£¾å±oª©¤W¾K¤ß©ó¬ì¬ãªº¤j¤j­Ì, ¬O§_¦³¦Ò¶q²{¹êªº¹B§@¡H¦b¤£­¹¤H¶¡·Ï¤õªºª¬ªp¤U,§Ú¤]¯u·Qªk³ß¥Rº¡ªºÀR­Ô¥ú©ú½AÀöªº¥¼¨Ó

²q·Q¤j,

°w¹ï±z´£ªºÈЦ]ÃĮĦn¨ì¶W¥G¹w´Á¤Ó¦h , ¦Ó³QDSMB´£«eµ²§ôÁ{§É

§Ú»{¬°³o³¡¤À¥i¯à¯uªº¬O·Q¤Ó¦h...

©Ò¦³¦¬®×¤H¼Æªº³]©w¬OÃÒ©ú¹êÅ禳®Ä©Êªº³Ì¤Ö¤H¼Æ»Ý¨D,©Ò¥H,´£«eµ²§ôÁ{§ÉÀ³¸Ó¬O®Ú¥»´N¤£¦s¦bªº¥i¯à©Ê

¦pªG¦b¤U²z¸Ñ¿ù»~, ÁٷнЫüÃÒ

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/12/23 ¤U¤È 06:30:55²Ä 1421 ½g¦^À³
Jerry ¥S

ÁÂÁ±z!

±zªº¤ß±¡ , §Ú­Ì·íªÑªFªº , ¦h¦³¦P·P

±zªº©IÆ~ , §Ú·Q¤½¥q¤]³£¬Ý±o¨£Å¥±o¨ì , À³¸Ó·|¦³¦]À³

¤S¤p§Ì½Ð±Ð±zªº°ÝÃD , ¥u¬O·Qª¾¹D , ¹L¤F¨â­Ó¥b¤ëªº²{¦b , ¦¬®×¼Æ¬O§_¦³©Ò¼W¥[? 150¤H¨ì²{¦bªº¦¬®×¼Æ¬O¨Ó¦Û¼Ú¬wªº°^ÄmÁÙ¬O¨Ó¦Û¥_¬ü?

³o·íµM³£¬O·Q§PÂ_¦¬®×ªº³t«×¬O§_¦³©Ò¶i¨B?

§Ú­Ì¦h«æ©ó·Qª¾¹D´Á¤¤¤ÀªRªºµ²ªGÁÙ¦³¦ó®É¥i¥H¸Ñª¼

·íµM³Ì¦nªºµ²ªG¬O , ¦]ÃĮĦn¨ì¶W¥G¹w´Á¤Ó¦h , ¦Ó³QDSMB´£«eµ²§ôÁ{§É , À³¬O¤j®a³Ì·Q¨£¨ìªº

¤£¹L·QÂk·Q , ¹ÚÁÙ¬O§O°µ±o¤Ó¤j

§Æ±æ¤½¥qºÉ¶q§V¤O , §â¦¬®×³t«×´£¤É , ³Ì¦n¬O´Á¤¤¤ÀªR«áªº«áÄò¦¬®×¼Æ¯à¦b¤@¦~¤º§¹¦¨

¬O©Ò¦Ü¬ß

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GJerry10148116  µoªí®É¶¡:2019/12/23 ¤U¤È 02:42:53²Ä 1420 ½g¦^À³
²q·Q¥S§A¦n

§Aı±o³o­Ó¸ê°T¬O10¤ëªìÁÙ¬O¤W¶g¨ú±oªº­«­n¶Ü¡H

­«­nªº¬O¤½¥q´N¬OÁÙ¨S°µ´Á¤¤¤ÀªR

­«­nªº¬O¤½¥qªº¶i«×´N¬OºC¨ìµLªk§Ô¨ü

­«­nªº¬O§Y¨Ï©ú¤Ñ¤½§i´Á¤¤¤ÀªR¡A¶i«×¤]¥u¬O¨ì¤F´Á¤¤

ºâ¤F¡A¬Ý¨Ó¤j®a¤]¤£¬O«Ü¦b·N¡A´N¤£Ä~Äò³o­Ó¸ÜÃD¤F

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/12/20 ¤U¤È 03:39:17²Ä 1419 ½g¦^À³
Jerry ¤j

½Ð±Ð¤@¤U

±zªº¤j¤å»¡ :

2017/4~2018/6¡A¤£¨ì¤@¦~¥b¦¬®×132¤H

2018/5~2019/12¡A¶W¹L¤@¦~¥b¦¬®×¤£¨ì40¤H

³o­Ó¸ê®Æ¬O12¤ë³Ì·sªº¶Ü?

¤p§Ì¤W­Ó¤ë¤]´¿½Ð±Ðµo¨¥¤H , ±o¨ìªº°T®§¬O 10¤ëªìªº®É­Ô , Â÷´Á¤¤¤ÀªRªº174¤H ÁÙ®t´X­Ó¤H

¤p§Ìªº·N«ä¬O , ±z¼gªº2018/5~2019/12 ¬O§_¤]¬O10¤ëªìªº¸ê®Æ?

ÁÂÁ±z!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GJerry10148116  µoªí®É¶¡:2019/12/20 ¤W¤È 11:10:42²Ä 1418 ½g¦^À³
§Ú¥u¯à»¡¡A¤j®a¹ï¸gÀç¹Î¶¤¯uªº¬O«D±`¼e®e

­«ÂIÁ¿¤T¦¸

¬ì¾Ç¤WªºÄYÂÔ»P°õ¦æ¤O¥»¨­¤@ÂI³£¤£½Ä¬ð

¬ì¾Ç¤WªºÄYÂÔ»P°õ¦æ¤O¥»¨­¤@ÂI³£¤£½Ä¬ð

¬ì¾Ç¤WªºÄYÂÔ»P°õ¦æ¤O¥»¨­¤@ÂI³£¤£½Ä¬ð

³o¨âªÌ±q¨Ó³£¤£¬O¤G¾Ü¤@¡A¦Ó¬O¥i¥H¨Ã¦æªº

¤j®a¿ðºÃªº¬O°õ¦æ¤O¡A«H²³´N§â¬ì¾ÇÄYÂÔ¨º¤@®M®³¨Ó¦Û§Ú¶Ê¯v

¦P¼Ë¤@®MÁ{§Éprotocol

2017/4~2018/6¡A¤£¨ì¤@¦~¥b¦¬®×132¤H

2018/5~2019/12¡A¶W¹L¤@¦~¥b¦¬®×¤£¨ì40¤H

½Ð°Ý³o¬O°l¨DÄYÂÔÁÙ¬O°õ¦æ¤O¤Ó®t¡H

¤ß®®ªº°ÝÃD±q¨Ó¤£¬O¤j®a¤£­n¬ì¾ÇªºÄYÂÔ

¦Ó¬O¥D¨ÆªÌ°õ¦æ¤O¤Ó®t¡A³o¨â¦~¨Óªº­pµe¥]§t®ü¥~¶Ò¸ê±q¨Ó¨S¦³¦b©Ó¿Õªº®É¶¡ÂI§¹¦¨¹L

¦pªG½²±Ð±Â¬O¬ì¾Ç®a¨S¦³°õ¦æ¤Oªº¸Ü¡A¨º´N¥h¨D¤~§ä¦³°õ¦æ¤Oªº¤HÀ°¦£

­±¹ï°ÝÃD¡A¸Ñ¨M°ÝÃD¡A³o¬O¤@®a¦b¤½¶}¥«³õ¥æ©öªº¤½¥qÀ³¦³ªººA«×§a

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/12/19 ¤W¤È 09:56:03²Ä 1417 ½g¦^À³
·PÁ²q·Q¤j¦b²£«~ª©¤À¨Éªº¹ù¤j±M¤å¡A

¯uªº¬O¦³»¡ªA¤p§Ì¡A¤p§Ì±q¤ß®®¤W¿³Âd¥H¨Ó¡A±q3¦ì¼Æ¤@¸ô¶R¡A¶R¨ì50ÁÙ¦b¶R¡A

³Q®M¨c¦h¦~¤]¬O¬Ý¶}¤F¡A

¤£¦n·N«ä¡A³o¥b¦~¦h¨Ó¹ê¦b¹ï©óÁ{§É¶i«×§Ö«ö©`¤£¦í¡A

¤£¹L¤p§ÌÁÙ¬O«Ü»{¦P½²¸³ªº¤H«~©M±M·~¡A

¤U¦¸ªÑªF·|«e¡A¤p§Ì¤£·|¦b¤Wª©µo¨cÄÌ¡A

¥u·|Ä~ÄòÀqÀq¥[½X¶R¶i¤ä«ù¤½¥q¡A

§Æ±æ¤ß®®ÃĪ«¤Î¦­¤W¥@³yºÖ¯f¤Í¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/12/18 ¤W¤È 11:07:12²Ä 1416 ½g¦^À³
³o¸Ì¦³¤@½gÃö©óSAGE-217©M AXS-05 ¤G´ÁMDDÁ{§É¸ÕÅ窺¤ñ¸û

§Ú­Ìª¾¹DSAGE-217¤T´ÁªºMOUNTAIN¥¢±Ñ¤F , ¦ÓAXS-05 ªº¤T´Á¦¨¥\¤F

Sage And Axsome Face Off In Depression

Mar. 12, 2019 2:11 PM ET

§@ªÌ : Biotech Beast

seekingalpha.com/article/4248099-sage-and-axsome-face-off-in-depression

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/12/18 ¤W¤È 10:17:05²Ä 1415 ½g¦^À³
·í¤j®a¤@ª½«e¶i¡A«ùÄò°±¯d­ì¦a¡A¿ð¦­·|¥¢¥hÀu¶Õ¡A

finance.yahoo.com/news/axsome-therapeutics-announces-axs-05-110010714.html

Axsome Therapeutics¡AInc.¬O¤@®aÁ{§É¶¥¬qªº¥Íª«»sÃĤ½¥q¡A­P¤O©ó¶}µoªvÀø¤¤¼Ï¯«¸g¨t²Î¡]CNS¡^¯e¯fªº·s«¬Àøªk¡A¦ý¸ÓÀøªkªºªvÀø¿ï¾Ü¦³­­¡CAxsomeªº®Ö¤ßCNS²£«~­Ô¿ï²£«~²Õ¦X¥]¬A¥|­ÓÁ{§É¶¥¬qªº­Ô¿ï²£«~¡GAXS-05¡AAXS-07¡AAXS-09©MAXS-12¡CAXS-05¥Ø«e¥¿¦b§Ü§íÆ{ªvÀø¡]TRD¡^ªº3´Á¸ÕÅç¡A­««×§íÆ{¯g¡]MDD¡^ªº3´Á¸ÕÅç©M»Pªüº¸¯ý®üÀq¤ó¯f¡]AD¡^¬ÛÃöªºÄ¼°Êªº2/3´Á¸ÕÅ礤¡CAXS-05ÁÙ³Q¶}¾v¥Î©ó§ÙµÒªvÀø¡CAXS-07¥Ø«e¥¿¦b¶i¦æ¨â¶µ°¾ÀYµhªº«æ©ÊªvÀøªº3´Á¸ÕÅç¡CAXS-12¥¿¦b¶}¾v¥Î©óµo§@©ÊºÎ¯fªºªvÀø¡CAXS-05¡AAXS-07¡AAXS-09©MAXS-12¬O¥¼¸gFDA§å­ãªº¬ã¨s¥ÎÃÄ«~¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/12/18 ¤W¤È 10:06:25²Ä 1414 ½g¦^À³
»{¦PJerry¤j»P«i©¹ª½«e¤j¡A

¹L¥h³\¦hª©¤Í¦b³o¤@¦~¨Ó³£´£¥X«Ü¦h¦¸¡A

¤½¥q­n¿n·¥¶Ò¸ê¡A§V¤O±À¦¬®×¶i«×¡A

¦¬®×­nªá¿ú¡A¤½¥q¦pªG¦]¬°¸êª÷ªºÃö«Y¡A¤£Ä@·N¶}©l°µ¥¢´¼©M¼~Æ{ªºÁ{§É¡A

¦Ü¤Ö­n§V¤O¶Ò¸ê¡A»°§Ö§â¤â¤W¤T­Ó¦b¶i¦æªºÁ{§É¹êÅç°µ§¹¡A

§Æ±æ§Oµo¥Í¯E¹©¡B¥ÍµØ¬ì¡B¥_·¥¬P³o¨ÇÃļt¤Ï¦Ó¤ñ¤ß®®¦­§¹¦¨¹êÅ窺µ~¹Ò¡A

¥xÆW¥Í§Þ¤jÀô¹Ò½T¹ê¤£¦n¡A¶Ò¸ê»ù¦ì¤]¤£º}«G¡A¦ý³o¨Ã¤£¥Nªí§¹¥þµLªk§ä¨ì¸êª÷¡A

¥u¯à¬è뤽¥q­n¥[ªo°Ú~

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2019/12/17 ¤U¤È 06:39:59²Ä 1413 ½g¦^À³
¥t¥~°w¹ï¤j¤á¤H®a¤j´£¥XªºÁ{§É³]­pªº°ÝÃD, ®Ú¾Ú¦b¤Uªº¤F¸Ñ, Á{§É³]­p¥»¨­¨S¦³°ÝÃD, °ÝÃD¬OÁ{§ÉSite¶}¤Ó¤Ö

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2019/12/17 ¤U¤È 05:35:09²Ä 1412 ½g¦^À³
«D±`ÃÙ¦P Jerry ¤j¤@¤å, ¤½¥qªº°ÝÃD±q¨Ó´N¤£¦b²£«~ªº¬ì¾Ç­±, ¦Ó¬O¸gÀçºÞ²zªº¼h¦¸

¥H¥Ø«eªºÀt³t¦¬®×, ±q2017 ªºªÑªF·|¤W¤½¥q´N¤w¸gªí¥Ü·|¿n·¥¶Ò¸ê, µ²ªG©O?

2019¦~¦~3¤ë¤j±iºX¹ªªº·d¤F­ÓÁ{®ÉªÑªF·|, ±ÂÅvµ¹¥S§Ì¤½¥q(SyneuRx Neuroscience), ·í®ÉªÑªF¥i¬O¤j¤O¤ä«ù, µ²ªG©O? ¦³¥ô¦ó·sªº¶i«×¶Ü??

¥t¥~¤½¥q¦b¤µ¦~ªÑªF·|¤W¦Û«Hº¡º¡ªºªí¥Ü»PBig Data ¦X§@¥i¥H¥[³t¦¬®×, ¦¹¦X§@...¤Ú©Ô¤Ú©Ôªº, µ²ªG¦¬®×¥[³t¤F¶Ü¡H¦n¦nªº¤@­Ó Nuroscience ªº»â°ì, ·d±o¤ñoncology ÁÙºC, ³o¥i¯u¬O©l®Æ¥¼¤Î

¯uªº«Ü·Q°Ý¤½¥q¬O¤£¬O·d¿ù­«ÂI¡H§V¤O¿ù¤è¦V¡H

Á¿©ú¥Õ¤@ÂI´N¬O»°§Ö§â¿ú§ä¶i¨Ó°Õ¡I»°§Ö§â®×¤l¦¬§¹°µ§¹ÃÒ©ú¦Û¤vªº¯à­@¡I

¦pªG³s¦ÑÁ󤽶}ªºµo¨¥, ¶i«×¤W³£¤£¨ã°Ñ¦Ò·N¸q, »»»»µL´Á, Ãø¹DÁÙ«ü±æ¥«³õ¯uª÷¥Õ»Èªº·R¬ÛÀH¶Ü¡H

¤£¹L¤]µo¤å¨ì²Ö¤F, ³o¨Ç¤pªÑªF¹ï¤½¥qªº¤ÏÀ³, ©{¦pª¯§p¤õ¨®...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/12/17 ¤U¤È 12:40:12²Ä 1411 ½g¦^À³
¤p§ÌÁ`¬OµL½t©Mµo¨¥¤H¿Ë¦Û³q¸Ü¡A

¹w­p­n§ä®É¶¡¿Ë¦Û¥h¤½¥q«ô³X¡A²¦³º¿Ë¤Í§ë¤Jªº³¡¦ì¤]¤£¤Ö¡A

Á`­n¦n¦n¸ò¿Ë¤Í»¡©ú¤½¥q²{ªp¡A

¨C¦~¥u¦³ªÑªF·|¤~¥i¥H¤F¸Ñ¤½¥qª¬ªp¡A

¸ê°T¹ê¦b¤Ó¤£³z©ú¡A

¤p§Ìª¾¹D¥»ª©¤£­ã¤j®a¯dÁpµ¸¤è¦¡¡A

¤j®a´N¦³®É¶¡ªº¦U¦Û¥h«ô³X¤½¥q¡A

¸Ñµª¤¤ºÃ´b¤F¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤j¤á¤H®a10140174  µoªí®É¶¡:2019/12/17 ¤W¤È 10:01:46²Ä 1410 ½g¦^À³
±q¤@¦~¦h«e´N¦³»¡¹L, ¤½¥qªº¦¬®×¦³°ÝÃD. Á{§Éªº³]­p¥ß·NÁö¦n, ¦ý³y¦¨¦¬®×ªº°ÝÃD . ¨Ì¼Ë¬O¤@­Ó¥¢±Ñªº³]­p¡D
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GJerry10148116  µoªí®É¶¡:2019/12/17 ¤W¤È 09:48:02²Ä 1409 ½g¦^À³
±q6/12¨p¶Ò¦W³æ¤½¥¬¨ì²{¦b¤]¹L¥b¦~¤F

¤½¥q¦A«×¶i¤JÀR®¨®¨ªº¥V¯v¼Ò¦¡

¬Q¤Ñ¬Ý¨ìAxsomeªºAXS-05 MDD¤T´Á¹LÃöªº®ø®§¦Ê·P¥æ¶°

finance.yahoo.com/news/axsome-therapeutics-announces-axs-05-110010714.html

¤H®a¤@¼Ë¬O¤T´ÁÁ{§ÉªºCNS¾AÀ³¯g¡A¥b¦~¦¬§¹327­Ó¯f¤H«á¶}µP¦¨¥\

§Ú­Ì©O¡H

¦A¦^ÅU¤@¤U¤µ¦~¥|¤ë¼gªºSND13ºë¬ü¶i«×ªí

2017/6 ªÑªF·|¡G¦¬®×62¤H (¨â­Ó¤ë¤º)

2018/6 ªÑªF·|¡G¦¬®×132¤H

2019/2 Á{®ÉªÑªF·|¡G¦¬®×150¤H¥ª¥k

2019/6 ªÑªF·|¡G¦¬®×150¤H¥ª¥k¡A¹w©w¦~©³´Á¤¤¤ÀªR

²{¦b©O¡H¤£¬O174´N­n´Á¤¤¤ÀªR¶Ü¡H

±q¥h¦~132¤H¨ì²{¦b¤@¦~¥b40¦h­Ó¯f¤H¦¬¤£¨ì¡H

CNSÃø¦¬®×¡A¨ºAxsome¦¬ªº¬O¥~¬P¤H¶Ü¡H

PS1¡G¸Ü»¡Axsome¥h¦~12/27ªÑ»ù2¤¸¡A²{¦b79.8¡A§Ú­ÌÄ~Äò³o¼Ë·d¤U¥hªº¸Ü·|¬O¬Û¤Ïªºµ²ªG¶Ü¡H

PS2¡G¤W¦¸¤£¤p¤ß»~¶Ë¥_·¥¬P¡Aµ²ªG¤H®a´«¤F¸gÀç¹Î¶¤«áµo¼«¹Ï±j¡A¯u¤£§Æ±æ§Ú­Ì¤]±o¨«¨ì³o¤@¨B

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/12/13 ¤W¤È 10:49:02²Ä 1408 ½g¦^À³
¨È·à±d¦b¥xÆW¸ê¥»¥«³õ¶Ò¤£¨ì¿ú¡A¥u¦n¥h¬ü°ê¶Ò

www.businesstoday.com.tw/article/category/80401/post/201912060011/%E9%80%A38%E6%A0%B9%E8%B7%8C%E5%81%9C%EF%BC%8C%E5%86%8D%E6%8B%897%E6%A0%B9%E6%BC%B2%E5%81%9C%EF%BC%81%E9%80%99%E6%AA%94%E9%9B%B2%E9%9C%84%E9%A3%9B%E8%BB%8A%E3%80%8C%E6%96%B0%E8%97%A5%E8%82%A1%E3%80%8D%20%20%E7%99%BC%E7%94%9F%E4%BA%86%E4%BB%80%E9%BA%BC%E4%BA%8B%EF%BC%9F

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/12/9 ¤W¤È 09:23:55²Ä 1407 ½g¦^À³
²q·Q¤j¡B¦U¦ìª©¤Í¦­¡A

³Ìªñ¥Xª©ªº¨â½g¥I¶O¥«³õ³ø§i³£¦³´£¨ì¤ß®®¡A³sµ²¦p¤U

hitzdairies.com/2019/12/08/cognitive-impairment-disorders-treatment-market-is-set-to-garner-staggering-revenues-by-2018-2028/

www.businesswire.com/news/home/20191206005158/en/Dementia---Pipeline-Review-H2-2019--

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/12/8 ¤U¤È 04:48:47²Ä 1406 ½g¦^À³
12­Óªø´Á§é¿i¤Hªº°I®z¯e¯f , ¯«¸g¯e¯f¦û¦h¼Æ

www.genetinfo.com/investment/featured/item/28972.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/12/5 ¤W¤È 08:26:03²Ä 1405 ½g¦^À³
«C¤Ö¦~·R¤Wºô ®É¼Æ¶V°ª¶V¼~Æ{

2019-12-05 05:30:00

news.ltn.com.tw/news/life/paper/1336691

¡e°OªÌ§d«G»ö¡þ¥x¥_³ø¾É¡f¸³¤ó°òª÷·|¤µ¦~¥H¤j¥x¥_¦a°Ï°ê°ª¤¤Â¾¥Í¬°¹ï¶H¶i¦æ½Õ¬d¡Aµo²{¼~Æ{µ{«×¶V°ªªÌ¡A°²¤é¤WºôÁ`®É¼Æ°ª©ó¤»¤p®Éªº¤ñ¨Ò´N¶V°ª¡A¥­§¡¨C¹j¤Q¤ÀÄÁ·Q¤Wºô¤ñ¤@¤p®É¥H¤WªÌ¡A¨ä¦³©úÅã¼~Æ{±¡ºü¦Ó»Ý´M¨D±M·~¨ó§Uªº¤ñ¨Ò¤]°ª¡C±M®a»{¬°¡A«C¤Ö¦~ºô¸ô¨Ï¥Î¹L«×·|³y¦¨¨­¤ß¼vÅT¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/12/2 ¤W¤È 11:53:49²Ä 1404 ½g¦^À³
­±¹ï§íÆ{¯gªº³±Åµ , ¤HÃþ¦³¹L­þ¨Ç¾Ä°«¡H

¨Ó·½¡GÃÄ©ú±d¼w¡@2019-12-02

med.sina.com/article_detail_103_2_74851.html

«á°O

§íÆ{¯gªºµo¯f­ì¦]¤ñ§Ú­Ì¥Ø«e©Ò¤F¸Ñªº­n´_Âø±o¦h¡A¨S¦³¤@ºØ³æ¤@ªºªvÀø¤èªk¯àµ¹¨C­Ó±wªÌ±a¨Óº¡·Nªºµ²ªG¡C§Ú­Ì§Æ±æ¡AÀHµÛ¬ì¬ã¤H­û¹ï§íÆ{¯gµo¯f¾÷¨îªº¤£Â_²`¤J¬ã¨s¡A¥H¤Î¬ÛÀ³Àøªk»PÃĪ«ªº§ó·s­¡¥N¡A²×¦³¤@¤Ñ¡A§Ú­Ì¯àÀ°§U©Ò¦³§íÆ{¯g±wªÌÅX´²Å¢¸n¦bÀY³»ªº³±¶³¡A​​Åý¶§¥ú¦A¦¸·Ó¶i¥L­Ìªº¤º¤ß¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/29 ¤U¤È 08:05:51²Ä 1403 ½g¦^À³
¨jÀòCFDA¦³±ø¥ó®Ö­ãªºAD·sÃÄGV971³QÁ|³ø½×¤å³y°²

­«½S¡IÄǼݹê¦WÁ|³øªüº¸¯÷®üÀqGV971 ½×¤å³y°²¡I

¨Ó·½¡G»Z¤½­^2019-11-29

ÄÇ¼Ý ¡G ¥_¨Ê¤j¾Ç¥Í©R¬ì¾Ç¾Ç°|°|ªø¡B­º³£Âå¬ì¤j¾Ç®Õªø

med.sina.cn/article_detail_103_1_74796.html

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/28 ¤W¤È 05:21:59²Ä 1402 ½g¦^À³
¤p½T©Ê¤j

Ä@»D¨ä¸Ô±z¤U³o­Óµ²½×ªº²z¥Ñ

¥ýÁ¤F¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p½T©Ê10148065  µoªí®É¶¡:2019/11/28 ¤W¤È 12:36:10²Ä 1401 ½g¦^À³
¯u¯u°²°²¡A°²°²¯u¯u¡C

§O¤Ó´Á«Ý¤ß®®¯à±aµ¹§A­Ì¦h¤jªºÀ°§U

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GRF10147837  µoªí®É¶¡:2019/11/27 ¤U¤È 04:44:18²Ä 1400 ½g¦^À³
ÁÂÁ²q·Q¤jªº¦^ÂÐ,·PÁÂ
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/11/27 ¤U¤È 03:11:17²Ä 1399 ½g¦^À³
·PÁ²q·Q¤j¡A

¤p§Ì¹L¥h­P¹q¦h¦¸¡Aµo¨¥¤H³£«ê¥©¤£¦b¡AÁ`¬OµL½t©Mµo¨¥¤H²á¡A

³£¬O¥N²z¤H¡AÃø©Ç¤@°Ý¤T¤£ª¾¡A

¤p§Ì¥¼¨Ó·|¶Ô³Ò¨Ç¡A¦h©Mµo¨¥¤H½Ð¯q¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/27 ¤U¤È 03:07:04²Ä 1398 ½g¦^À³
¤p·ç¤j

¤£³£¬Oµo¨¥¤H¶Ü? Ãø¹DÁÙ¦³§O¤H?

¤p§Ì¤@ª½³£¥H¬°¬O¤½¥qªºµo¨¥¤H , ­YÁÙ¦³¨ä¥L¤½Ãö¤H¤h , ¤p§Ì¤]´N¤£±o¦Óª¾¤F

¹ï¤è°·½Í ¦Û«H ¸ÛÀµ , ¥æ½Í¬Æ¬O´r§Ö§r!

§Æ±æ±z¤]¸ò§Ú¤@¼Ë , ¬Û½Í¬ÆÅw!

RF ¤j

²Ó¸`´N¤£¦h»¡¤F , ¤p§Ìªº·Pı , ¤½¥qª¾¹D¥«³õ­n¬Æ»ò , ¥u¬Oê©óÁÙ¤£¦¨¼ô , ¤£¯à°ª½ÍÁï½×

¦Ó¤p§Ìªº¤ß±o(·íµM¤]¦³¥i¯à»~¸Ñ) ´N¥u¦³¤­­Ó¦r

[ ¥¿­±¦V«e¬Ý ]

¦Ü©ó±z´£ªº´Á¤¤¤ÀªR°²³]±¡ªp

Run-in (4¶g)¶¥¬qªºNaBen²Õ , ¤£ºÞ¦³µL¤ÏÀ³ , ¬O¤£¶i¤J8¶gªºÂùª¼¶¥¬q

¥u¦³¦w¼¢¾¯²ÕµL¤ÏÀ³ªº¨ü¸ÕªÌ¤~·|¶i¤J8¶gªºÂùª¼¶¥¬q

ªp¥BRun-in (4¶g)¶¥¬qªº¦³¤ÏÀ³¼Ð·Ç¬OPANSS¤À¼Æ­°´T¹F12.5%ªÌ

»P8¶gÂùª¼¶¥¬qªº¦³¤ÏÀ³¼Ð·Ç¥²¶·¬OPANSS¤À¼Æ­°´T¹F20% , ¬O¤£¦Pªº

»¡¯uªº , ¤p§Ì¤]¬O¤@­Ó¤j¥~¦æ , ¥u·|­Ê¼Ëµe¸¬Äª

¥Î¤§«e¤p§Ì´£ªº¾ãÅéÅܲ§¼Æ ( one sample variance )½Õ¾ãªk , ÁÙ¦³¨Ò¥i´`

­Y¥Î¨ä¥L¤è¦¡ , ¤p§Ì´N¤£ª¾¬O§_¯à¤£¯à³o¼ËÀ³¥Î¤F?

¥H¤W²³æ»¡©ú

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/11/27 ¤U¤È 03:04:44²Ä 1397 ½g¦^À³
»¡¨ì¥_·¥¬P¡A¦Ü¤Ö¥_·¥¬PÁÙ¦³­ì©lªÑªFÄ@·N¼W¸ê¡A

°ê¹©¤]§V¤O¸ò¬ì§Þ·~¦ÑÁó¡BÀç«Ø·~¦ÑÁó¡B¶º©±·~¦ÑÁó¶Ò¸ê¡A¬ãµoªºÃĪ«¤]¨S¦³³æÀ£¤@¶µ¡A¤]¬O¦h¶µ¨Ö¦æ¡A

¤ß®®¤µ¦~ªÑªF·|»¡¦Ò¼{¥¢´¼©Î¼~Æ{¯g­n¶i¤JÁ{§É¡A¤]¤w¸g¥b¦~¹L¤F¡A¶}©l¤F¶Ü?

¤ä«ù¤½¥q«Ü¦n¡A¦ý¬Ý¨ì¤½¥q»Ý­n¥[ªoªº¦a¤è¤]­nª½»¡¡A

¨ä¹êªÑ»ù´e¬OµL§«¡A¨S©ñ®ø®§¤]«ÜOK¡A½²¸³«Ü½ñ¹ê§C½Õ¡A¤j®a³£«ÜªY½à¡A

ÁÙ¬O§Æ±æ¤½¥q¥[ªo¡A¦­¤éÅýÃĪ«°Ý¥@¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/11/27 ¤U¤È 02:58:33²Ä 1396 ½g¦^À³
¨ä¹ê¸êª÷±q¤£¯Ê¥F¡A

¥u¬O¦³¨S¦³·Q¥Î¨ì¸Ó¥Îªº¦a¤è¡A

³s®ü¹B¡B»È¦æ³£¥i¥H®³¨ì¥H³Ð§ë¬°¦¨¥ß¥Ø¼Ð³æ¦ìªº¸êª÷¤F¡A

¤@®³³£¬O´X¤Q»õ¤¸¬°³æ¦ìªº¡A¤£¥Î¦b»XµÛ²´·úÅ@¯è¤F¡A

³o¨Ç¤½¥q®Ú¥»¸ò³Ð§ë©v¦®§è¤£¤WÃä¡A

·s¤½¥qÁö¦h¡A¦ý¯u¥¿¦³¼ç¤Oªº¦³´X®a¡A

¨C¦~·s¦¨¥ßªº¤½¥q¦ó¨ä¦h¡A

¯u¥¿­n§ë¡A·íµM¬O­n§äÁZÀuªº¼ç¤OªÑ¡A

¤£¥Î®³¨ä¥L¤£¬O¯u¥¿¼ç¤Oªº¨Ó¤ñ¡A

´N¹³°ê¤º¬Y¸¹ºÙµo®i¥Í§Þ·sÃĪº¸ô¤H¥ý¥Í¡A

¦³§ë¥Í§Þªº³£ª¾¹D­nÁ׶}¥L¡A¦]¬°¥L¥u¬O®³¥Í§Þ¬ãµo¬°¦W¨ì¥«³õ®³¸êª÷¦Ó¤w¡A

·d¤F³o»ò¦h¦~¡A¤]¨S·d¥X¤°»ò¦W°ó¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªY½à¼Æ¦r¬ü10147157  µoªí®É¶¡:2019/11/27 ¤U¤È 02:38:35²Ä 1395 ½g¦^À³
¸êª÷¯àready¡A¨º¬O®ÉªÅ­I´º¤£¦P¡A·í®É°ê¤º¥Í§ÞÁÙ¦b¯ó³Ð¡A¤½¥q¤£¦h

·|ÁܽЦ^°ê¥Øªº¬O­n·í»âÀY¦Ï¡A¬O­n·í«ü¼Ðªº

´N¹³Áܽаê¥~¤j¼t§ë¸ê¤@¼Ë¡A¤g¦a¤]¬O°t¦X¨ì©³

²{¦b·sÃĤ½¥q¦Êªá»ô©ñ¡A·íµMµLªk¹³¦­´Á¤@¼Ë

¦bÀô²y¥Í§Þ¤ë¥Z­º­¶¦³­Ó·s¾U¤½¥q¤¶²Ð

ÂI¶i¥h¦³ªñ¤»¤Q®aÅ¥³£¨SÅ¥»¡¹Lªº¥Í§Þ·s³Ð¤½¥q

³o­Ó³W¼Ò¬O¦­´Á¸êª÷readyªº®É¥N¤ñ¤£¤Wªº

¦³³o»ò¦h®a¤½¥q¡A¦pªG¨C¤@®a³£­n¤@¤d¸U¬ü¤¸¸êª÷¡A¨º¬F©²¬O­n¥X¸ê¦h¤Ö¿ú?

³oÁÙ¬OÀô²y¥Í§Þ¤ë¥Zºô¯¸¦³¤¶²Ðªº¡A¦b¨º60®a¤½¥q¤§¥~¡AÁÙ¤£ª¾¹D¦³¦h¤Ö¨S¦³¦W®ðªº¥Í§Þ·s³Ð¤½¥q......

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªY½à¼Æ¦r¬ü10147157  µoªí®É¶¡:2019/11/27 ¤U¤È 02:14:16²Ä 1394 ½g¦^À³
¥u­n¤½¥q©ñ®ø®§¤½¶}¶i«×¡A¤£©ÈªÑ»ù¤£º¦

µØ¦w¬O¤@­Ó¨Ò¤l

¥h¦~¦³©ñ®ø®§¡A¤µ¦~¤]¦³©ñ®ø®§¡A¥«³õ¡B¶i«×©M±ÂÅv³£¦³´£

¤µ¦~­n¨â­ÓÁ{§É­n±µªñ¤G´Á¸Ñª¼¤F¡AªÑ»ù¤£´Nº¦¤F¤@­¿

¦b¿³ÂdªºªYÄ£¡A³o®a¤]±`©ñ®ø®§¡A¥i¯à¬O¦]¬°10¤ëªìªº¥«³õ©M±ÂÅv¶i«×¸ê°T

ªÑ»ù¦b10¤ë16¤é-21¤é³o´X¤Ñ¡A¦³º¦¤F20%¡AÁöµM«á¨Ó¤S¶^¤F

¶h¹F¼Ú¬w±ÂÅv¥XÄl®É¤]º¦¤F¡A³s¤T®Úº¦°±¡AÁöµM²{¦b¤]¤S¶^¦^¥h¤F

¦ý¦P¼Ë­n¸Ñª¼

¨È·à±d¤@½u­GÀù©MÁx¹DÀù«e¦³©ññ¬ù±ÂÅv®ø®§¶Ü¡H§Ú¨S¦³¥ô¦ó¦L¹³¡AÁöµM³£¸Ñª¼¥¢±Ñ¤F¡C

¥_·¥¬P¤£¤]­n¸Ñª¼¤F¡A¥«³õ©Î±ÂÅv³¡¤À¤]¬OÀR®¨®¨ªº

±ÂÅvÀR®¨®¨ªÑ»ù¤]´N±ý®¶¥F¤O

³oºØ±ÂÅv°T®§¬O¥~³¡§ë¸ê¤Hµû»ù¤½¥qªº«ü¼Ð¤§¤@

¤Ó¦wÀR¡A¥~¬É®Ú¥»¤£ª¾¹D¤½¥qªº»ù­È¡A¤]¤£ª¾¹D¸gÀç¼h¦³¦b°µ¨Æ

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GRF10147837  µoªí®É¶¡:2019/11/27 ¤W¤È 10:56:52²Ä 1393 ½g¦^À³
Hi ²q·Q¤j

§Úªº·Qªk¤ñ¸û¤g¬¶¤@ÂI¡A¦pªGSND13¦b²Ä¤@¦¸Âùª¼¤H¼Æ¤ñ¬°43:141¡AµM«á¨Ì·Ó½²±Ð±Â¤§«e³X½Í³ø¾É»¡¹êÅç²Õ¥ÎÃĪº¤ÏÀ³²v«ÜÃø¶W¹L50%¡A¦w¼¢¾¯²Õªº¤ÏÀ³²v¬ù¦b30-40%¡A°²³]¦w¼¢¾¯²ÕªºÀø®Ä¬°35%¹êÅç²Õ¬°50%¡A©Ò¥Hnon-responseªº¤ñ¨Ò¤H¼ÆÀ³¸Ó¬°22:85¤H¡D¥[°_¨Ó¬ù107¤H¡A¤j·§¦û174¤Hªº¤»¦¨¡A©Ò¥Hªí¥Ü¥u¦³60%ªº¤H·|¶i¤J²Ä¤G¦¸Âùª¼(¸ò½²±Ð±Â³X½ÍÁ¿ªº¤@­P¡A¬ù·|¨ê±¼4¦¨ªº¤H)¡A¤£ª¾¹D½²±Ð±Â¦bªÑªF·|¤WÁ¿ªº¥Ø«eªº¤ÏÀ³²v²Å¦X¹w´Á¡A¬O¤£¬O«üªº´N¬O¬ù¦³¤»¦¨ªº¤H¶i¤J²Ä¤G¦¸Âùª¼?¦Ó³o­Ó¤]ªí¥Ü²Ä¤@¦¸Âùª¼ªºÁ`¤ÏÀ³²v¤j·§¸¨¦b40%¥ª¥k¡D¦Ó¶i¤J²Ä¤G¦¸Âùª¼«á¡A¥i¥Hª¾¹Dªº¬O¹êÅç¦w¼¢¾¯²Õ¤À°tªº¤ñ¨Ò¬°53¤H(22/2+85/2)¡A©Ò¥H´N¬O53:53¤H¡D¥i¥H¹w´Áªº¬O¹êÅç²Õ¸Ì¬°(11+42)¤H¡A­ì¥»ªº¨º11¤HÀ³¸ÓÁÙ¬O¤£·|¹ïNABEN²£¥Í®ÄªG¡A¦Ó¨º42¤H°²³]¦³20%ªº¤H¹ïNABEN²£¥Í¤ÏÀ³¡A©Ò¥H¬ù8­Ó¤H¡D¦Ó¦w¼¢¾¯²Õªº¤H(11+42)¡A°²³]¨º11¤H¦³20%ªº¤H²£¥Í¤ÏÀ³¡A¬ù¨â­Ó¤H¡A¦Ó­ì¥»ªº42¤HÀ³¸Ó³£¤£·|²£¥Í¤ÏÀ³(¦]¬°¥»¨Ó´N¬O¦w¼¢¾¯²ÕµL®Äªº¤H¡A¶i¤J²Ä¤G¦¸Âùª¼ÁÙ¬O¦Y¦w¼¢¾¯)¡D©Ò¥Hµ¥©ó¶i¤J²Ä¤G¦¸Âùª¼¦³¤ÏÀ³ªº¤H¬ù¬°8+2=10¤H¡A©Ò¥HÀ³¸Ó¬O¦pªG²Ä¤@¦¸Âùª¼ªº¤ÏÀ³²v¬°40%¡A¸g¹L²Ä¤G¦¸Âùª¼Á`¤ÏÀ³²v´£¤É¦Ü45%¡A¬O¤£¬O´N¤£¥Î¼W¥[¤H¼Æ¤F?ÁÙ¦³¥t¥~¤@­Ó±ø¥ó´N¬O­n²Ä¤@¦¸Âùª¼ªº¤H­n¦³¤»¦¨ªº¤H¶i¤J²Ä¤G¦¸Âùª¼¡Aªí¥Üpower¤~¦³¾÷·|¹F¨ì80%?

ÁÙ¦³¥i¥H½Ð²q·Q¤j¤À¨É¤@¤U¸ò¤½¥q²á§¹ªº¤ß±o¶Ü?ÁÙ¬O¤£¤è«K¤À¨É¤]¨SÃö«Y¡AÁÂÁ¡D

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/11/27 ¤W¤È 10:48:22²Ä 1392 ½g¦^À³
²q·Q¤j±z¦n,

·PÁ±zªºÄ_¶Q«Øij¡A

¥i§_«_¬N½Ð±Ð¡A±z©M¤½¥qÁpµ¸®É¡A³£¬O©M­þ¤@¦ìÁpµ¸¡A

»¡¹ê¦bªº¡A¤p§ÌÁpµ¸ªº¨º¤@¦ìµ¡¤f¹ê¦b¬OµLªkµ¹¤p§Ì¤Ó¦h«H¤ß¡A

¨º¤@¦ìµ¡¤f¹ï°ê¤º¥Í§Þ²£·~ªº²{ªp¤]¤£¤Ó¦³·§©À¡A

·PÁ²q·Q¤j~

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/27 ¤W¤È 10:42:50²Ä 1391 ½g¦^À³
¤p·ç¤j

«Øij±z¸ò¤½¥q²á²á , §Oåx¦b¤ß¸Ì , ¤é¤l·|¤ñ¸û¦n¹L

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/11/27 ¤W¤È 09:40:26²Ä 1390 ½g¦^À³
²q·Q¤j©M¦U¦ìª©¤Í¦n,

¤p§Ì¤ä«ù¤ß®®¡A¤]¬O¤@±i¨S½æ¡A©ú¦~ÁÙ¦³«ùÄò¼W«ùªº¥´ºâ¡A

¦ýÁÙ¬O°J¤ß´Á¬ß¤ß®®­n§V¤O¥h¶Ò¸êª÷¡A

ÁöµM·í¼é¨S¦³«Ü¥Î¤O®¼¥Í§Þ¡A¦ý¤]½T¹ê¦³³]¥ß¥Í§Þ³Ð§ë¡A¤½¥qÁÙ¬O­n§V¤O¹Á¸Õ¦UÃþºÞ¹D¶Ò¸ê(¥]¬A·í¼é³]ªº¥Í§Þ³Ð§ë)¡A

¤p§Ì¬Ý¤½¥q³o¤@¦~¦h¨Óªº°Ê§@¡A±À´ú¤½¥q¤j·§´N¬O­n¼µ¨ì SND-13¹êÅ稫§¹¸Ñª¼¡A

´Á«Ý¸Ñª¼¦¨¥\¥i¥HÀò±o±ÂÅvª÷¡A¦]¦¹¤]¤£°µ¨ä¥LÁ{§É¡A¤]¤£¿n·¥¶Ò¸ê¡A

²{¦b¤½¥q°ß¤@½äªº´N¬O SND-13¥i¥H¦¨¥\¡A¥u¶Ò¥i¥H°µ§¹ SND-13ªº¸êª÷¡A

¤½¥qºA«×¬O±¤°â¡A¦]¦¹¤£Ä@·N¥Î«K©y»ù®æ§â¨ä¥LÃĪ«±ÂÅv¥X¥h¡A¤]¤£·Q¥D°Ê©M¨ä¥L¤jÃļt¦X§@¡A

¥H¤W¯ÂÄݤp§Ì±À´ú¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/11/27 ¤W¤È 09:24:08²Ä 1389 ½g¦^À³
¼Æ¦r¤j±z¦n,

¥Ø«e·í¼éºX¤Uªº³Ð§ë½T¹ê¦³¦¨¥ß¥Í§Þ³Ð§ë¡A¤£¹L¬Û¸û©ó¨ä¥L²£·~Àò±oªº¸ê·½©M¤ä«ù¡A¥Í§Þ²£·~ÅãµM«D±`¤Ö¡A

·í¼é¦³¨S¦³¯u¤ß¤ä«ù¥Í§Þ¡A¨ä¹ê°Ý·~¬É¤ßÁn³Ì·Ç¡A

¤p§Ì¤§«e°Ñ¥[°ê¤º¬Y¥Í§Þ¤½¥qÁ`¸g²zªº³¬ªù®y½Í¡A³o¦ìÁ`¸g²z´N´£¨ì«e¼éµo®i¥Í§Þ®É¡A

«e¼é°Ê°_¨ÓÁܽЮȩ~°ê¥~ªº¥Í§Þ²£·~¸g²z¤H¦^°ê¡A§ë¸êªº¸êª÷³£¬O¤HÁÙ¨S¦^¨Ó¡A¸êª÷´N¤w¸gready¤F¡A

¤p§Ì¦b«ß®v¬É­t³d¥ø·~±¾µP©M¨ÖÁʪº¦X¹Ù¤HªB¤ÍÆ[¹î¨ì²{¦b¹ï©ó¥Í§Þ¤½¥q­n±¾µP¡A³]¤U¤@¨Ç¤º³W¡A

±q¯E¹©¸Ñª¼«e©M¸Ñª¼«á¡A¥Í§Þ·sÃĤ½¥q¤WÂd¼Æ¦r³Ì²M·¡¡A¤£¨¥¥i³ë¡C

´N¤p§Ìªº¦X¹Ù¤HªB¤Í´£¨ì¥ú¦b­»´ä¤W¥«´N­n400¸U¬ü¤¸¡A

¤ß®®³oºØ¤w¸g¸êª÷¦Yºòªº·sÃĤ½¥q¬O¤£¤Ó¥i¯à¦³¯à¤O¥hªº¡A¦ý¯E¹©¤â¤W²{ª÷ÁÙ¦³40»õ¤¸¡A¤S¦³¥úÀY­ô¤ä«ù¡A

·íµM·|·Q¿ìªk¨«¥X¥h¡A¦ý¤p§Ì¯u¤ßı±o¦pªG·íªì¤ß®®¨S¦b¥xÆW±¾µP¡A¦Ó¬O¿ï¾Ü¬ü°ê¡A©Î³\¤@¤Á¬ãµo·|§ó¶¶§Q¡A

¤£½×¤p§Ì¦³¨S¦³§ë¸ê¤ß®®¡AÁÙ¬O´Á«Ý¤ß®®¯à¶Ò¨ì§ó¦h¸êª÷¡A¦­¤é§âÃĪ«±À¨ì¥«³õ

°¾°¾¤ß®®¤w¸g¿ï¤F¥xÆW¤W¥«¡A¤]¥u¯à³Q³o¤jÀô¹Ò©ì²Ö¡AµLªkÀò±o¾A·íªºµû»ù¡A¼vÅT¶Ò¸ê¡A

¤p§Ì¨­Ãä¤]¦³¿Ë¤Í¦Aµ¥¤ß®®ªºÃÄ°Ý¥@(¹L¥h¤T¤£¤­®É¥´¥h°Ý·|¤£·|¦b¥xÆW¦¬®×¡A²{¦b¤w¸g¤£´Á«Ý¤F)¡A³Ìªñ¤]¦³¦P¨Æªø½ú½T¶Eªü¯÷®üÀq¡A

¤p§Ì¤]¬O¸ò¦P¨Æ¤À¨É¥i¥H´Á«Ý¤ß®®ªºÃĪ«°Ý¥@¡A

¦ýµ¥¤F³o»ò¦h¦~¡A¿ð¿ðµLªk¬Ý¨ì¯uªº¶i¤JÁ{§É¦¬®×¡A

²×Âk¤@¥y¡A´Á«Ý¬F©²¹ï¥Í§Þªº­«µø¬Oª±¯uªº¡A½²¸³¥[ªo¡A¤ß®®¥[ªo¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/27 ¤W¤È 08:15:52²Ä 1388 ½g¦^À³
¨C­ÓªB¤Í³£¦³±z¤ß¤¤ªºµû¦ô©M·Qªk

´N¦p¦P¨C®a·sÃĤ½¥q©Ò¬ãµoªºÃĪ«¤]¦U¦³¦Uªº¥D«ÈÆ[±ø¥ó

¤@®a¤½¥qªº¤@­ÓÃĪ«¸Ñª¼¤£¦¨¥\ , ¨Ã¤£¯à°÷¥Nªí¨ä¥L¤½¥qªºÃĪ«¤]¤£·|¦¨¥\ , ¤Ï¤§¥çµM

¬ã¨s¸ê®Æ¦ó¥Î? ·íµM¬OÀ°§U§Ú­Ì¦Û¤vµû¦ô¬Y­Ó·sÃĪº¦¨¥\²v

²{¶¥¬q¥xÆWªº¸ê¥»¥«³õ¹ï·sÃĤ½¥q¯uªº¬O¤£¤Íµ½

©Î³\´N¦p¬Y¤j¦ÑÁ¿ªº , ¨º¤Ñ¦³·sÃĤ½¥qEPSÁÈ­Ó50 , 100ªº , ¥«³õ´N·|§ïÆ[

¸Ü»¡¦^¨Ó

°²¦p±z¹ïSND-13¤£¤Ó¤F¸Ñ

½Ð®³°_¹q¸Ü©M¤½¥q²á²á , ¬Û«H±z·|¦³ÁŵM¶}®Ôªº·P¨ü

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªY½à¼Æ¦r¬ü10147157  µoªí®É¶¡:2019/11/27 ¤W¤È 12:08:08²Ä 1387 ½g¦^À³
¸É¦r

°·¥Ã2017¦~12¤ë¤½§i²×¤î¿³ÂdªÑ²¼¶R½æ¡A§Ö¨â¦~¤F¡A²{¦b®ü¥~±¾µP¦n¤F¶Ü¡H

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªY½à¼Æ¦r¬ü10147157  µoªí®É¶¡:2019/11/27 ¤W¤È 12:03:00²Ä 1386 ½g¦^À³
¬F©²¹ï¥Í§Þ¤£¤ä«ù?

¤p·ç¤j±z«e¤@½g2019/10/30

¤~»¡°ê¤º¬F©²¦¨¥ß¤F¥Í§Þ³Ð§ë

¦¨¥ß¥Í§Þ³Ð§ë¡A¤£´N¬O¬F©²¤@­Ó¤ä«ù¥Í§Þªº¨Ò¤l?

²{¦b»¡¬F©²¹ï¥Í§Þ¤£¤ä«ù?

ªÑ»ù¤£¦n´N©Ç¬F©²?

«ç»ò¤£©Ç¥«³õ¤W·sÃıµ³sªº¸Ñª¼¥¢±ÑÅý§ë¸ê¤H¹ï·sÃÄ«o¨B?

¨È·à±d¦b¬ü°êµo¦æADR¦³¦³¤ñ¸û¦n¶Ü?

¨È·à¥²´I¦³¤H¦b±·

¨º»òADRÀ³¸Ó·|®i²{À³¦³ªº¨­»ù¶¶«K©Ô©ï¥xÆWªÑ»ù¡Aµ²ªG©O?

¦M¨¹¤£¤J¡A¶Ã¨¹¤£©~

¬Ý¬Ý¡A­»´ä¶Ã¤F¦h¤[¤F

¤¤¬ü¶T©ö¾ÔÁÙ¨Sµ²§ô¡A¥¼¨Ó°ê»Ú±¡¶ÕµLªk¹w´ú

¯E¹©¬O¤l¤½¥q

¤ß®®IPO¥i¬OÀ£¨­®a

¤£­n±q¤@­Ó§|¸õ¨ì¥t¤@­Ó§|

2017¦~12¤ë¤½§i²×¤î¿³ÂdªÑ²¼¶R½æ¡A§Ö¨â¦~¤F¡A²{¦b®ü¥~±¾µP¦n¤F¶Ü¡H

¤ß®®­n®ü¥~IPOªº¸Ü¡A·d¤£¦n¸Ñª¼ÁÙ¤ñ±¾µP§Ö

¨ì®É­Ô¸Ñª¼¥¢±Ñ¡A¥[¤W¤SÁÙ¨S±¾µP¡A¨º·Q½æ³£¨S¿ìªk½æ¡A¤]¨S¦a¤è½æ¤F

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/11/26 ¤U¤È 01:00:17²Ä 1385 ½g¦^À³
¦U¦ìª©¤Í¤j®a¦n,

¬Û«H¦³§ë¸ê¤ß®®ªºªB¤Í¡A¤@©w¤£¥u§ë¸ê¤ß®®¡A¦³¨Ç¤ß¤Í¥i¯à¤]«ù¦³¯E¹©¡A

³Ìªñ¯E¹©ÄÀ¥Xªº®ø®§¬O³W¹º5¦~¤º¤j³°¤l¤½¥q­n¦b³°¡B´ä¡B¬Pªº¨ä¤¤¤§¤@¤W¥«¡A

·|¥ý±N¤j³°¤l¤½¥qÄÀªÑµ¹¤j³°§ë¸ê¤H¦A¤W¥«¡A

¯E¹©¦³¥úÀY­ô¤ä«ù¡A©|¥BÁÙ¥²¶·³z¹L¤l¤½¥qÄÀªÑ¤Î¤W¥«¨Ó¶Ò¶°¸êª÷¡A

¤ß®®¯Ê¥F¦³¤Oªº¤jªÑªF¡A«e³~¹ê¦bÁ}Ãø¡A½²¸³¥[ªo°Ú~~

¤p§Ì¹ï¯E¹©ªº³W¹º¥u¦³¨âºØ·Qªk

1.°ê¤º¹ï¥Í§Þ·sÃĤ½¥qªºµû»ù¹L§C¡A¬JµMµû»ù¦p¦¹§C¡A¦³¯à¤Oªº¤H´N¥h°ê¥~¶Ò¸ê

2.¥xÆW¹ï¥Í§Þ·~¶V¨Ó¶V¤£¤Íµ½¡A¬F©²¤]¤£¤ä«ù¡A¤j®a¥u¦n¥Î¸}§ë²¼¡A¨«¨ì®ü¥~¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/25 ¤U¤È 12:57:01²Ä 1384 ½g¦^À³
ªÑ»ù¤£º¦¨SÃö«Y

ÃÛ¦n°¨¨Bµ¥®É¾÷

ºë¯«¬ì¥ÎÃÄ¡A¤@¦Y´N¬O¤@½ú¤l¡H

www.storm.mg/amparticle/1977076

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/21 ¤W¤È 11:41:40²Ä 1383 ½g¦^À³
¥»¨Ó¬O¤£·Q½ÍªÑ»ù , ¦ý¬O¬Ý¬Ý³o®a©M¤ß®®«Ü¹³ªº¤½¥q

¤]¬O±M¬ã ºë¯«¤Àµõ , AD , ¯kµh ªº·sÃĤ½¥q , ¨S¦³À禬 , ³Ì§Öªºpipeline ¬Oºë¯«¤Àµõªº¤G´Á , ³o®a¤½¥q¥s°µ Karuna Therapeutics

pipeline : karunatx.com/programs/#pipeline

¶g¤@ Karuna ¤½¥q«Å¥¬¥¦ªºªvÀø«æ©Êºë¯«¤Àµõ¯g·sÃÄKarXT , ¹F¨ì¤G´ÁÁ{§É²×ÂI

¨â¤ÑªºªÑ»ùötº¦6­¿ ( ±q 17.68 º¦¨ì 123.99 ) , Á`¥«­È¶W¹L 29 »õ¬üª÷

www.google.com/search?q=krtx+stock+price&oq=KRTX&aqs=chrome.2.69i57j0l7.4214j0j7&sourceid=chrome&ie=UTF-8

¤ÏÆ[¤ß®®Á`¥«­ÈÁÙ¦b 1.7 »õ¬üª÷ªþªñ¥´²V

§@¬°¤ß®®ªÑªFªº§Ú­Ì , ¥²µM¬O¤£³Ó®D¼N

´Á«Ý¤½¥q¦³§Q¦h , ¦³·sÁ|±¹ , ´N¦hµo§G¤@ÂI§a , ¤£­n·í´e¸¬Äª¤F

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¶³²H­·»´10142966  µoªí®É¶¡:2019/11/11 ¤U¤È 07:20:44²Ä 1382 ½g¦^À³
°O±o¤µ¦~ªÑªF·|¦³»¡¤@¦~¤º­n¿ì²z¨p¶Ò2¸U±iªÑ²¼¡A¤w¸g§Ö¹L¥b¦~¤F¡A¦~©³«e¤£ª¾¬O§_¦³§ä¨ì·s§ë¸êªÌ¥[¤J¨p¶Ò¦æ¦C¡A¥i¥HÆ[¹î¬Ý¬Ý¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/10 ¤U¤È 05:29:52²Ä 1381 ½g¦^À³
¥L¤s¤§¥Û

2019¦~¤W¥b¦~¥þ²yÃĪ«¾P°âÃB TOP 100

¨Ó·½¡GÃÄ´ç¡@2019-11-10

­ì³Ð¡G¼Æ¾Ú¤§Án

med.sina.com/article_detail_103_2_73883.html

°ê»Ú¤W¬O«ç»ò¬Ý«Ýªüº¸¯÷®üÀq¯fÃĪ«GV-971ªº¡H

¨Ó·½¡GInsight¼Æ¾Ú®w¡@2019-11-10

­ì³Ð¡GLyuan

med.sina.com/article_detail_103_2_73880.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/4 ¤U¤È 04:33:21²Ä 1380 ½g¦^À³
<<< Your Weekly Reminder That FDA Approval and Insurance Coverage Are Often Linked >>>

By Rachel Sachs

blog.petrieflom.law.harvard.edu/2016/11/30/your-weekly-reminder-that-fda-approval-and-insurance-coverage-are-often-linked/

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/2 ¤U¤È 03:00:36²Ä 1379 ½g¦^À³
¦w¶i°h¥X¤¤¼ÏÃĪ«¡BÁp¤â¦ÊÀÙ¡G­«½SÃĪ«¼Ò¦¡¦º¤`³qª¾

¨Ó·½¡G¬ü¤¤ÃÄ·½¡@2019-11-01

med.sina.com/article_detail_100_1_73546.html

¬Q¤Ñ¡A¦w¶i«Å¥¬±N°h¥X¤¤¼Ï¯«¸gÃĪ«¬ãµo¡Bµô­û180¤H¡A¦ý»¡±N·|³q¹L¨ä¥¦¼Ò¦¡°Ñ»P³o­Ó»â°ìªº·sÃĵo²{¡C

´¿´X¦ó®É»sÃĤu·~°ª«×¨Ì¿à©Ò¿×ªº­«½SÃĪ«¡Aªí­±©w¸q¬°¦~¾P°â¶W¹L10»õ¬ü¤¸ÃĪ«¡B¦ý¦b20¦~«e¥u¦³¼sªx¨Ï¥Îªº¤j²³±`¨£¯fÃĪ«¤~¯à¹F¨ì³o¼Ëªº¾P°â·~ÁZ¡C·í¦~«Ü¦h¤H«ü³d»sÃÄ·~¹L«×Ãöª`³o¨Ç°ª§Q¼í¤j²³ÃĦө¿µøÄY­«¯ÊÂå¤ÖÃĪº¨u¨£¯e¯f¡A¦Ó¤¤¼Ï¯«¸g¬O­«½SÃĪ«ªº¥D­n²Õ¦¨³¡¤À¡C

¤¤¼Ï¯«¸gÃĪ««h¦b³o¨Ç¥D­n¨M©w¦]¯À¤W»P¸~½FÃĪ«¤j¬Û³w®x¡C°£¤F¤ä¥Iªý¤O¤j¡BÁ{§É¶}µo±¶®|¤£¦h¡A·¥¤Ö¦³³æ­Ó°ò¦]Åܲ§¥i¥H»P±`¨£¤¤¼Ï¯e¯f«Ø¥ß¦]ªGÃö«Y¡B¾Ú¦ô­p­n§ä¨ì¥ô¦ó¥i¾a¤¤¼Ï­P¯f°ò¦]³£»Ý­n¼ÆÉE¥H¤W¤j¼Ë¥»¡C¤H¸£¤Ó½ÆÂø¤S¤Ó²³æ¡C½ÆÂøªº¬O¤HÅ骺¤@¥b°ò¦]¶È¦b¤j¸£ªí¹F¡B¯«¸gºôµ¸¥\¯à½ÆÂø¨ì¦¨¬°¤H¤u´¼¯àªº²×·¥¥Ø¼Ð¡C²³æªº¬O­±¹ï¦p¦¹´_Âø¨t²Î·~¬É³Ì±j¤j¸£¤]Åã±o«D±`²³æ¡C¤£¶È¦w¶i¡A«Ü¦h¤jÃļt³£¤w¸g°h¥X¤¤¼Ï¯«¸g¡B¨S¦³°h¥Xªº¦p¦Ê°·¤]­±Á{ÄY®m¬D¾Ô¡C·íµM·sÃĤ]¤£¤@©w´N­n«ö·Ó¥D¬y¼Ò¦¡µo²{¡A§Ú­Ì¦³®É»Ý­n¨«¥XµÎ¾A°Ï¡CSage®Ú¾Ú²£°ü¥Í²£«e«á§O¥¥²m¾Jତô¥­ªi°Ê»P§íÆ{ªºÃöÁp¶}µo¤FZulresso¡A¨Ã¦¨¥\³]­p¤@­Ó¦b­«¯g§íÆ{Åã¥Ü¤G´ÁÀø®Äªº¤fªAª©Ãþ¦üª«Zuranolone¡C

·íµM¸~½F¤]¬O²{¦b³Ì¤j¥¼º¡¨¬»Ý¨D¤§¤@¡A°ò¦¬ã¨sªº¦h¦~°ª±j«×§ë¤J¤]¥O¸~½F¥Íª«¾Ç¦³¤Fªø¨¬ªº¶i®i¡A¸~½F§K¬ÌÀøªkªº¿³°_¥O§K¬Ì¾Çªº¤j¶q¦¨ªG¥i¥H¦b¸~½F»â°ìÂà¤Æ¡C¦ý¬O½èºÃ¸~½F¹L«×§ë¤JªºÁn­µ¤]¬O¦s¦bªº¡A¦p¸~½FÃĪ«¥¨ÀY¿ÕµØ¬ãµoÁ`ºÊ¥h¦~´N¤½¶}´£¥X³o­Ó°ÝÃD¡C

¤¤¼Ï¯e¯fÄY­«µ{«×³q±`³Q§C¦ô¡A³Ìªñ¹ï¦P®É±w¦³§íÆ{¡B­ý³Ý±wªÌªº¤@­Ó½Õ¬dÅã¥Ü93%¯f¤H»¡¦pªG¥u¯àªvÀø¨ä¤¤¤@­Ó·|Àu¥ý¿ï¾ÜªvÀø§íÆ{¡CSageªºCEO»¡«Ü¦h¤H«ü³dZulresso»Ý­nºwª`60¤p®É¤Ó¤£¤è«K¥»¨­´N¬O§C¦ô¤F²£«á§íÆ{ªºÄY­«©Ê¡C·sÃħë¤J¨Ã¤£Á`¬O»P¯e¯f­t¾á¦P¨B¡A¦w¶i³o¨â¤ÑªºÁ|°Ê»¡©ú¶Ç²Î­«½SÃĪ«¼Ò¦¡°ò¥»¤W¤w¸g¹Ø²×¥¿¹ì¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/11/1 ¤W¤È 08:30:53²Ä 1378 ½g¦^À³
ÁÂÁ¤p·ç¤jªº¸ê°T

¤]ÁÂÁ¤ä«ù¤ß®®ªºªB¤Í

´Á¬ß½²±Ð±Â¦h¤@¨ÇÁ{§Éªº¸ê°T¶gª¾§ë¸ê¤H

Åý§ë¸ê¤H¦³¥R¤Àªº¸ê®Æ¥h¤ÀªRµû¦ô , ¶i¦Ó°Ñ»P¤½¥qªº¶Ò¸ê

©Î³\³o¼Ë¥i¥H¥[§ÖÄw¸êªº¸}¨B , ¨Ã¥H³Ì¦³®Ä²vªº¤è¦¡¥[³t¦¬®× , ±À¶iÁ{§É

´Á«Ý!

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/10/30 ¤W¤È 11:18:49²Ä 1377 ½g¦^À³
¤ß®®ªºÃĪ«¹ê¦b¥O¤H«D±`¤ÞÀV´Á¬ß¡A¹ï§ë¸ê¤H¨Ó»¡¬O§ë¤J¦¨¥»²×©óÂର¹ê½èªº§Q±o¡A

¦ý¹ï¯f¤Í©M®aÄݨӻ¡¡A¬O±Ï©R¥P¤¦ªº¥X²{¡A

ª©¤Í¤@©w³£¬O¹ï¤ß®®ªºÃĪ«¦³«H¤ß¤~·|§ë¸ê¡A¤p§Ì¤]¬O¡A

¤ß®®¥Ø«e´N¬O¥d¦b¸êª÷¡A¥H­PµLªk±Ä¥Î²q·Q¤j«Øij¥[³t¦¬®×ªº­¹±J¸É¶K¡A

ÁÙ¬O§Æ±æ¤ß®®­n¿n·¥¶Ò¸ê¡A¦h¤èª§¨úÄ@·Nªø´Á§ë¸êªº¨p¶Ò§ë¸ê¤H¡A

¥R¹ê¤F¸êª÷¡A¤~¦³¯à¤O§âÁ{§É§¹¦¨°Ú!!!

money.udn.com/money/story/10161/4062483

°ê¤º¬F©²¤]¦¨¥ß¤F¥Í§Þ³Ð§ë¡A¤ß®®¦b¶Ò¸ê­n¥[ªo°Ú!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/10/29 ¤W¤È 08:47:13²Ä 1376 ½g¦^À³
ÁÂÁ¶³²H­·»´¤j¥i¯à¨Ó¦Û«¸µo¨¥¤Hªº°T®§¤À¨É

°²¦p2020ªÑªF±`·|«e , SND-13¤´¥¼´Á¤¤¤ÀªR , §Ú·QªÑªF·|·|©ì±o«Üªø , ¦]¬°¬ÛÃö°ÝÃD·|Åý½²±Ð±Âªá«Ü¦h®É¶¡

¦ý¬O , À³¤£¦Ü©ó¨ì¨º­Ó®É­ÔÁÙ¨S´Á¤¤¤ÀªR (174-150=24)

´Á¤¤¤ÀªRªºµ²ªG¤@¥¹¤½§G , µ¥©ó¸Ñ¶}«Ü¦h°ÝÃDªºµª®× , ¬ÛÃöijÃDÀ³·|¤Ö«Ü¦h

¦b¦¹¤p§Ì·Q«Øij¤½¥q

¬O§_´Á¤¤¤ÀªR©Ò»Ýªº174¦ì¨ü¸ÕªÌ§¹¦¨¦¬®× , ¥H­«¤j°T®§µo¥¬¶gª¾ , ÅýªÑªF­Ì¦³­ÓÃÐ , ´Á¤¤¤ÀªRªº¥i¯à®ÉÂI´N¦b3.5­Ó¤ë«á

¤£­nÅýªÑªF­Ì²@µLÀYºü¦a µ¥!µ¥!µ¥!µ¥!

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¶³²H­·»´10142966  µoªí®É¶¡:2019/10/28 ¤U¤È 09:16:32²Ä 1375 ½g¦^À³
²q·Q¤j¡A¤@¯ë·sÃÄ´Á¤¤¤ÀªRÄݩ󭫤j°T®§¡A¤@©w·|¤½§i¡Aªk»¡·|¤£¤@©w·|¶}¡A¦³Ãö¬ÛÃöºÃ¼{¡A«Øij¤j®a©ú¦~ªÑªF·|¤@©w­n°Ý²M·¡¡A³Ì¦n¥h°Ñ¥[¡A³o¬O¯à°÷§ó¤F¸Ñ¤½¥q¶i«×¬O§_²Å¦X¹w´Á¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/10/28 ¤U¤È 03:53:59²Ä 1374 ½g¦^À³
¿D¬wCADENCE-BZÁ{§É¸ÕÅ窺¼Ð·Ç§ó°Ê

ÀË´úªº¨â²Õ¥­§¡®t²§¥Ñ7¤À­°¬°5¤À , ¼Ë¥»¼Æ¥Ñ 160 ´î¬° 100

¸ÕÅç¤p²Õ¦³¸ÑÄÀ­ì¦] , ¦ý¤p§Ì¤£ª¾¨ä¨Ï¥Î¦óºØ­pºâ¤è¦¡ , ¨â²Õ¥­§¡®t²§¥Ñ7¤À­°¬°5¤À , ¼Ë¥»¼Æ¬°¦ó¥i¥Ñ 160 ´î¬° 100 ?

´Á«Ý¤j¤j­Ìªº¸Ñ»¡

www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=367929&showHistory=true&isReview=true

<<<

©Ò¦³¼Æ¾Ú±N¨Ï¥ÎSAS 9.4¶i¦æ¤ÀªR¡C§Ú­Ì±N¤ñ¸û°ò½u®É¦U²Õ¤§¶¡ªº¤H¤f²Î­p¾Ç©MÁ{§É®t²§¡]¦W¸qÅܶqªº¶OªÙº¸ºë½TÀËÅç(Fisher exact test for nominal variables)©M³sÄòÅܶqªºMann-WhitneyÀËÅç©Î¿W¥ß¼Ë¥»tÀËÅç¡^¡CÀø®Ä±N®Ú¾Ú¼Ð·ÇªºªvÀø·N¦V¡]ITT¡^¤ÀªRµ{§Ç¶i¦æµû¦ô¡]§Y¡A¹ï©ó¨º¨Ç¥¼§¹¦¨12¶g¬ã¨s´Áªº¤H¡A§Ú­Ì±N«O¯d¥L­Ì¹ï¬ã¨sµ²ªGªº³Ì«áÆ[¹î¡^¡CÁ{§Éµû¦ôªº¥­§¡ÅܤƱN¨Ï¥Î²V¦X¼Ò«¬­«½Æ´ú¶q¡]MMRM¡^¤èªk¶i¦æµû¦ô¡A¨ä¤¤ªvÀø¡A¨C©P©M¨C©PªvÀø¤§¶¡ªº¬Û¤¬§@¥Î¬°©T©w®ÄÀ³¡AÄdºI¬°°ß¤@ªºÀH¾÷®ÄÀ³¡F°ò½u­È±N¬O¨óÅܶq¡CMMRM¤ÀªR±N¨Ï¥ÎSAS PROC²V¦Xµ{§Ç¶i¦æ¡CP­È±N°ò©óÂù§ÀªºÀËÅç¡AÅãµÛ©Ê¤ô¥­¬°0.05¡C

Laneµ¥¤Hªº¬ã¨s°ò©ón=52¨ÒºC©Êºë¯«¤Àµõ¯g±wªÌ¡C13¥L­Ì³ø§i¤FCohenªº®ÄÀ³¤j¤p¡]d¡^ 1.53¡C§Ú­Ìªº±wªÌ¡]¦­´Áºë¯«¯f±wªÌ¡^ªº¥­§¡PANSSÁ`¤À¸û§C¡]65.0¡^¡A¼Ð·Ç®t¬°14.3­Ó³æ¦ì¡A¹w­p¸Ó²Õ±wªÌªºÀø®Ä·|§ó¤p¡C§Æ±æalpha­È¬°0.05¡AÀË©w¤O¬°0.8¡A§Ú­Ì§Æ±æ¯à°÷©ñ¤ß¦aÀË´ú¥X¥­§¡PANSS Totalªº®t²§¦Ü¤Ö¬°7­Ó³æ¦ì¡C¨C²Õ±N»Ý­n66¦W°Ñ»PªÌ¡]n = 132¡^¡C¦b12¶gªº®É¶¡¤º¡A§Ú­Ì¹w­p·l¯Ó²v¬°15¢H¡C¦]¦¹¡A§Ú­Ì±N»Ý­nÀH¾÷¤À°t¤j¬ù160­Ó¨ü¸ÕªÌ¡C

­ì¦]¡G

°ò©ó¨â²ÕtÀËÅ窺­ì©l¼Ë¥»¶q­pºâ±o¥X¤F160¦ì¨ü¸ÕªÌªº«O¦u¦ô­p¡C¦ý¬O¡A§Ú­Ì²{¦b§Æ±æ­×§ï¼Ë¥»¶q­pºâ¡A¥H«K¦b¬ã¨s¤è®×´Á¶¡§Q¥ÎPANSS¤À¼Æªº­«½Æµû¦ô¡C±q­Û²z¾Çªº¨¤«×¨Ó¬Ý¡A¸Óµ¦²¤¨ã¦³Àu¶Õ¡]§Y»Ý­n¶i¦æÀH¾÷¤À²Õªº±wªÌ¸û¤Ö¡A¥i¯à¥X²{ªº¤£¨}¨Æ¥ó©Î¯Ê¥FÀø®Ä¡^©M¨ã¦³¦¨¥»®Ä¯q¡]¥i¥H§ó¦­§¹¦¨¬ã¨s¡^¡C§Ú­Ìªº¤Ï½Æ¸ÕÅ窺Áa¦V©Ê½è¨Ï§Ú­Ì¯à°÷ÀË´ú¨ì¸û¤pªº®ÄÀ³¶q¡]§Y¡A¨Ï¥Î¸Ó¨óij¥ý«eª©¥»¤¤³]¸mªº14.3­Ó³æ¦ìªº¬Û¦P¼Ð·Ç°¾®t¡A¥­§¡PANSSÁ`¤À¦Ü¤Ö¬°5­Ó³æ¦ì¡^¡C°²³]¨â§ÀÀËÅ窺ÅãµÛ©Ê¤ô¥­³]¸m¬°0.05¡A¬°¤FÀË´ú¨â­ÓªvÀø²Õ¤§¶¡ªº¥­§¡PANSSÁ`¥­§¡±o¤À®t²§¦Ü¤Ö5­Ó³æ¦ì¡]SD = 14.3¡^¡A§Ú­Ì»Ý­n¨C²Õn = 39¡A¤~¯à¨Ï¬ã¨s¨ã¦³90¢Hªº¥\®Ä¡]·í°ò½u»P°ò½u¤§¶¡ªº¬ÛÃö©Ê®É¡^ÀH³X´ú¶q­È¦Ü¤Ö¬°0.6¡A¨Ã¥B¦UºØÀH³X´ú¶q­È¤§¶¡ªº¬ÛÃö©Ê³Ì¤j¬°0.5¡^¡C¦b12¶gªº®É¶¡¤º¡A§Ú­Ì¹w­p·l¯Ó²v¬°20¢H¡C¦]¦¹¡A§Ú­Ì±N»Ý­nÀH¾÷¤À°t¤j¬ù100­Ó¥DÃD¡C

©ó24/04/2018 9:14:24 AM§ó·s

>>>

¥t¥~ , ¤j®a­Y¦³³o¶µÁ{§Éªºµ²ªG , ¤]½Ð¦@¤À¨É

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/10/28 ¤W¤È 09:50:25²Ä 1373 ½g¦^À³
¬ü°ê¬ã¨s¡G«O«ù¼ÖÆ[¤ßºA , ¥i¯à¡u¯S§Oªø¹Ø¡v

¦³¤j¤jª¾¹D¶Ü ?

SND-13 ´Á¤¤¤ÀªRªºµ²ªG , ¬O­n¶}ªk»¡? ÁÙ¬O¥u¥Î­«¤j°T®§¤½§i?

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¶³²H­·»´10142966  µoªí®É¶¡:2019/10/24 ¤U¤È 06:51:36²Ä 1372 ½g¦^À³
¦~ªìªº®É­Ô¡A¤ß®®¦³±ÂÅv¤l¤½¥q³B²z¥H«á¬ÛÃö¹ï¥~±ÂÅvªº¨Æ©y¡A³o¬O¦nªº¶}©l¡A¥u¬O²{¦b¥u»D¼Ó±èÅT¡A«o¬Ý¤£¨ì¤H¡A¤µ¦~§Ö¹L¤F¡A¤½¥q¤è­±¶i®i¦p¦ó¡A¤j®a³£¦Aµ¥³£¦A²q¡A°T®§¤Ö¤§¤S¤Ö¡A¤S­nµ¥¨ì©ú¦~ªÑªF·|¤~¯à¦³®ø®§¡A§Æ±æ©ú¦~ªÑªF·|«e¦³¦n®ø®§¡A¦]¬°·sÃÄÁ{§É¶i«×¸ò±ÂÅv§ñÃöªÑªFªº«ùªÑ«H¤ß¤Î¤½¥q¥¼¨ÓªºÄvª§¤O¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/10/24 ¤U¤È 03:49:18²Ä 1371 ½g¦^À³
¤p©¯¹B¤jªº·Qªk¹ï¤½¥q¦Ó¨¥³Ì¬°¬Ù¨Æ , ¥i¥H¥u±Mª`¬ãµo

¤p§Ìªº·Qªk¬O¦]ÃĨî©y , ¹³¦³BTD¥u­n¤@­Ó¤T´Á«K¥i¥Ó½ÐÃÄÃÒ¥B¦¨¥\¸û¦³§â´¤ªº , ¤T´ÁÁ{§Éªá¶O¸û¤Öªº , Ä´¦pSND-11 ~ 13¤§ÄÝ , ¥Ñ¦Û¤v¨Ó°µ¤T´Á

²¦³º¤T´Á¦Û¤v°µ , ¤£¶È´x±±Åv¦b¦Û¤v , ¥i¥HÁקK¦p¤j¼t¤£¿n·¥©ì©µªº­·ÀI , ¥BÃÄ«~¤W¥««áªºÅv§Qª÷¬Û¹ï¸û°ª(¥i¯à®t¨ì¨â¤T­¿) , ¹ï¤ß®®³oºØ¤£¦Û¤v¦æ¾Pªº¤½¥q , ¬Û¹ï¦³§Q

©Ò¥H¤pªº¥D±i³o¨ÇÁ{§É°²¦p¥i¥Hµo©ñ¸É¶Kª÷ªº¸Ü , ¥H³o­Ó¤è¦¡¨Ó¥[§Ö¦¬®×³t«×

¨ä¥LÁ{§Éªá¶O¤j¥B¤£©ö§â´¤¦¨¥\«×ªº , °²¦p¦³¤j¼t­n±ÂÅv¦X§@ , ´N¥Ñ¥L­Ì¨Ó°õ¦æ¥H¤À´²­·ÀI

ºë¯«¤ÀµõÁ{§Éªº¦¨¥\ , µS¦p¤ß®®¥´³q¥ô·þ¤G¯ß , ¹ï¤ß®®ªº«áÄòµo®i¤Ó­«­n¤F

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2019/10/24 ¤U¤È 01:52:15²Ä 1370 ½g¦^À³
²q·Q¤j¤j...

¦pªG¥[³t¸ò¦U¤jÃļt½Í±ÂÅv...

¤×¨ä¬O¨º¨Ç¯Ê¥Fºë¯«¤Àµõ/¼~Æ{¯g/¥¢´¼¯g ¬ÛÃöÃÄ«~ªº¤jÃļt...

±ÂÅv¥X¥h«á...¥Ñ¤jÃļt¦b¦UÂå°|¤H¯ß¥h±À°Ê·|¤£·|¤ñ¸û§Ö...

·íªì¤¤ªø´Á¥Ø¼ÐÁp¦X°ê»Úª¾¦WÃļt°µ¬°¦X§@¹Ù¦ñ...¤½¥q¤]¯à§ó±Mª`©ó·sÃĶ}µo...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/10/24 ¤U¤È 01:06:23²Ä 1369 ½g¦^À³
§Ú­Ì¬O¤£¬O¥i¥H«Øij¤½¥q±Ä¯Ç¤pªº¬Q¤Ñªº´£Ä³ , ¦bªk³W½d³ò¤º , µ¹¤©°Ñ¥[Á{§É±wªÌ­¹±J¥æ³q¸É¶K , ¦ý¨¥©ú¦b°Ñ»PªÌ­Ó¤HÀH³Xµ²§ô«áµoµ¹ , ¥H´î§C°h¥X²v¨Ã¥[§Ö¦¬®×³t«×?
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2019/10/24 ¤W¤È 10:35:44²Ä 1368 ½g¦^À³
«i©¹ª½«e¤j¤jªº¨£¸Ñ«Ü¦³¹D²z...

¤£ºÞ¬Oºë¯«¤Àµõ/¼~Æ{¯g©Î¥¢´¼¯g³£¬O²{¤µ¤Î¥¼¨ÓÃe¤jªº·sÃįʤf...

¦U°ê·sÃĤ½¥q¦P®É¶¡¤]¦b¿n·¥Æp¬ã³o¨Ç»â°ìªº·sÃÄ...®É¶¡¬y³u¤U...·|¤£·|¦]¤p¥¢¤j...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¶³²H­·»´10142966  µoªí®É¶¡:2019/10/24 ¤W¤È 10:32:21²Ä 1367 ½g¦^À³
§ë¸ê¤H«ùªÑ®É¶¡ªø¡A¬O¹ï¤½¥qªº¤ä«ù¡A¦Ó¤½¥q¬O§_§ó¦]¿n·¥ªº´M¨D¥ô¦ó±ÂÅvªº¾÷·|¤~¯àÃÒ©ú²£«~ªº»ù­È¡A¦³Ãö°Ó·~¼Ò¦¡¦p¦ó¡A©Î³\·sÃĤ½¥q¦³©Ò¤£¦P¡A¦ý§ë¸ê¤H¤ÞÀV´Á¬ßªº¬O¬Ý¨ì¹ê½è©Êªº±ÂÅv¸ò¿n·¥©ÊªºÁ{§É¤~¯àÅý§ë¸ê¤H§ó¦³«H¤ßªº«ù¦³¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2019/10/24 ¤W¤È 09:00:52²Ä 1366 ½g¦^À³
¨Dª¾­Y´÷¤j, ¹ï©ó±z©Ò´£¤ÎªºªÑªF¤À¥¬ªí, ¦b¤U»{¬°¤ÀªRªÑªFµ²ºcªº·N¸q¤£¤j, ªÑªFµ²ºc¥»¨­´N¬O½ÆÂøªºÁ`¦X! ¦³¨ÇªÑªF©Î³\¤À´²¦b¤£¦P±b¤á, ¦Ó¦UªÑªF¶i³õ®É¶¡«e«á¤£¤@, ¥»¨­¸êª÷»Ý¨D½Õ«×·Qªk¤£¤@, ¦A¥[¤W³o¶¡¤½¥qªº§@­· - ÄYÂÔ§C½Õ, ¦]¦¹§Ú¤£»{¬°ªÑªFµ²ºc»P¤½¥qªº¥¼¨Ó®i±æ¦³¥¿¬ÛÃö

¦ý¬O±zÂI¨ì¤F¤@­ÓÃöÁä - ¾ú¨Ó¦¬®×/¸ÕÅç¶i«×³£¸û¹w´Á±ß

¶i«×©l²×¸¨«á¤~¬O¤½¥q³Ì¤jªº°ÝÃD, ¦b¤U«ùªÑ¤]ºâ«Üªøªº¤@¬q®É¶¡,¦ó¹Á¤£ª¾¹D¸êª÷¤~¬O³Ì¤jªº¥dÃö¦]¯À?

¦L¶H©Ò¤Î, ¦Ü¤Ö¨â³õªÑªF·|³£´£¨ì¤½¥q·|¿n·¥¶Ò¸ê, ¦ý¬O¥H¥Ø«e¦~¤¤¥u¨ì¦ì1.75»õªº¸êª÷, ¦b¤U¹ê¦b¤£À´, ¨s³º¤½¥q¬OµL¯àÁÙ¬O¤£Ä@ºÉ³t¶Ò¸ê, ¥H¥[§Ö©Ò¦³ªº¸}¨B?? ¨ä¹ê¤£ºÞ¬OµL¯à©Î¬O¤£Ä@¹ï¤½¥qªø»·¨Ó»¡¶Ë®`¤£¤p!

³o´N¹³¬OÂû¥Í³J³J¥ÍÂûªº°ÝÃD, ¶Ç»¡¤¤ªº°­«Î, ¨ì©³¬O¯u¦³°­, ÁÙ¬O¬Ý°_¨Ó¹³¦³°­, ¾É­P¤H­Ì¤£´±±µªñªº´c©Ê´`Àô, ¸ê¥»¥«³õ¥çµM

¤Þ²q·Q¤jªº¦^¤å¦p¤U:

©Î³\SND-13ªº´Á¤¤¤ÀªR­Y¼Æ¾Ú¨Î , À³¸Ó´N¦³±ÂÅv¾÷·| , ¸êª÷¥i¯à´N¤£¬O°ÝÃD

¸êª÷­Y¤£¬O°ÝÃD , Á{§É´N¦³¾÷·|¥þ­±±À¶i

¸Õ·Q¬O§_©RÄa¤@½uªºÀ£¦bSND-13ªº´Á¤¤¤ÀªR¼Æ¾Ú¨Î??? ¤Ï¤§¤S¦p¦ó? ¥H³o¼Ë¦¬®×ªº³t«×, ¸ê¥»¥«³õ·|°µ¦p¦ó·Q? °Z¤£§â¤½¥q¶V©¹¦º­J¦P¸Ì¨«? ¥¼¨Ó¶Ò¸ê¤£´N§ó¨¯­W?

¥H¤½¥q²{¦bªºpipeline, ´Nºâ¨ä¤¤¤@­Ó«~¶µ±ÂÅvªºª÷ÃB²¤§C©ó¥«³õ¦æ±¡, ¦Ü¤Ö³£¥i¥H§áÂ५³õ¹ï©ó¤½¥qªº¬Ýªk

¦A­«¥Ó¤@¦¸, ¹ï©ó¤½¥q²£«~ªº¬ì¾Ç©Ê, ¦³BTD±¾«OÃÒ, ³oÂI¯uªºµL¶·¹L«×µÛ¾¥

¦ý¬O, ¹ï©ó¤½¥qªº°Ó·~¸gÀç¯à¤O, ¯uªº¬OµLªk²z¸Ñ!

¦^ÅU2016¦~½²¸³ªº¥Í§Þ³Ð·s²£·~ªº¡u°Êª«©Ê¡v¤@¤å, ¤º¤å¤¤´£¨ì¡u°Êª«©Ê¡v«D±`²Å¦X¥Í§Þ³Ð·s²£·~¦³»ùÃҨ餧¤j´TÂ\Àú¡u°l°ª±þ§C¡v²{¶H, ¦P®É¤]´£¤Î¦P®É¸gÀÙ¦¬¯q©M¡u°Êª«©Ê¡v¤§¶¡¦³¤@­Ó¦^õX¾÷¨î¡A¥i¥H¸ÑÄÀ¤W¤UÂ\°Êªº´T«×¡A²×±N¾É­P®£·W©M«H¤ß»]µo¡A³y¦¨°I°h¡A¸gÀÙ¦M¾÷¥Ñ¦¹¦Ó¨Ó¡C

ÁöµM¦¹¤å¥D­n¥H²£·~­±¨ÓÄÄ­z, ¦ý¤]¦P¼Ë¾A¥Î¦b²{¦b³æ¤@¤½¥qªº±¡ªp, «H¤ß»]µo¤£¥¿¬O¥Ø«eµ~¹Òªº³Ì¨Î¼g·Ó¶Ü??

¦p¦óºÉ³t§áÂàÄÁÂ\ªºÂ\Àú¤è¦V, ¤~¬O¤½¥qªº·í°È¤§«æ§a? ³o¬O¦b¤U¹ï¤½¥q³Ì¤jªº½èºÃ

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¨Dª¾­Y´÷10148579  µoªí®É¶¡:2019/10/23 ¤U¤È 11:55:38²Ä 1365 ½g¦^À³
¹ï³Ìªñ¦U¦ì¥ý¶i´£¨ìªºÁ{§É¶i«×/«ùªÑ¤è­±¡A¤p§Ìı±o¡A

¥HªÑÅv¤À´²ªí¨Ó¬Ý¡A³¡¤À¤jªÑªF¦³¼W¥[«ùªÑ¡A¦ý400±i¥H¤WÁ`¤H¼Æ¤ÎÁ`«ùªÑ¦Ê¤À¤ñ¬O¤U­°ªº¡A

µLªk³æ¯Â¥H¨ä§PÂ_¤½¥qª¬ªp¬O¦n¬OÃa¡A¦]¦¹¥ý«e§Æ±æ¯àª¾¹D¦p¦ó¬d§ä¸û§Y®Éªº¸ê°T¡A

¬O¦ó¤H¡B­þ­Óªk¤H­°§C©Î¼W¥[«ùªÑ¡A°Ñ¦Ò»ù­È©Î·|¸û°ª¡C

¥t¥~³Ìªñ©Ó»X²q·Q¤j¤À¨É¸ê°T¡A¤Î¦A½¹L¥H«eªº¸ê°T¡A¤p§Ì»{¬°

SND-13¥i¯àÁÙ­n2¦~¤~¯à§¹¦¨¦¬®×¸Ñª¼(ªÑªF·|¥ç¦³´£¨ì2020-2021¸Ñª¼)¡A¾ú¨Ó¦¬®×/¸ÕÅç¶i«×³£¸û¹w´Á±ß¡A

¤p§Ì²{¦b¤£»{¬°2020´N¥i§¹¦¨¦¬®×¡A¦A¥[¤W¤ÀªR¼Æ¾Ú¦A¨ì¸Ñª¼¦Ü¤Ö­n3-4­Ó¤ë¡A¤[¤@ÂI¥b¦~³£¥i¯à¡A

¦]¦¹2021¯à§¹¦¨¸Ñª¼´Nºâ²Å¦X²{¦æ¹w´Á¤Î¦¬®×¶i«×¡A¦Ó­n»¡¦n®ø®§¡A¥i¯à¬ðµM´£«e¸Ñª¼¤~¬O¦n®ø®§¡A

¦ýÁ{®ÉªÑªF·|¤S±j½Õ¤£·|´£«e¸Ñª¼...

¦A«h¥H¨ä¥LÃĪ«Á{§É¶i«×¡A¸û¦­¶}©lªº©t¨àÃÄSND-11¤ÎSND-12¡A­pµe¦¬®×¤H¼Æ¤]³£¦³¦Ê¤H¥H¤W¡A

¥B¸ÕÅçÁÙ¤À¶¥¬q¡A­ì¥i¥H¸û¤p³W¼Ò(¦¬®×¤H¼Æ¸û¤Ö)¶i¦æªº¡A¬Ý¨Ó¤]ÁÙ­n¦Aªá¤£¤Ö®É¶¡¡A

¤p§Ì»{¬°§Ö«h¤]­n¨ì2021¦~¤F...

¦]¦¹¥¼¨Ó2¦~½T«O¸êª÷·|¬O³Ì­«­nªº¨Æ¡C

¦A½Ð¦U¦ì«ü±Ð¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/10/23 ¤U¤È 04:23:29²Ä 1364 ½g¦^À³
ADªº¥@¬ö¤j®× µ²ªG·|¦p¦ó???

www.genetinfo.com/international-news/item/31357.html

­è­è¡IBiogen«Å¥¬2020¦~ªì´£¥æªüº¸¯ý®üÀq¯f·sÃĤW¥«¥Ó½Ð

¨Ó·½¡GÂåÃÄÅ]¤è

med.sina.com/article_detail_100_2_73058.html

ªüº¸¯ý®üÀq¯f·sÃÄ°_¦º¦^¥Í¡I¥¦¬°Ô£¯àªï¨Ó¡§Åå¤Ñ°fÂࡨ¡H

¨Ó·½¡GÃÄ©ú±d¼w¡@2019-10-23

med.sina.com/article_detail_103_2_73066.html

¦Ç¦â¤¤ªº¬õÂI¡G¦Ê°·ÀÀ´£¥æAduªºBLA¥Ó½Ð

¨Ó·½¡G¬ü¤¤ÃÄ·½¡@2019-10-23

med.sina.com/article_detail_100_1_73091.html

´ñ°·ADÃĪ«aducanumab±N¥Ó½Ð¤W¥«¤½¥q¥«­È¼É¼W150»õ¬ü¤¸

¨Ó·½¡G·s®öÂåÃÄ·s»D¡@2019-10-23

½sĶ丨newborn

med.sina.com/article_detail_100_2_73109.html

´N¹³³ø¾É©ÒÅã¥Üªº

°ÝÃDªºÃöÁä¦b©ó¡A°w¹ï¤W­z¨â¶µÃöÁäIII´Á¬ã¨s¶i¦æªº¤@¶µ·sªºªø´Á¤ÀªR¡A¨äµ²ªG¾ÚºÙ¬OEMERGE¬ã¨sÀò±o¶§©Êµ²ªG¡AENGAGE¤´µM¬O³±©Êµ²ªG¡A¦Ó«e¤@¶µ¬ã¨sªº¨È²Õ¼Æ¾Ú¤ä«ù¤FEMERGE¬ã¨sªº¶§©Êµ²ªG¡C¦P¼ËªºÁ{§É³]­p «o¦³¤£¦Pªºµ²ªG¡C

FDA¦P·N¦Ê°·´£¥æ³o­ÓBLA¥Ó½Ð¡A¦ýFDA¨ì©³¤°»òºA«×¦Ê°·¨Ã¥¼¤½¶}¡C¥i¯à»¡ªº¬O¥Ó½ÐÀH«K¡B«áªG¦Û­t¡A¤]¥i¯à»¡ªº¬O¦P§Ó­Ì¨¯­W¤F¡C³Ìªñ¬ü°ê¬F©²¥[¤j¤FAD¬ã¨s¤ä«ù¤O«×¡AFDA¥i¯à¤£·Q°f¾ú¥v¼é¬y»´©ö§_©w¤@­Ó­«­n²£«~¦Ó§â²y½ðµ¹±M®a²Õ¡C¬Æ¦Ü¥i¯à©ñ¼e¼Ð·Ç§å­ã³o­Ó²£«~¤W¥«¡B¥Ñ¤ä¥I³¡ªù¨M©w¬O§_¨Ï¥Î¡A·íµM§ó¥i¯à­n¨D¦Ê°·¦A°µ¤@­Ó¤T­ÓÁ{§É¡B§@¬°¨M³Ó§½¡C

¦Óaducanumab¦pªGÀò±o§å­ã¥i¯à¦¨¬°·sªºÃĤý¡A¤]±N¦b«Ü¤jµ{«×¤W§ïÅܥͪ«»sÃĪº§ë¸ê¤è¦V¡C

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/10/23 ¤W¤È 09:30:15²Ä 1363 ½g¦^À³
«i©¹ª½«e¤j©Ò´£ªº®É¶¡¦¨¥» , ¬Û«H¤j®a³£¦³¦P·P

­Ó¤Hı±o¤ß®®¤£´±¦A¶}Á{§É , ¦b©ó¸êª÷¦]¯À

©Î³\SND-13ªº´Á¤¤¤ÀªR­Y¼Æ¾Ú¨Î , À³¸Ó´N¦³±ÂÅv¾÷·| , ¸êª÷¥i¯à´N¤£¬O°ÝÃD

¸êª÷­Y¤£¬O°ÝÃD , Á{§É´N¦³¾÷·|¥þ­±±À¶i

©Ò¥H²{¦bªº­«ÂI , ¤pªº»{¬°´N¦bSND-13ªº©Û¶Ò³t«×

¤½¥q¤w´£¥X¦]À³µ¦²¤ , §Æ±æ¥i¥H¥[§Ö¦¬®×³t«×

¦A¤£¦æ , ¥u¦n¾Ç¬Y¨Ç¤j¼t , ²½¥X¥æ³q­¹±J¸É§U , ¨C¤H5,000¬ü¤¸ , 348*0.5¸U*31 = 5,394¸U¥x¹ô

¦hªá­Ó5,394¸U¥x¹ô , ¥i¯à¸`¬Ù¤@¨â¦~ªº©Û¶Ò®É¶¡ , ´«¨Óªº¬OÃĪ«¦­¤é¤W¥« , ¦­¤é¦³À禬¨Ã³yºÖ±wªÌ , ¤@Á|¦h±o§r!

¤µ¤Ñ¦­¤W¤u°Ó®É³ø³ø¾Éªº [ ¥þ²y³Ì¶QÃĪ«½æ½ ¿ÕµØ½Õ°ª¤µ¦~°]´ú ] www.chinatimes.com/realtimenews/20191023000270-260203?chdtv

ÁõÄݤ@¦¸©Ê°ò¦]Àøªk¡A±MªùªvÀø¨u¨£ªº¥®¨à¯«¸g¦Ù¦×¯e¯fªºZolgensma¦b5¤ë©³±À¥X«á¡A¨C¦W±wªÌªº¶O¥Î°ª¹F210¸U¬ü¤¸¡]¹O6,477¸U¥x¹ô¡^¡CQ3·í©u¾P°â°ª¹F1.6»õ¬ü¤¸

»¡©ú¤F¥u­nÀø®Ä¦n , ¦A¶QªºÃij£¦³±wªÌ¨Ï¥Î

½²±Ð±Âªººâ½L¸Ó«ç»ò¥´©O?

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2019/10/23 ¤W¤È 08:41:11²Ä 1362 ½g¦^À³
¤d±i«ùªÑ¤W¶g¤]¨ì¨â¦~·s°ª...¯u¦³½ì
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/10/22 ¤U¤È 09:26:39²Ä 1361 ½g¦^À³
¬ÝµÛªÑ»ù¤S¦^¨ì­ìÂI¤F....¥xªÑ³£³Ð·s°ª¤F......
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2019/10/22 ¤U¤È 08:44:13²Ä 1360 ½g¦^À³
Axsome Theraputics:

AXS05 (Major Depressive Disorder - BTD) - P3 ongoing ¥b¦~¤º¦¬§¹¬ù300­Ó¯f±w, ¨Ã¥B§Y±N¸Ñª¼

axsometherapeuticsinc.gcs-web.com/news-releases/news-release-details/axsome-therapeutics-announces-completion-patient-enrollment-0?field_nir_news_date_value[min]=2019

Minerva Nurosciences

www.marketwatch.com/story/minervas-stock-plunges-to-lead-all-premarket-losers-after-cyber-attack-delays-enrollment-in-a-phase-3-trial-2019-10-01?siteid=yhoof2&yptr=yahoo

¤£¹L´N¬O¦]¬°Àb«È§ðÀ»¤FCRO¤½¥q, ¾É­PP3 delay ¦¬®×, ¤@¤ÑªÑ»ù¶^±¼´X¥G3¦¨

Synurex:

SNG12 Status update: Coming soon (2018/5/22 Phase 3 IND ~)

½Ð°Ýª©¤W¦³­þ¦ì¤j¤j¥i¥HÄ@·N¤À¨É¤@¤U²{¦b¨ì©³¬O¬Æ»ò±¡§Î??

¬JµM¤W¤F¿³Âd, ¦b¨É¦³¸ê¥»¥«³õ¦ñÀHªº§Q¯q, ¤]±o­t°_¹ïªÑªFªº³d¥ô, µLµø©ó®É¶¡¤]¬O¦¨¥»¦]¯Àªº¤½¥q, ²£«~¦AÀu¨q, µL©Ç¥G¥«³õµLªkµ¹¤©°ª¥«­ÈªºªÖ©w, ¥u¯à»¡³o¤@½Ò¤pªº¾Ç¨ìªº¤Ó±ß!!

¦pªG, ´Á¤¤¤ÀªRªº®É¶¡¤S¸õ²¼©O?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¥ì´Ë¦è¨È10148695  µoªí®É¶¡:2019/10/21 ¤W¤È 07:40:47²Ä 1359 ½g¦^À³
¶}µo¸£ªºÃĪ«¡A¬Ý°_¨Ó¤£¿ù¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/10/20 ¤W¤È 10:04:06²Ä 1358 ½g¦^À³
ºK¦Û jamanetwork.com/journals/jamapsychiatry/fullarticle/1746121

ªí 1

Age, mean (SD), y ==> 36.3 (7.9) , 38.4 (9.7)

No. of patients using typical/atypical antipsychotics ==> 13/14 , 14/11

¥ÎÃĤH¼Æ :

Amisulpride ==> 1 , 2

Chlorpromazine ==> 1 , 4

Flupenthixol ==> 2 , 0

Haloperidol ==> 9 , 9

Quetiapine fumarate ==> 2 , 1

Risperidone ==> 7 , 6

Sulpiride ==> 1 , 1

Ziprasidone ==> 0 , 1

Zotepine ==>¡@4 , 1

¤µ¤Ñ¦­¤W¶]¨Bªº®É­Ô¡@, ¬ðµM·Q°_½²±Ð±Âªº¤@¥y¸Ü---¦~¬ö»´ªº , ®ÄªG¤ñ¸û¦n

³o¥y¸Ü½²±Ð±Âµ¹¤F§Ú­Ì¬Æ»ò±Ò¥Ü?

µo²{³o­Ó²{¶H¬O¦brun-in¶¥¬q? ÁÙ¬O¦b[©µ¦ù]¶¥¬q?

¥H«e§Ú­Ì¤@ª½¦b·Ð´oNaBen·|¤£·|¹ï¦è¤è¤HµL®Ä

½²±Ð±Âªº³o­Ó»¡©ú , ¦b§Ú¬Ý¨Ó , °T¸¹©Î³\¤w¸g¥X¨Ó¤F , ¥u¬O¤j¤p¦p¦ó?

¤]´N¬O¤ñ¸ûªº°ò·ÇÂI---¦~¬ö¤jªÌªºÀø®Ä¨ì©³¬O¦b¨º­Ó¦ì¶¥? ©M¦w¼¢¾¯²Õ¤@¯ë(µL¤°®ÄªG)? ©ÎÁö¤£¦p2a¦ý¨ã¤@¯ë¤ô·ÇªºÀø®Ä(¤w¦³®ÄªG)?

¤£ºÞ°ò·Ç¬O¬Æ»ò , ¥i¥H½T©wªº¤@ÂI , ´N¬O¦~¬ö»´ªº¤w¦³®ÄªGÅã²{

«e­±©Òªþªº2a´Áªºªí1 : benzoate²Õªº¥­§¡¦~ÄÖ¬O 38.4 ·³ (¼Ð·Ç®t 9.7·³)

­ì¨Óªº¥ÎÃĤ]¬O¨å«¬©M«D¨å«¬ªº³£¦³ , ©Î¥i¤£¥²¦b·NÃĪ«°t¦Xªº®t²§(©Î³£¦³D2§Ü«ú§@¥Î?)

½²±Ð±Â§â¤J¿ï¦~ÄÖÁY¬° 18 ~ 45 ·³ , µL½×¬Æ»ò®É­Ô¶}©l , ¦Ü¤Ö³£ÁÙ¦³¤@¥b¼Ë¥»¬O³o­Ó¼Ð·Ç , ¤£¬O¶Ü?

¤j®aÁÙ¦³¬Æ»ò¬Ýªk©O? ´Á«Ý±zªº¸É¥R«ü¥¿

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/10/2 ¤U¤È 05:05:30²Ä 1357 ½g¦^À³
¤£Ä@·N­±¹ï¥¢´¼¡@½Ð³Æ§´1,300¸U

2019-10-02 16:52Áp¦X³ø °OªÌ½²©É¯u¢¬§Y®É³ø¾É

udn.com/news/story/7266/4081649

·s©±¯Ñ²ñÂå°|¯«¸g¤º¬ì¥D¥ô¼BijÁ¾»¡¡A¦pªG¤£Ä@·N¤Î¦­¨¾ªv¥¢´¼¯g¡A¨º³Ì¦n³Æ¦³1300¸U¤¸¦s´Ú¡C¦]¬°ªvÀø¥¢´¼¯g8¨ì10¦~¬ù²ö­nªá¶O1,300¸U¤¸¡C

¼BijÁ¾¤]¯S§O±j½Õ¡A­±Á{¥¢´¼¯g³Ì­«­nªº¬O¡u¹w¨¾³Ó©óªvÀø¡v¡A²Ä¤@­«­n±±¨îºC©Ê¯f¡B¦A¨Ó¬O­n¹B°Ê¡Bª`­«¶¼­¹(¦h¦a¤¤®ü¶¼­¹¡B¦h½­ªG¡B¤Öªo¬µ¤Ö¤Î¤H¤u­¹«~)¡B¦hªÀ¥æ¤]¬O¥¢´¼¯g¹w¨¾ªº­«­nµ¦²¤¡C

¦b¥²´Iºô¦h¦h«¢°Õ , ¤£ª¾¹D¬O§_¤]¬O¤@ºØ¹w¨¾µ¦²¤ ?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/9/29 ¤W¤È 09:42:57²Ä 1356 ½g¦^À³
¶}®Ô¤Ö¤k¤@¤i¶¡µS¦p¬¡«Í ¦o¿©±w¨u¨£ªº§ÜNMDA¨üÅ鸣ª¢

2019-09-29 09:28Áp¦X³ø °OªÌù¯u¢¬§Y®É³ø¾É

udn.com/news/story/7266/4074950?from=udn_ch1cate0_pulldownmenu

¤¤°êÂåÃĤj¾Çªþ³]Âå°|ºë¯«Âå¾Ç³¡¥DªvÂå®v¨¦¤j¬°ªí¥Ü¡A§ÜNMDA¨üÅ鸣ª¢¡]Anti-NMDA receptor encephalitis¡^¬O2008¦~¤~³Qµo²{ªº¯e¯f¡A­P¯f­ì¦]¤£§¹¥þ²M·¡¡A¥i¯à¦]¤£©ú¯f¬r·P¬V©Î¸¡µÄ¸~½F»¤µoNMDA§ÜÅé¡A¾É­P±wªÌ¸£¤¤ªºNMDA¨üÅé³Q«ú§Ü¡B¯«¸g°T¸¹¶Ç¾É¥X²{°ÝÃD¡A¦]¦Ó¥X²{¦k·Q¡B¤Ûı¡B»{ª¾¥\¯à°h¤Æ¡B°Ê§@»Ùê¡BÅöíwµ¥¯gª¬¡C

³o¨Ç¯gª¬Ãþ¦ü«äı¥¢½Õ¯g¡A¦ý«äı¥¢½Õ¯g¶i®i¸û½wºC¡A¦Ó³o­Ó¯e¯fªº¯fµ{«hÅܤƧֳt¡A¸g±`Åý©P¾D¤H·P¨ì±wªÌ¡u¤@¤i¶¡§¹¥þÅܤF­Ó¤H¡v¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/9/23 ¤W¤È 08:51:11²Ä 1355 ½g¦^À³
¥_°ê¤§¹ÒªººÆ¨g´d¼@¡G±q­h«Ý¨ì¾Ö©ê¡A·ç¨åºë¯«¯f°|ªvÀø¥v

global.udn.com/global_vision/story/8664/3959503

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GYOYO10140343  µoªí®É¶¡:2019/9/20 ¤W¤È 09:16:53²Ä 1354 ½g¦^À³
±ÂÅv§Q¦hÀ³¸Ó§Ö¦³®ø®§¤F,³o¬Ý°_¨Ó¬O¤@­Ó¥ý¦æ«ü¼Ð
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/9/20 ¤W¤È 07:14:11²Ä 1353 ½g¦^À³
¨Ñ¤j®a°Ñ¦Ò..........

=====================================================

1.¨Æ¹êµo¥Í¤é:108/09/19

2.¤½¥q¦WºÙ:SyneuRx Neuroscience

3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©ÎÁpÄݤ½¥q):SyneuRx Neuroscience¤½¥q¬°¥»¤½¥qÃö«Y

¥ø·~¤§¥S§Ì¤½¥q¡A­t³d¤H§d¶®¬Â¤k¤h¬°¥»¤½¥q¸³¨Æªø¤§°t°¸¡C

4.¬Û¤¬«ùªÑ¤ñ¨Ò(­Y«e¶µ¬°¥»¤½¥q¡A½Ð¶ñ¤£¾A¥Î):¤£¾A¥Î¡C

5.µo¥Í½t¥Ñ:

1.¥»¤½¥q©ó108¦~2¤ë27ªÑªF·|¨Mij³q¹L¤Î108¦~3¤ë18¤é¸³¨Æ·|¨Mij³q¹Lñ­q±M§QÅv

±ÂÅv¦X¬ù®×¡C

2.¬°¥[±j«O»Ù¥»¤½¥q¥H¤Î¤½¥qªÑªF¤§Åv¯q¡A¥»¤½¥q»PSyneuRx Neuroscienceñ­q±M

§QÅv±ÂÅv¦X¬ùªþ¿ý¡A°£­ì¦X¬ùªk«ß¤W¤§«O¥þ¥~¡A·s¼WSyneuRx Neuroscience¦p¹H¤Ï

±M§Q±ÂÅv¦X¬ù¤§Ãg»@©Ê±ø´Ú¤Î»PSyneuRx Neuroscience³]¥ßÁp¦W±b¤á¡AÂÇ¥H«O»Ù¦A

±ÂÅv¤§¸gÀÙ§Q¯qªð¦^¥»¤½¥q¡C

6.¦]À³±¹¬I:µL¡C

7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:

1.­ì¦X¬ù¤½§i¤º®e½Ð°Ñ°u108/03/18¡u¥»¤½¥q¸³¨Æ·|¨Mijñ­q±M§QÅv±ÂÅv¦X¬ù®×¡v

¤§­«¤j°T®§¡C

2.­ì¦X¬ù¦CSyneuRx Neuroscience¤§¤l¤½¥q¡GSYNEURX LIFESCIENCE¡ASYNEURX

LIFESCIENCE US INC¡ASYNEURX NEUROSCIENCE HK LIMITED¤Î¤ß¼Ö¥ÍÂ妳­­¤½¥q¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/9/17 ¤U¤È 03:59:37²Ä 1352 ½g¦^À³
¤W«h³ø¾Éªº½×¤å

Habitual tea drinking modulates brain efficiency: evidence from brain connectivity evaluation

²ßºD©Ê¶¼¯ù½Õ¸`¤j¸£®Ä²v¡G¨Ó¦Û¤j¸£³s³q©Êµû¦ôªºÃÒ¾Ú

§@ªÌ :

Junhua Li 1, 2, 3 , Rafael Romero-Garcia 4 , John Suckling 4 , Lei Feng 5

1 Laboratory for Brain-Bionic Intelligence and Computational Neuroscience, Wuyi University, Jiangmen, China

2 Centre for Life Sciences, National University of Singapore, Singapore

3 School of Computer Science and Electronic Engineering, University of Essex, Colchester, United Kingdom

4 Brain Mapping Unit, Department of Psychiatry, University of Cambridge, Herchel Smith for Brain and Mind Sciences, Cambridge, United Kingdom

5 Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

www.aging-us.com/article/102023/text

In summary, our study comprehensively investigated the effects of tea drinking on brain connectivity at both global and regional scales using multi-modal imaging data (i.e., functional and structural imaging) and provided the first compelling evidence that tea drinking positively contributes to brain structure making network organization more efficient. Our study suggests that tea drinking is effective in preventing (slowing) or ameliorating cognitive decline and that tea drinking might be a simple lifestyle choice that benefits brain health.

Á`¤§¡A§Ú­Ìªº¬ã¨s¨Ï¥Î¦h¼ÒºA¦¨¹³¼Æ¾Ú¡]§Y¥\¯à©Mµ²ºc¦¨¹³¡^§¹¥þ¦a½Õ¬d¤F¶¼¯ù¹ï¥þ­±©M°Ï°ì¤Ø«×¤j¸£³s³q©Êªº¼vÅT¡A¨Ã´£¨Ñ¤F²Ä¤@­Ó¥O¤H«HªAªºÃÒ¾Ú¡A§Y¶¼¯ù¹ï¤j¸£µ²ºc¥¿­±ªº§@¥Î , ¨Ï±oºôµ¸²Õ´§ó¦³®Ä²v¡C§Ú­Ìªº¬ã¨sªí©ú¡A¶¼¯ù¦³®Ä¹w¨¾¡]´î½w¡^©Î§ïµ½»{ª¾¯à¤Oªº¤U­°¡A¶¼¯ù¥i¯à¬O¤@ºØ¦³¯q©ó¤j¸£°·±dªºÂ²³æ¥Í¬¡¤è¦¡¿ï¾Ü¡C

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/9/17 ¤W¤È 11:54:13²Ä 1351 ½g¦^À³
¸£¯«¸gºô¸ô¬ã¨sµo²{ ³Ü¯ù¥i§ïµ½¤j¸£»{ª¾¯à¤O

2019-09-17 09:54¬ì§Þ·s³ø

udn.com/news/story/6897/4050379

¯ù¤¤¦³¨S¦³§t³æ¹ç»Ä ?

§O¥ú¥uª¾¹D¯ù¦h×ô¡B©@°ØÆPªº¡A¤H®a³æ¹ç»Ä¤]¬O¤@¤j©@¡I

­ì¤åºô§}¡Gkknews.cc/health/3m4obo.html

¯ù¸­¤¤ªº³æ¹ç»Ä¦b¬õ¯ù¤¤ªº§t¶q¬ù¬°5%¡Aºñ¯ù¤¤¬ù¬°10%¬O¦Ê¬ì¤¤³Ì¬°±`¨£ªº¤ñ¨Ò¤ÀªR

³æ¹ç»Äªº§@¥Î¶°¤¤ªí²{¦b¦¬ÀÄ©Ê¡]¥i¨Ï²Ê¤jªº¤ò¤Õ¦¬ÁY¡BºòÁ^¦Ó´î¤Ö½K¯¾¡^¡B²M°£¦Û¥Ñ°ò¡]«P¶i·s³¯¥NÁ¡A«O«ù¥Ö½§¬¡¤O¡^¡B­°§CÁx©T¾J¡B¨¾¤î¯×ªÕ¦b¦åºÞ¤¤°ï¿n¡A¦P®É¤]·|³y¦¨­G²Gµ}ÄÀ¡A¤£¯à¥¿±`®ø¤Æ¡Bªýê¤HÅé¹ïÅKªº§l¦¬¡C

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/9/17 ¤W¤È 11:32:31²Ä 1350 ½g¦^À³
ÅnÀò­º´Ú³Ð·sµ¹ÃÄ«¬°¾ÀYµhÀøªk , ¤¦³ÁÆF¥_ ( Lundbeck ) 19.5»õ¬ü¤¸¦¬ÁÊAlder

¨Ó·½¡GÃÄ©ú±d¼w¡@2019-09-17

med.sina.com/article_detail_103_2_71635.html

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/9/9 ¤W¤È 11:45:56²Ä 1349 ½g¦^À³
­ì¥»¥H¬° FDA ªº[¦A¥ÍÂå¾Ç¥ý¶iÀøªk»{©w]( regenerative medicine advanced therapy ) (RMAT)¤ñ BTD ÁÙ±j

³Ì¥D­nÁÙ¬O¦WºÙ¤Ó§l·ú

­ì¨Ó¤£¬O

¤Ï¦Ó¬O BTD ¤ñ RMAT ÁÙ±j

ÃĪ«¦pªG²Å¦X¥H¤U±ø¥ó¦³¸ê®æÀò±oRMAT«ü©w¡G¡]i¡^¸ÓÃĪ«¬O¦A¥ÍÂå¾ÇÀøªk; ¡]ii¡^¸ÓÃĪ«¦®¦bªvÀø¡A§ïÅÜ¡A°fÂà©Îªv·UÄY­«©Î¦M¤Î¥Í©Rªº¯e¯f©Î¯f¯g; ¡]iii¡^ªì¨BÁ{§ÉÃÒ¾Úªí©ú¸ÓÃĪ«¦³¥i¯à¸Ñ¨M¦¹Ãþ¯e¯f©Î​​¯f¯g¥¼º¡¨¬ªºÂåÀø»Ý¨D¡C

¤j­P¤W , RMAT Àò±oªº¦n³B©M BTD ¬Û·í

¦ý¬O , RMAT Àò¨úªº±ø¥ó¸û¼eÃP

²¦³º , RMAT ªº¨ú±o , ¶È­n¨D¸ÓÀøªk¨ã¦³¸Ñ¨M¥¼³Qº¡¨¬ÂåÀø»â°ìªº¼ç¤O

¦ý BTD «h¥²¶·ÃÒ©ú¸Ó²£«~¬Û¹ï©ó²{¦³Àøªk , ¥i¥H´£¨Ñ¹ê½è©Êªº§ïµ½

www.genetinfo.com/investment/featured/item/26626.html

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GYOYO10140343  µoªí®É¶¡:2019/9/3 ¤W¤È 09:38:25²Ä 1348 ½g¦^À³
¤ß®®¦¹½g¤½§i¥i¥H¸ÑŪ«Ü¦h­«ÂI:

D.¤w§ë¤J¤§²Ö¿n¬ãµo¶O¥Î¡G¬°«O»Ù¤½¥q¤Î§ë¸ê¤HÅv¯q¡AÁקK¼vÅT¥¼¨Ó°ê»Ú±ÂÅv½Í§P¡A¤£¤©¤½¶}´¦ÅS¡C

¸ÑŪ:±qÀ禬¤Î¥«³õ¨¤«×¨Ó¬Ý¸ÑŪ:¤£¥u¦¹SND-51,¥]¬ASND-13,SND-12©ÎSND-11¥i¯àÀH®É¦³±ÂÅv§Q¦h,¥B¬°«O»Ù§ë¸ê¤HÅv¯q,±ÂÅv¬Ý°_¨Ó¤£¬O¬°±ÂÅv¦Ó±ÂÅv,À³·|Åý¤½¥q§Q¯q³Ì¤j¤Æ;

C.¤w³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥iªÌ¡A¥¼¨Ó¸gÀç¤è¦V¡G±N¨Ì¸ÕÅç­pµe©ó¬ü°ê¡B¤¤°ê¤j³°¡B¼Ú¬w¡B¥[®³¤j¡B¥xÆWµ¥¦a¿ï¾Ü¶i¦æÁ{§É¤G´Á¸ÕÅç¡C

¸ÑŪ:¦¬®×¤H¼Æ¤w±q¬ü°ê©Ý®i¦Ü¥þ²y¥D­n°ê®a,·|¥[§Ö¦¬®×¤H¼Æ

(6)¥«³õ²{ªp:

¥¢´¼¯g¤Î¨Öµoºë¯«²§±`¬O·¥«×ÄY­«¥¼Àòº¡¨¬ªºÂåÀø»â°ì¡A¯f±w¤H¼ÆÃe¤j«o¤SµLÃÄ¥iÂå

­ì®ÆÁö¨Ó¦Û¤ÑµM¬É¡AµM¥»¤½¥q¦Û¦æ¶}µo¨Ã´x´¤¯Â¤Æ¡B¦X¦¨¡B»s¾¯µ¥§Þ³N¤Î¦h¶µ±M§Q¡A¤G´ÁÁ{§É¸ÕÅç³\¥i¥H¤Æ¾ÇÃÄ¡B¨Ã«D´Óª«Ãĥӽгq¹L¡C°£¤FGMP»s¾¯¥H¦Û¦³§Þ³N²¾Âà©e¥~¥Í²£¡A¥»¤½¥q¤ÎÃö«Y¥ø·~ SyneuRx Lifescience US Inc.¿W¤O§¹¦¨©Ò¦³ªº¸ÕÅç¤ÎeCTD IND°e¥ó¡A¬O°ê¤º²Ä¤@®a¤£»ÝCRO¡A¨ã³Æ§Þ³N¯à¤O¡B¦Û¦æ°e¥ó¬ü°êFDAªº·sÃĤ½¥q¡C

¸ÑŪ:¦¹Ãļç¤O°ª(µLÃÄ¥iÂå),¥B¤½¥q«Ø¥ß¦Û¦æ°e¥ó¯à¤O,¹ï¤½¥qÄvª§¤O¤Î费¥Î±±¨î¬Ò¥¿­±¬Ý«Ý

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GYOYO10140343  µoªí®É¶¡:2019/9/3 ¤W¤È 09:19:53²Ä 1347 ½g¦^À³
¤½¶}¸ê°TÆ[´ú¯¸­«¤j°T®§¤½§i

(6575)¤ß®®¤½§i¥»¤½¥q¬ãµo¤¤¤§¥¢´¼¤Î¨Öµoºë¯«²§±`ªvÀø·sÃÄSND51(Tannquilynne)¡A³q¹L¬ü°ê­¹«~ÃĪ«ºÞ²z§½(FDA)¤§·sÃÄÁ{§É¸ÕÅç(IND)¼f§å¡B®Ö­ã°õ¦æ¤G´Á¤HÅéÁ{§É¸ÕÅç

1.¨Æ¹êµo¥Í¤é:108/09/02

2.¤½¥q¦WºÙ:¤ß®®¥ÍÂåªÑ¥÷¦³­­¤½¥q

3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©ÎÁpÄݤ½¥q):¥»¤½¥q

4.¬Û¤¬«ùªÑ¤ñ¨Ò(­Y«e¶µ¬°¥»¤½¥q¡A½Ð¶ñ¤£¾A¥Î):¤£¾A¥Î

5.µo¥Í½t¥Ñ:

¥»¤½¥q¬ãµo¤¤¤§¥¢´¼¯g¤Î¨Öµoºë¯«²§±`ªvÀø·sÃÄSND51 (Tannquilynne)¡A³q¹L¬ü°ê­¹«~ÃĪ«ºÞ²z§½(FDA)¤§·sÃÄÁ{§É¸ÕÅç(IND)¼f§å¡B®Ö­ã°õ¦æ¤G´Á¤HÅéÁ{§É¸ÕÅç¡C

(1)¬ãµo¤¤·sÃĦWºÙ©Î¥N¸¹¡GSND51 (Tannquilynne)¡A¥¢´¼¯g¤Î¨Öµoºë¯«²§±`·sÃÄ¡C

(2)¥Î³~¡GªvÀø¥¢´¼¯g¤Î¨Öµoºë¯«²§±`¡C

(3)¹w­p¶i¦æ¤§©Ò¦³¬ãµo¶¥¬q¡G¤G´Á¤HÅéÁ{§É¸ÕÅç¡C

(4)¥Ø«e¶i¦æ¤¤¤§¬ãµo¶¥¬q¡G

A.´£¥X¥Ó½Ð/³q¹L®Ö­ã/¤£³q¹L®Ö­ã¡G¥¢´¼¯g¤Î¨Öµoºë¯«²§±`ªvÀø·sÃÄSND51(Tannquilynne) ¡B¤G´Á¤HÅéÁ{§É¸ÕÅçÀò®Ö­ã¡C

B.¥¼³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥iªÌ¡A¤½¥q©Ò­±Á{¤§­·ÀI¤Î¦]À³±¹¬I¡G¤£¾A¥Î¡C

C.¤w³q¹L¥Øªº¨Æ·~¥DºÞ¾÷Ãö³\¥iªÌ¡A¥¼¨Ó¸gÀç¤è¦V¡G±N¨Ì¸ÕÅç­pµe©ó¬ü°ê¡B¤¤°ê¤j³°¡B¼Ú¬w¡B¥[®³¤j¡B¥xÆWµ¥¦a¿ï¾Ü¶i¦æÁ{§É¤G´Á¸ÕÅç¡C

D.¤w§ë¤J¤§²Ö¿n¬ãµo¶O¥Î¡G¬°«O»Ù¤½¥q¤Î§ë¸ê¤HÅv¯q¡AÁקK¼vÅT¥¼¨Ó°ê»Ú±ÂÅv½Í§P¡A¤£¤©¤½¶}´¦ÅS¡C

(5)±N¦A¶i¦æ¤§¤U¤@¬ãµo¶¥¬q¡G±N®Ú¾Ú¥»´ÁÁ{§É¸ÕÅçµ²ªG¨M©w¦p¦ó¶i¦æ¡C

A.¹w­p§¹¦¨®É¶¡¡G¹w­p2021-2022¦~§¹¦¨ªì¨B¦¬®×¡A±©¹ê»Ú®Éµ{±N¨Ì°õ¦æ¶i«×¨M©w¬O§_½Õ¾ã¡C

B.¹w­pÀ³­t¾á¤§¸q°È¡GµL¡C

(6)¥«³õ²{ªp¡G¥¢´¼¯g¤Î¨Öµoºë¯«²§±`¬O·¥«×ÄY­«¥¼Àòº¡¨¬ªºÂåÀø»â°ì¡A¯f±w¤H¼ÆÃe¤j«o¤SµLÃÄ¥iÂå¡A¼ç¦bªºÃĪ«¥«³õ³W¼ÒÃø¥H½T¤Á¦ôºâ¡C2018¦~¥þ²y¥¢´¼¤H¤f±À¦ô¦³5000¸U¤H¡A¦ýÀHµÛ¤HÃþ¥­§¡¹Ø©R¤£Â_©µªø¡A¥¢´¼¯g¤H¼Æ±N«æÁØÃk¤É¡A¥Bªñ¥b¥¢´¼¯g±wªÌ¦ñÀHºë¯«¦æ¬°²§±`¯gª¬ (Behavioral and psychological symptoms of dementia¡A²ºÙºë¯«²§±`¡ABPSD)¡A¨Ò¦p¦k·Q¡B¤Ûı¡B¿ù»{¡Bļ°Ê¡B¼É¤O¡B¼~Æ{µ¥¡A§ó¬O¥[­«®a®x¤ÎªÀ·|¤§·ÓÅ@­t¾á¡CµM¦Ó¹ïBPSD¥Ø«e©|µL®Ö­ã¤§ÃĪ«¡AÁ{§É¤W¦h¥H¥é³æ¥~¨Ï¥Î(off-label use)§Üºë¯«¯fÃĪ«¡A¨ä«o¦³´£°ª¦º¤`²v¥H¤Î¼W¥[¤ß¦åºÞ¦h¶µ°Æ§@¥Î¤§­·ÀI¡AFDA¦b2008¦~µo¥¬¥þ­±Äµ§i (blackbox warning) ¨Ï¥Î§Üºë¯«¯fÃĪ«¦b¦Ñ¦~¥¢´¼¯g±Ú¸s¼W¥[¦º¤`²v¡A¥i»¡¬O³·¤W¥[Á÷¡Cªü¯÷®üÀq¥¢´¼¯g¨Ã«D³æ¤@¾÷Âà¯e¯f¡ASND51°£¤F§í¨î¥k±ÛÓi°ò»Ä®ñ¤Æ¨»¨C(»Ã¯À)(D-amino acid oxidase¡ADAAO)¡A¥H´£°ª¥k±Ûµ·Ói»Ä¿@«×¡A¬¡¤Æ¤j¸£NMDA¨t²Îªº¥\¯à¡A¬O·s¾÷Âà·sÃÄ¡C¤£¥u©ó¦¹¡AÁÙ¥i¥H«ú§ÜÃþ¾ý¯»¡Btau ³J¥Õ¨H¾ý¡A¨ã¦³§Ü®ñ¤Æ¡B§Üµoª¢¡A§í¨î¤AñQÁxÆPà­¨»¨C(»Ã¯À)ªº¦h­«­«­n¾÷¨î¡C¥»¤½¥q¦­¥ý³z¹LSND14ªºªì¨B¤HÅéÁ{§É¸ÕÅçÃÒ©ú¡A§í¨îDAAO¥i«ì´_»´«×¥¢´¼¯g±wªÌ¤§»{ª¾¥\¯à¡A¦b¦¹°ò¦¤W¥»¤½¥q¥ø¹Ï¬°§ó´Æ¤âªº¥¢´¼¯g¨Öµoºë¯«²§±`¡A¶}µo¥X§ó¦³®Äªº¦h¾÷Âà³æ¤@ÃĪ«ªvÀø¡C

SND51­ì®ÆÁö¨Ó¦Û¤ÑµM¬É¡AµM¥»¤½¥q¦Û¦æ¶}µo¨Ã´x´¤¯Â¤Æ¡B¦X¦¨¡B»s¾¯µ¥§Þ³N¤Î¦h¶µ±M§Q¡A¤G´ÁÁ{§É¸ÕÅç³\¥i¥H¤Æ¾ÇÃÄ¡B¨Ã«D´Óª«Ãĥӽгq¹L¡C°£¤FGMP»s¾¯¥H¦Û¦³§Þ³N²¾Âà©e¥~¥Í²£¡A¥»¤½¥q¤ÎÃö«Y¥ø·~ SyneuRx Lifescience US Inc.¿W¤O§¹¦¨©Ò¦³ªº¸ÕÅç¤ÎeCTD IND°e¥ó¡A¬O°ê¤º²Ä¤@®a¤£»ÝCRO¡A¨ã³Æ§Þ³N¯à¤O¡B¦Û¦æ°e¥ó¬ü°êFDAªº·sÃĤ½¥q¡C

6.¦]À³±¹¬I:µL

7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:·sÃĶ}µo®Éµ{ªø¡B§ë¤J¸g¶O°ª¥B¨Ã¥¼«OÃÒ¤@©w¯à¦¨¥\¡A¦¹µ¥¥i¯à¨Ï§ë¸ê­±Á{­·ÀI¡A§ë¸ê¤HÀ³¼f·V§PÂ_ÂÔ·V§ë¸ê¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/9/2 ¤W¤È 07:57:15²Ä 1346 ½g¦^À³
±M®aÆ[ÂI¡þ¤j³°³Ð·sÃÄ°Ó¾÷ §L®a¥²ª§

2019-09-01 22:40¸gÀÙ¤é³ø ±iÁl¤¤

udn.com/news/story/7485/4023074?from=udn-catelistnews_ch2

¤¤°ê¤j³°8¤ë¤U¦¯³q¹L·sª©¡m¤¤µØ¤H¥Á¦@©M°êÃÄ«~ºÞ²zªk¡n(²ºÙÃĺުk)¡A±N©ó¤µ¡]2019¡^¦~12¤ë1¤é¶}©l¬I¦æ¡C³o¶µ­×¥¿«áªºÃÄ«~®Ú¥»¤jªk¡A±N¥D¾É¤¤°ê¥¼¨Ó¤Q¦~ªºÃÄ«~µo®i¡C­±¹ï³o¥þ²y²Ä¤G¤j¡A¨C¦~¶W¹L¤H¥Á¹ô1.7¥ü¤¸ªº¥¨¤j¥«³õ¡A³o¦¸¤j­×ªk²£¥Íªº·s§½­±¡A±N¼vÅT¥þ²yÃÄ«~ªºµo®i¡A¤]­È±o¥xÆW¥Í§ÞÂåÃIJ£·~Ãöª`¡C

...

¦P®É¡A²Ä15±ø¡u°ê®a¤ä´©¥HÁ{§É»ù­È¬°¾É¦V¡B¹ï¤HÅé¯e¯f¨ã¦³©ú½T©ÎªÌ¯S®íÀø®ÄªºÃĪ«³Ð·s¡A¹ªÀy¨ã¦³·sªºªvÀø¾÷²z¡B¹ï¤HÅé¨ã¦³¦h¹v¦V¨t²Î©Ê½Õ¸`¤z¹w¥\¯àµ¥ªº·sÃĬã»s¡v¡A»P²Ä23±ø¡u¹ïªvÀøÄY­«¦M¤Î¥Í©R¥B©|µL¦³®ÄªvÀø¤â¬qªº¯e¯f¥H¤Î¤½¦@½Ã¥Í¤è­±«æ»ÝªºÃĪ«¡A¤¤´ÁÁ{§É¸ÕÅç¤w¦³¸ê®ÆÅã¥ÜÀø®Ä¨Ã¯à¹w´ú¨äÁ{§É»ù­Èªº¡A¥i¥Hªþ±ø¥ó§å­ã¡C¡v³o¨â±ø¤åµLºÃ¬°³Ð·sÃĪ«¤j¶}¤è«K¤§ªù¡C

¤ß®®®³¨ìFDA BTDªº¸ÕÅ礤·sÃÄ ¡A¥i¤£¥i¥HÀò¦¹Àu«Ý ¡A´£¦­¶i¤J¤¤°ê¤j³°¥«³õ ?

???

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/8/29 ¤W¤È 11:41:34²Ä 1345 ½g¦^À³
¹ù¥S¦C¤F´X­Óºô§} , ´£¨Ñµ¹¤j®aÂsÄýSCZ±wªÌªA¥Î¤ß®®µo®i¤¤·sÃĪº¤@¨Ç¸gÅç

<<<

¦³½ìªºSCZ½×¾Â»P§{¶¡¸gÅç

>>>

liawbf.pixnet.net/blog/post/49092320

«¢!¤j®a¬Ý¤F ¤£ª¾·|¤£·|¦³ÅåÆA¤§³B?

ÁÂÁ¹ù¥Sªº¤À¨É

¦P®É , ¬O§_¥i½Ð¹ù¥S¥´¶}³sµ² , ¥H¤è«K¤j®a«e©¹ªY½à

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/8/27 ¤W¤È 10:53:45²Ä 1344 ½g¦^À³
·s»D¦@½à (2019¦~8¤ë26¤é)

Amgen±N¥H134»õ¬ü¤¸²{ª÷¦¬ÁÊOtezla®

Otezla ®¡]apremilast¡^¬O¥Î©ó¤û¥ÖÅ~©M»È®h¯fÃö¸`ª¢ªº¤fªA»s¾¯

Otezla¦b2018¦~ªº¾P°âÃB¬O 16»õ¬ü¤¸

Otezla¦b¬ü°ê¥H¥~ªº50¦h­Ó¥«³õÀò±o§å­ã¡A¨ä¤¤¥]¬A¼Ú·ù ©M ¤é¥»¡A¨Ã¥B¦b¬ü°ê¾Ö¦³¦Ü¤Ö¨ì2028¦~ªº±M§QÅv

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/8/27 ¤W¤È 09:59:39²Ä 1343 ½g¦^À³
¶³²H­·»´¤j

§Ñ¤F­þ¦ì¤j¤j¶Kªº

³ø§i³sµ²¦b¦¹ ( 2019/02(?)¥Xª©ªº )( p.25 )

www2.deloitte.com/content/dam/Deloitte/cn/Documents/finance/deloitte-cn-mna-medicine-and-biotechnology-industry-driven-by-innovative-drugs-en-190514.pdf

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¶³²H­·»´10142966  µoªí®É¶¡:2019/8/27 ¤W¤È 09:10:11²Ä 1342 ½g¦^À³
½Ð°Ý²q·Q¤j §A»¡ªº³ø§i¦h¤[«eªº¨Æ ¦³¬Û¸ê®Æ¶Ü
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/8/27 ¤W¤È 08:41:22²Ä 1341 ½g¦^À³
¤W¦¸ Deloitte ªº³ø§i ( Capital Market Review and Outlook )

¹ï SyneuRx ªº´y­z

<<<

After the completion of Phase III clinical trial/NDA, SyneuRx will obtain high-value down payment, milestone payment and royalty after marketing through cooperation and out-licensing

with multinational pharma companies.

>>>

³o¬O¯uªº¶Ü ?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¶³²H­·»´10142966  µoªí®É¶¡:2019/8/26 ¤U¤È 01:09:36²Ä 1340 ½g¦^À³
¤µ¦~¦³¥h°Ñ¥[ªÑªF·|ªº,À³¸Ó³£ª¾¹D¤j­P°T®§¤F§a,§Ú¨S¥h°Ñ¥[¦ý±q§A­Ìµo¤åªº¤º®e¦n¹³¦b¦~©³¤~¦³¨ãÅé®ø®§,³o®a¤½¥q¯uªº«Ü§C½Õ,©Ò¥H¬ÛÃö®ø®§³£­n¦³­«¤j°T®§µo¥¬¤~·|¦³,·íµMµ¥«Ý«Ü·Î¼õ,¤½¥q¤è­±¥Ø«e¦n¹³¤]³£«Ü§C½Õ,¥u¯àÀqÀqÀR«Ý¤½¥qªº¥¿¦V°T®§¤F.
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/8/25 ¤U¤È 07:30:03²Ä 1339 ½g¦^À³
µ¥ªF­· ­Ô®É¾÷ ±æ¬K­·

§Ú­Ì¥i§_½Ð¤½¥q¨C¤ëµo§G¤@¦¸Á{§É¸ÕÅ窺¦¬®×¼Æ ?

Åý§Ú­Ì¥i¥H¼ÆµÛ¨C­Ó¦¬®×¼Æªº¤p¿Oªw«e¶i

ÂI«G¶Â·t¤¤ªº´Á«Ý---¶ZÂ÷¾¤©úÁÙ¦³¦h»· ?

½Ð¤½¥q§OÅý¤pªÑªF¦bµ¥«Ý¤¤ ¿W¦Û©Ó¨ü¸ê°TªÅ¥Õªº©t¿W

¬O©Ò¦Ü¬ß

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/8/6 ¤U¤È 05:14:18²Ä 1338 ½g¦^À³
¹ù¥SÀ°§Ú­Ì¾ã²z¿D¬wCADENCE-BZÁ{§É¸ÕÅ禳Ãö­f¥Ò»Ä¶u¥[¦¨ªvÀø¦­´Áºë¯«¯fªº¤¶²Ð¼v¤ù

liawbf.pixnet.net/blog/post/49056552

¹ù¥S¤]»¡

¤ß®®¬O§_¤]¥i¥H°Ñ¦Ò³oºØ¼Ò¦¡¨Ó«Å¶Ç?

³o­ÓÁ{§É¸ÕÅç¤w¦b2018/10§¹¦¨¦¬®× , Åý§Ú­ÌÀR«Ý¨äÁ{§Éµ²ªGªºµo§G , ¸ê¥H¤ñ¸û­f¥Ò»Ä¶u¹ïªF¦è¤è¤HºØªºÀø®Ä¬O§_¦s¦b®t²§?

ÁÂÁ¹ù¥S

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/7/31 ¤U¤È 07:17:16²Ä 1337 ½g¦^À³
¤p¨È¤j

±zªº¤j«v°Ý , ¥iÃø­Ë¤p§Ì¤F

§Úªº°T®§ °£¤F½×¤å¥~ , ´N¬O½²±Ð±Â¦bªÑªF±`·|´£¥Üªº¤F

½×¤å´X¥G¦h¬O°Êª«¸ÕÅç , Áö¼W¥[¤F«H¤ß , ¦ý²¦³º¤£¬O¤HÅé

½²±Ð±Â¦bªÑªF±`·|ªº´£¥Ü , ´N¦¨¤F§Ú­Ì¿à¥H§PÂ_ªºµïµ·°¨¸ñ¤F

½²±Ð±Â¦b¤µ¦~ªÑªF±`·|¦³ÃöSND-13ªºÁ{§É°T®§´£¥Ü¤F´X­Ó­«ÂI :

1.´Á¤¤¤ÀªR¹w­p¦b¦~©³

2.¤j¼Æ¾Ú¤½¥q¨ó§U©Û¶Ò±wªÌ , ¹w­p¦b6¤ë©³¤W½u

3.©Û¶Òªº±wªÌ¤¤ , ¶V¦~»´Àø®Ä¶V¦n

4.¾É¤J¡BÂùª¼¡B©µ¦ùµ¥¶¥¬qªº¤ÏÀ³²v²Å¦X¤½¥q¹w´Á(©Î³\§Ú­Ì©M¤½¥q¤§¶¡ªº°ò¥»»{ª¾¤£¦P)

5.­Y¦³¤ñ¹w´Á¦n±o¦h©Î·N¥~ªº®t , ¤]¤£·|´£«eµ²§ô¸ÕÅç(À³«ü¦¬®×348¤H¬°°ò·Ç)

6.­Y´Á¤¤¤ÀªRµû¦ô»Ý¹F1384¤H , ¤]¬O¬Ý¨ì°T¸¹ªº¦n²{¶H , À³¥H¦n®ø®§µø¤§ ;µM­Yµû¦ôµ²ªG¤£¥Î¼W¥[¦¬®×¼Æ(§Y«O«ù­ì¨Óªº348 ¤H) ¨º¤£´N­n¤@¡K(«Ü´Îªº¦¨»y , ¬°§K¼vÅT¤j®a¦Û§Úªº§PÂ_ , ©hÁô¤§)

³o¨Ç­«ÂI , ¦³¥i¥H±ÀºtªºÅÞ¿èÃö«Y

­Ó¤H·íµM¤]¦³©Ò«ä¦Ò , ¥u¤£¹L¤£©y¦b¦¹³Ù¼M

¹L¥h¤p§Ì¤]¶K¹L¤@¨Ç¬Ýªk , ²{¦b¨ÌÂÂ¥¼§ïÅÜ , ¥u¬O»Ý­n®É¶¡µ¥«Ý

ªþ¤WSND-13 2a´Áªºp ­È , ´£¨Ñ¤j®a°Ñ¦Ò

³o¬O¼Ë¥»¼Æ¬°47ªº±¡§Î , ­Y¼Ë¥»¼Æ¼W¬°190 , p­ÈÁÙ·|¤p¤W¤d­¿¤§ÃÐ

³o¤]Ãø©Ç¹ù¥S¼g¤F¤@½g¦n¤å , »¡p­È´N¬O p !

t­È------------p ­È -----------------------------------------------¶µ¥Ø------------------------

7.6-----1.32533E-09 ( 0.00000000132533 ) ----- PANSS Total scores

7.4-----2.60993E-09 ( 0.00000000260993 ) ----- PANSS Positive subscale

6.2-----1.57521E-07 ( 0.00000015752100 ) ----- PANSS Negative subscale

5.7-----8.68802E-07 ( 0.00000086880200 ) ----- PANSS General psychopathology subscale

¨Ó·½ :

jamanetwork.com/journals/jamapsychiatry/fullarticle/1746121

ªí 2

¦³½Ð¤j®a«ü¾É«ü¥¿©M¸É¥R

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p¨È10135608  µoªí®É¶¡:2019/7/31 ¤W¤È 11:14:45²Ä 1336 ½g¦^À³
SND-13Á{§É¤G´Áb¶¥¬q¦X¨Ö¤T´Á¸ÕÅçªvÀøºë¯«¤Àµõ¯g¡A¹w­p2019/Q3´Á¤¤¤ÀªR,½²±Ð±Â¨Æ¥ý­n¤j®a¤£­n¤Ó°ª»P¡A¦]¬°´Á¤¤¤ÀªR¥D­n¦bµû¦ô­n¤£­n¼W¥[¦¬®×¤H¼Æ¡A¨Ã¤£¬O²³©Ò´Á«Ýªº¸Ñª¼¡A§Ú­Ì³£¤£ª¾¹D·|¤£·|¦p´Áµo§G¡H²q·Q¤j¥\½Ò°µ±o«Ü¶Ô¡B«Ü»{¯u¡A¦³¨S¦³°T®§¬°¤j®a¸Ñ´b¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¦ÑÁÂ10148222  µoªí®É¶¡:2019/7/30 ¤U¤È 12:19:51²Ä 1335 ½g¦^À³
¤S¯}50¤¸¤F

¤£¬O¤~²{¼W50¤¸¶Ü

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/7/28 ¤U¤È 04:31:17²Ä 1334 ½g¦^À³
³o¦p¦ó³q¹L BBB ?

·s«¬CAR-T²Ó­MÀøªk°ª®Ä§ðÀ»­P©R©Ê¸£½F¥i²M°£80%ªº¸~½F

¨Ó·½¡G ¥Íª«¨¦ ¡@2019-07-28

med.sina.com/article_detail_103_1_69168.html

CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity

www.nature.com/articles/s41587-019-0192-1

­ì¨Ó¬O¦bÆ`¤º»¼°eCART.BiTE²Ó­M , ¤@¨Ó¥iª½±µ§ðÀ»¸~½F , ¤G¨Ó¦]³q¤£¹LBBB , ¤£·|¥~·¸¨ì©PÃä¨t²Î , ³y¦¨©PÃä¾¹©xªº°Æ§@¥Î

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10148412  µoªí®É¶¡:2019/7/26 ¤U¤È 07:13:38²Ä 1333 ½g¦^À³
½Ã§÷¤½§G¾ý¯»¼Ë³J¥Õªº¬ÛÃö©Ê¬ã¨s

¨Ó·½¡G¬ü³qªÀ ¡@2019-07-26

med.sina.com/article_detail_100_2_69114.html

µ²ªGªí©ú¡A¦å¼ß¤¤A(Beta)1- 42/A(Beta)1-4ªº¤ñ­È»P¸£¯á²G¤¤A(Beta)1-42/A(Beta)1-40ªº¤ñ­È¤§¶¡¦s¦b¬ÛÃö©Ê¡]´µ¥Öº¸°Òµ¥¯Å¬ÛÃö«Y¼Æ(rs)*2=0.502, p<0.001¡^¡A¦]¦¹¡A³q¹L´ú¶q¦å¼ß¤¤ªºA(Beta)1-42/A(Beta)1-40ªº¤ñ­È¯à°÷¤F¸Ñ¸£²Õ´¯fÅܪº¶iµ{¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2019/7/19 ¤W¤È 10:52:53²Ä 1332 ½g¦^À³
¤ß®®:¤½§i¥»¤½¥q¸³¨Æ·|¨Mij³q¹LÅܧó·|­p®v¨Æ°È©Ò

¡°¨Ó·½¡G¥xÆWÃÒ¨é¥æ©ö©Ò2019/07/18 20:00

------------------------------------------------------------------------------------------

5.·s·|­p®v¨Æ°È©Ò¦WºÙ:¦w¥ÃÁp¦X·|­p®v¨Æ°È©Ò

8.Åܧó·|­p®v¤§­ì¦]:

¦Ò¶q¥»¤½¥qÀç¹Bµo®i¤Î¬ÛÃö·~°Èªº·s»Ý¨D.

------------------------------------------------------------------------------------------

ªñ´Á¦w¥Ã»PªÑ¥«¤ñ¸û¬ÛÃö°T®§:

¦w¥ÃÄâÂd¶R¤¤¤ß ¿ìÀu½è¥ø·~¤WÂd®y½Í

2019-06-19 09:21¸gÀÙ¤é³ø ³¯ºÑ¶³

money.udn.com/money/story/5636/3879489

-------------------------------------------------------------------------------------------

Àç¹Bµo®i¤Î¬ÛÃö·~°Èªº·s»Ý¨D¡H¤j®a¦³¦ó·Qªk¡H

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/7/15 ¤U¤È 04:56:48²Ä 1331 ½g¦^À³
ÃD¥~¸Ü

­«¤j¬ð¯}¡IÀù¯g¬Ì­]ÂI¿UCAR-TÀøªk¤@¥b¥H¤W¤p¹«¸~½F³Q§¹¥þ²M°£

¨Ó·½¡GÂåÃÄÅ]¤è ¡@2019-07-14

¤Þ­zªº½×¤å

Enhanced CAR¡VT cell activity against solid tumors by vaccine boosting through the chimeric receptor.

science.sciencemag.org/content/365/6449/162

ÁÙ¦bÁ{§É«e,­Y¯à¤@Á|¬ãµo´¶¹M¤ÆªºCAR-T©Î¯à¤j³W¼ÒªºÀ³¥Î?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/7/14 ¤U¤È 05:02:27²Ä 1330 ½g¦^À³
¤å¦A½à

°·«O³Ìªá¿ú¤Q¤j¯e¯f¥XÄl «äı¥¢½Õ¯g­º¶iº]

2018-08-05 17:57Áp¦X³ø °OªÌ¾H®Ûªâ¢¬§Y®É³ø¾É

udn.com/news/story/7266/3291941

½ÃºÖ³¡¤½¥¬³Ì·s°·«Oªá¶O«e10¤j¯e¯f±Æ¦W¡A¥h¦~¥þ¥x«æºC©ÊµÇ¯f±wªÌ¦@ªá±¼°·«O¬ù503»õ¤¸¡A«ùÄòÂÍÁp³Ìªá¿úªº°ê¯f­º¦ì¡C¯S§Oªº¬O¡A«äı¥¢½Õ¯g¤]­º«×¤Jº]¡A¦~ªá°·«O127»õ¤¸¡C°·«O¸p¤ÀªR¡A¥i¯à©M°ê¤H§ó»{ÃѺ믫¯e¯f¦³Ãö¡A¥B·sÃİƧ@¥Î­°§C¨ÏªAÃĶ¶±q©Ê°ª¡A¦³§Uí©w¯f±¡¡B¦^ÂkªÀ·|¡C

ªþªí °·«Oªá¶O«e¤Q¤j¯e¯f±Æ¦W

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/7/14 ¤W¤È 07:48:25²Ä 1329 ½g¦^À³
§Ú°ê¦³40¸U¼~Æ{¯g±wªÌ 45¨ì64·³¬O°ª®p

2019-07-13 21:19Áp¦X³ø °OªÌ¼B¹ÅÃý¢¬§Y®É³ø¾É

udn.com/news/story/7266/3927238

®É¦Ü¤µ¤é¡A¤j®a¤w±µ¨ü¼~Æ{¯g¦¨¬°¤@ºØ´¶¹Mªº¯e¯f¡A¥@¬É½Ã¥Í²Õ´¦ô­p¡A¥þ²y¬ù1»õ2000¸U¤H¦³¼~Æ{¯g¡C

²{¦b¤j®a¤F¸Ñ¼~Æ{¯g¬O¤j¸£¯e¯f¡A¥u­n±µ¨ü¾A·íªvÀø¡A«K¦³¥i¯à§ïµ½¡A¶i¦Ó¦^Âk¤é±`¥Í¬¡¡C®Ú¾Ú¥@½Ã²Õ´²Î­p¡A¥­§¡¨C100¤H´N¦³3¤H¿©±w¼~Æ{¯g¡F¤k©Ê¤@¥Í¤¤µo¥Í¼~Æ{¯g¾÷²v¬O10%¦Ü20%¡A¨k©Ê¬O5%¦Ü12%¡C

½ÃºÖ³¡°·«O¸p²Î­p¡A105¦Ü107¦~¼~Æ{¯g¤H¼Æ³v¦~½w¨B¦¨ªø¡A105¦~38¸U3350¤H¡A106¦~39¸U5573¤H¡A107¦~¬°40¸U1059¤H¡C¥H107¦~¦]¼~Æ{¯g´NÂ媺40¸U1059¤H¤ÀªR¡A°ê¤º¼~Æ{¯g´NÂå±wªÌ¬ù¥e¥þ¥x2370¸U§ë«O¤H¼Æªº1.7%

­Y¥H´NÂå¤H¦¸¬Ý¡A¥h¦~¦]¼~Æ{¯gªù¶E´NÂå¤H¦¸¬°272¸U8984¤H¦¸¡A¬Û·í©ó¨C¦ì±wªÌ¤@¦~¥­§¡¦]¼~Æ{¯g´NÂå6¦Ü7¦¸¡C105¦~¦Ü107¦~°·«Oµ¹¥I¼~Æ{¯gÂåÀø¶O¥Î¤À§O¬O60.46»õ¤¸¡B64.07»õ¤¸»P66.15»õ¤¸¡A¥H107¦~¥Î©ó¼~Æ{¯gÂåÀø¶O¥Î66.15»õ¤¸­pºâ¡A¶È¥e·í¦~°·«OÁ`ÃB6853»õ¤¸ªº0.96%¡A³s¤£1%³£¤£¨ì¡C

¥H¦~ÄְϤÀ¡A¼~Æ{¯g±wªÌ¥H45·³¦Ü64·³¤k©Ê©~¦h¡A107¦~ªº¼~Æ{¯g±wªÌ¤¤¡A45·³¦Ü64·³¦³16¸U4427¤H¡A¬Û·í©ó¨C¤T¦ì¼~Æ{¯g±wªÌ¡A´N¦³¤@¤H¬O45¦Ü64·³¡F¨k¤k¤ñ¤j¬ù1¤ñ2¡A¤]´N¬O»¡¡A¤k©Ê¼~Æ{¯g±wªÌ¤H¼Æ°ª¥X¨k©Ê¤@­¿¡C

¥t¥~¡A±N¼~Æ{¯g¨Ì¯gª¬¤Î¯e¯fÄY­««×¤À¬°»´Æ{¯g¤Î­«Æ{¯g¡A107¦~»´Æ{¯g±wªÌ19¸U2¤d¦h¤H¡A­«Æ{¯g±wªÌ20¸U8¤d¦h¤H¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/7/4 ¤U¤È 08:55:04²Ä 1328 ½g¦^À³
³o¤SÅý§Ú·Q°_

¤µ¦~ªÑªF±`·| ½²±Ð±Â»¡¤F¤@­ÓÃöÁä

SND-13Á{§É(?) ¶V¦~»´ªº¨ü¸ÕªÌ®ÄªG¶V¦n

©Ò¥H§â¦¬®×ªº¦~ÄÖ ¥Ñ­ì¥»ªº18 ~ 55 ­°¬° 18 ~ 45 , ¥H¼W¥[Àø®Ä

³o¬O§_¸ò«e½g³ø¾É¦³Ãö---¶V¦~»´¤j¸£¯}Ãaªº¶V¤Ö , ¤]¶V®e©ö²£¥Í·sªº¯«¸g¤¸ , ¨Ó¹F¨ìÀø®Ä

«¢«¢!³oºØ²q·Q¬O§_©M¨Æ¹ê¬Ûªñ? ©Î«ÝÅçÃÒ

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/7/4 ¤U¤È 08:32:38²Ä 1327 ½g¦^À³
¦~¬ö¶V¤j¶VÃø²£¥Í·s¯«¸g¤¸­ì¦] ³º¬O§K¬Ì²Ó­M¤J«I¤j¸£

¨Ó·½¡G¾Ç³N¸g½n ¡@2019-07-04

med.sina.com/article_detail_103_1_68072.html

¬ì¾Ç®a­Ì½T¹ê§ä¨ìÃÒ¾Ú¡A¦¨¦~«á¤j¸£¤¤¨ÌµM·|²£¥Í·sªº¯«¸g¤¸¡A¥u¬OÀHµÛ¦~ÄÖ¼Wªø¡A³oºØ¯à¤O·|³vº¥¤U­°¡C»P¦¹¦P®É¡A»{ª¾¥\¯àÀHµÛ°I¦Ñ³vº¥°I°h¡C

´µ©ZºÖ¤j¾Çªº¬ã¨s¤H­û¦b¦Ñ¦~¤p¹«¤¤µo²{¡A§K¬Ì²Ó­M³ºµM·|¬ð¯}¦å¸£«Ì»Ù¤J«I¤j¸£¡A¤zÂZ¯«¸g·F²Ó­M¼W´Þ¡C³o¤@µo²{©Î³\¬°°I¦Ñ¬ÛÃöªº»{ª¾»Ùê´£¨Ñ¤F¼ç¦bªºªvÀø¹vÂI¡C

³o»ò¤@¨Ó¡A¤zÂZ¯À£^´N«Ü¥iºÃ¤F¡C¬O¤£¬O¥¦­Ì­°§C¤F¯«¸g·F²Ó­Mªº¼W´Þ¡H¬°¤FÀËÅç³oºØ¥i¯à©Ê¡A¬ã¨s¤H­û³]­p¤F¤@­Ó¹êÅç¡A§âT²Ó­M¿é¤J¦~»´¤p¹«ªº¸£¤¤¡CªGµMµo²{¡AÀHµÛ¹ï¤zÂZ¯ÀªºÅTÀ³¼W±j¡A¦~»´¤p¹«¸£¤¤¯«¸g·F²Ó­Mªº¼W´Þ¤]´î®z¤F¡C

¦Ó¦bÅé¥~§âT²Ó­M©M¯«¸g·F²Ó­M©ñ¦b¤@°_°ö¾iªº¹êÅç¶i¤@¨B½T»{¡AT²Ó­M½T¹ê·|³q¹L¤zÂZ¯À£^ª½±µ¤zÂZ¯«¸g·F²Ó­Mªº¼W´Þ¡C

ªþµù:

­f¥Ò»Ä¶u¹ï¤zÂZ¯À£^ªº½Õ¸` , ¥X²{¦b³o½g½×¤åùØ

Sodium Benzoate, a Food Additive and a Metabolite of Cinnamon, Modifies T Cells at Multiple Steps and Inhibits Adoptive Transfer of Experimental Allergic Encephalomyelitis

www.ncbi.nlm.nih.gov/pmc/articles/PMC1976122/

. §Ú­ÌÆ[¹î¨ìNaB±NÅèÀTÆP©Ê³J¥Õ( MBP )¤ÞµoªºT²Ó­M±qTh1ÂàÅܬ°Th2¼Ò¦¡¡A´I¶°½Õ¸`©ÊT²Ó­M¸s¡A¨Ã¤U½ÕT²Ó­M¤¤¦UºØ±µÄ²¤À¤lªºªí¹F¡C

. NaB§í¨îMBP( ÅèÀTÆP©Ê³J¥Õ )¤ÞµoªºT²Ó­Mªº­P¸£ª¢©Ê

. NaB§í¨î¨ÑÅé¤p¹«Å餺­P¸£ª¢©ÊT²Ó­Mªº²£¥Í

. NaB¦bMBP¤ÞµoªºµÊT²Ó­M¤¤Âà´«Th1¦ÜTh2²Ó­M¦]¤lªºªí¹F

.. ¤wª¾MS¬OTh1¤¶¾Éªº¦Û¨­§K¬Ì¯e¯f¡A¨Ã¥B±NTh1Âà´«¬°Th2ªí«¬¬O§ïµ½¯e¯fªº¤@ºØ¤è¦¡¡C¦]¦¹¡A§Ú­ÌÀˬd¤FNaB¬O§_¥i¥H«P¶iTh1Âà´«¬°Th2ªí«¬¡CIFN- £^¬Oªí¼xTh1ªí«¬ªº¥D­n²Ó­M¦]¤l¡A¦ÓTh2ªí«¬³q±`¥H²Ó­M¦]¤l¦pIL-4©MIL-10ªº¤Àªc¬°¯S¼x¡C

.. NaB¾¯¶q¨Ì¿à©Ê¦a¼W¥[IL-4©MIL-10ªºmRNAªí¹F¨Ã§í¨îMBP¤ÞµoªºµÊT²Ó­M¤¤IFN- £^ªºmRNAªí¹F

¥ì®Ô¾ÇªÌ¤]¦³¦P¼Ëªº¬ã¨sµ²ªG(¤HÅé)

­f¥Ò»Ä¶u¹ï¦hµo©Êµw¤Æ±wªÌTh1 / Th2°¾Â÷ªº¼vÅT¡C

www.ncbi.nlm.nih.gov/pubmed/27611715

. Our results showed that in the patient¡¦s group the percentage of CD4(+)IL-4(+) cells was significantly increased in the presence of all concentrations of NaB when PBMCs were stimulated by MBP (p = 0.001) or PHA (p < 0.03).

. The same results were obtained for normal donors in the highest concentration of NaB, 1000 µg/ml (p = 0.02).

. Moreover, in the patient¡¦s group the percentage of CD4(+)IFN-£^(+) cells was decreased significantly when the PBMCs were stimulated by PHA and NaB (p < 0.004) or by MBP and 1000 µg/ml of NaB (p < 0.03).

¦Ü©ó­f¥Ò»Ä¶u·|§_¦p³ø¾É¤@¼Ë , ¦b¤j¸£ùئP¼Ë§í¨îIFN-£^¦Ó²£¥Í·sªº¯«¸g¤¸ , ´NÅý SND-14ªºÁ{§É¨ÓÅçÃÒ

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/7/3 ¤W¤È 11:14:07²Ä 1326 ½g¦^À³
ÃĪ«±qÀò§å¤W¥«¨ì°Ó·~¤Æ¦¨¥\¡A¸ô³~¦³¦h»·¡H

¨Ó·½¡G·s®öÂåÃÄ·s»D ¡@2019-07-03

med.sina.com/article_detail_103_2_68012.html

§Ú­ÌÀ³¸Ó¥Ã»·»Ê°O¡AÃĪ«¬O¬°¤F¤HÃþ¦Ó¥Í²£¡A¤£¬O¬°¤F°l¨D§Q¼í¦Ó»s³yªº¡C§@¬°¤@®aÂåÃÄ¥ø·~¡A§Ú­Ì¤@©w­n®É¨è±N¯f±wªº§Q¯q©ñ¦b­º¦ì¡C¥u­n§Ú­Ì°í¦u³o¤@«H©À¡A§Q¼í¥²±NÀH¤§¦Ó¨Ó¡C

¡X¡XÀq§J«eCEO George W. Merck

¯u¹ê¥@¬Éªº¥ÎÃĥѤä¥IªÌ¿ï¾Ü¡A­°¿}¥«³õ¼sÁï¥B¿ï¾Ü©Ê¦h¡A­Y¯àÅã¥ÜÃB¥~ªº¤@¨Ç¦¬¯q¡A¦pÅé­«­°§C¡B´î¤Ö¯Ø®q¯ÀÁp¥Î¶q¡B§ïµ½¥D­n¤£¨}¤ß¦åºÞ¨Æ¥óµ¥¡A·|§ó®e©öűo¥«³õ¡C

¦b°ò©óÁ{§É¸ÕÅçµ²ªGÀò±o©x¤è§å­ã«á¡AÃĪ«­n¨ú±o°Ó·~¤Wªº¦¨¥\¡AÁÙ±N¨ú¨M©ó»PÄvª§¹ï¤âªº®t²§¤Æµ{«×¡A¹ï¯e¯fªvÀø¥«³õªº¼vÅT©M±wªÌ¥i¤Î©Ê¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/25 ¤U¤È 06:19:17²Ä 1325 ½g¦^À³
2019¦~±N¤W¥«ªº¤Q¤j­«½SÃĪ«

¨Ó·½¡G·s®öÂåÃÄ·s»D ¡@2019-06-25

½sĶ丨newborn

med.sina.com/article_detail_103_2_67692.html

¨ä¤¤²Ä¤QÀɬOJNJªvÀøTRDªºEsketamine»ó¼Q¾¯SPRAVATO™

[¸ÓÃĬO30¦~¨Ó­º­Ó¨ã¦³·s§@¥Î¾÷¨îªº­««×§íÆ{¯gÃĪ«¡A¦ýµL½×¬O»ù®æ¼ÐÅÒÁÙ¬O¦w¥þ­·ÀI³£¦s¦bª§Ä³¡C]

¦ý¹w¦ô2024¾P°âÃB¤]¹F 13 »õ¬ü¤¸

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/19 ¤U¤È 09:37:41²Ä 1324 ½g¦^À³
¤½§i¥»¤½¥q¨p¶Ò´¶³qªÑ¦¬¨¬ªÑ´Úº[¼W¸ê°ò·Ç¤é¤½§i

1.¨Æ¹êµo¥Í¤é:108/06/19

2.¤½¥q¦WºÙ:¤ß®®¥ÍÂåªÑ¥÷¦³­­¤½¥q

3.»P¤½¥qÃö«Y(½Ð¿é¤J¥»¤½¥q©ÎÁpÄݤ½¥q):¥»¤½¥q

4.¬Û¤¬«ùªÑ¤ñ¨Ò(­Y«e¶µ¬°¥»¤½¥q¡A½Ð¶ñ¤£¾A¥Î):¤£¾A¥Î

5.µo¥Í½t¥Ñ:¤½§i¥»¤½¥q¨p¶Ò´¶³qªÑ3,500¥aªÑ¡A¨CªÑ»{ÁÊ»ù®æ·s¥x¹ô50¤¸¡AÀ³¶Ò¤H

¤w©ó108¦~06¤ë19¤éú´Ú§¹²¦¡A¥»¤½¥q¶Ò¶°¸êª÷·s¥x¹ô175,000,000¤¸¡C

6.¦]À³±¹¬I:µL¡C

7.¨ä¥LÀ³±Ô©ú¨Æ¶µ:¥»¤½¥q­q©w108¦~06¤ë19¤é¬°¼W¸ê°ò·Ç¤é¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/15 ¤W¤È 07:54:43²Ä 1323 ½g¦^À³
¿«´Ë»sÃÄ­u´ä±¾µP °f¶Õ¼Éº¦

04:092019/06/15 ¤u°Ó®É³ø Ĭ±R·_

www.chinatimes.com/realtimenews/20190615000260-260203?chdtv

¤j³°³Ì¤jªººë¯«¯fÃÄ«~»s³y°Ó»¨´ËÃÄ·~¡A14¤é¥H¡u¿«´Ë»sÃÄ¡v¦WºÙ¥¿¦¡¦b­»´äÁp¥æ©Ò±¾µP¤W¥«¡AªÑ»ù¶}°ª14.31¢H¡A¦­½L¤jº¦26¢H¡A¤È«áº¦´T¶i¤@¨BÂX¤j¡A¤@«×¼Éº¦49¢H¡AºI¦Ü¦¬½L¡A´äªÑ¥«­È°ª¹F1,112.65»õ´ä¤¸¡A¦¨¬°³Ì¤j¥«­ÈÂåÃĪѡC

´äªÑ¤j½L14¤é¦¬¶^0.65¢H¡A¦ý¿«´Ë»sÃĤW¥«­º¤éªÑ»ù°f¶Õ¤W´­¡A¦¬³ø19.5´ä¤¸¡A¤Wº¦5.24´ä¤¸¡A¤jº¦36.75¢H¡C

ºI¦Ü2018¦~¡A¿«´Ë»sÃĪvÀø¤¤¼Ï¯«¸g¨t²Î¯e¯fÃĪ«ªº¥«³õ³W¼Ò¤w¹F1,974»õ¤¸¡A¥e¤j³°ÂåÃÄ¥«³õªº12.9¢H¡C¨ä¤¤¡A2018¦~ºë¯«¯e¯fÃþÃÄ«~ªº¥«³õ³W¼Ò¹F229»õ¤¸¡A¥e¤j³°¤¤¼Ï¯«¸g¨t²Î¯e¯fÃÄ«~¥«³õªº11.6¢H¡C

¤S¦³¨Ó¦Û·s®öÂåÃĺôªº®ø®§

»¨´ËÃÄ·~¤W¥«­º¤é¥«­È¹Gªñ1200»õ¡I¦¨´äªÑ³Ì¤j¥«­ÈÂåÃĪÑ

¨Ó·½¡G·s®öÂåÃÄ·s»D ¡@2019-06-14

med.sina.com/article_detail_100_2_67240.html

­«½S«~ºØªº»ù­È¤]¤Ï¬M¦b·~ÁZ¤W¡C»¨´ËÃÄ·~2018¦~ªºÀ禬¹F¨ì¤F77.223»õ¤¸¡A²b§Q¼í19.030»õ¤¸¡A³o¥÷²b§Q¼í¼Æ¾Ú¨¬¥H¦b´äªÑ±Æ¨ì¥Íª«ÂåÃĪѫe¤T¡C

»¨´ËÃÄ·~¦b¬ãµo§ë¤J¤Wªº¤j¤âµ§Åý¤HËߦޡC2016¦~¡B2017¦~¤Î2018¦~¡A¬ãµo§ë¤J¤À§O¬°4.031»õ¤¸¡B5.755»õ¤¸¡B8.8813»õ¤¸¡A¦û¦¬¤J¤ñ­«¤À§O¬°7.4%¡B9.3%¡B11.4%¡A¦û¾Ú°ê¤º¤@½u¤ô¥­¡C

¨Ì¾a¡§­º¥éÃÄ+³Ð·sÃÄ¡¨ÂùºÞ»ô¤Uªºµ¦²¤¡A»¨´ËÃÄ·~¥´ºâ¦b2019¦~¦Ü2020¦~±À¥Xªñ30ºØ¦b¬ãÃĪ«¡A¨ä¤¤¥]¬A15ºØ¨ã¦³°ª¼Wªø¼ç¤Oªº­«ÂI¦b¬ãÃĪ«¡]¥]¬A4´Ú1.1Ãþ³Ð·sÃĤÎ8´Ú¼ç¦b­º¥éÃÄ¡^¡C

°£¤F¦Û¬ã¤§¥~¡A»¨´ËÃÄ·~ÁÙ¹ï¥~¤Þ¤J¶}µo¡C5¤ë28¤é¡A»¨´ËÃÄ·~ªá¶O2.2»õ¬ü¤¸¤Þ¶i¡§¬ð¯}©ÊÀøªk¡¨ibilizumab¡]¥Î©óªvÀøµø¯«¸g¯áÅ誢ÀWÃлÙê¡]NMOSD¡^©M¨ä¥L¦Û¨­§K¬Ì¯e¯f¡B¦å²G´c©Ê¸~½F¡^¤¤°ê¶}µo©M°Ó·~Åv§Q¡C

*********

½²±Ð±Â¦b¤µ¦~ªºªÑªF±`·|´¿´£¥Ü

¤ß®®ªºSNS¨t¦C·|¥H¤¤°ê(¤j³°)¥«³õ¬°¥D

¤S»¡¶Ò¸ê·|¥H¨p¶Ò©Î±ÂÅv§@¼u©Ê¹B¥Î

¬JµM»¨´ËÃÄ·~¬O¤j³°³Ì¤jªººë¯«¯fÃÄ«~»s³y°Ó , ÁÙ¦³ªÖªá¿ú¤Þ¶i·s²£«~

³o·|¤£·|¦¨¬°¤ß®®¦b¤¤°ê¤j³°ªº±ÂÅv¦X§@¹ï¶H? ¥O¤H¦n©_!

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GFaFaFa10140966  µoªí®É¶¡:2019/6/15 ¤W¤È 05:15:49²Ä 1322 ½g¦^À³
»ñ°Ä½Ãµø ¥@¬ö¤jÁ¿°ó

鲁¥Õ¡Gªv疗ªü尔兹®üÀq综¦X¯gªº·s«ä¸ô

========

¡K

...

总结¤@¤U¡AAD脑内ªº¯f²z变¤Æ¦³5¤j类¡GÕ௻样´³块©M¯«经纤维缠结¡A胶质细­M¼W¥Í¡A¯«经细­M¤j¶q¦º¤`¥H¦Ü³y¦¨脑ªºµä缩¡C³Ì¦Z¡A¤]¬O³Ì­«­nªº变¤Æ¡A´N¬O¤j­±积ªº¬ðàD损伤©M丢¥¢¡C

¡K

...

§Ú们¬ì学®a¤@ª½¦³个单纯¦µ¯Àªº·Qªk¡A¥u­n§ä¥X­P¯f­ì¦]¡AÄ´¦p¦bAD¤¤´N¬OA£]¡A¨º¤\¥u»Ý­n¥h±¼这个­P¯f·½¡A´N¯à够药¨ì¯f°£¤F¡C现¦b¬Ý来这Ïú«ä¸ô¦³问题¡C¨Æ实¤W¡A§Ú们ªº¯f¤H¦b来医°|¬Ý¯f¤§«e«Ü¤[¡A¥Lªº脑¤l¨½¤w经¦³¤F¤@¨t¦Cªº¯f变¦bÀqÀq¦a进¦æ着¡C¦b过¥hªº10¨ì15¦~内¡A¥L脑¤l¨½­±ªºA£]¡A¤]´N¬O©Ò谓ªºÕ௻样ªº´³块¤w经³v渐积²Ö¡C¦A过3¨ì5¦~¡A¥Lªº¬ðàD开©l¨ü¨ì损伤¡ATau³J¥Õ组¦¨ªº这个¯«经纤维缠绕ªº¶q¤]´N¼W¥[¡AµM¦Z³v渐´N³y¦¨¤F¯«经细­Mªº¦º¤`¡C紧±µ着¡A¯«经细­Mªº¦º¤`带来脑µä缩¡A脑¥\¯àªº伤®`¡Aµ¥¨ì¥L来¨ì医°|¬Ý¯fªº时­Ô¡A´N¤w经¦³¤F©ú显ªº认ª¾»Ù碍¡A脑¤l¨½­±¦³¬Û当¤@³¡¤Àªº¯«经¤¸¤w经¦º¤`¡C¤j®aª¾¹D¯«经¤¸ªº¦º¤`¬O¤£¥i°fªº¡C这个时­Ô¦A¥h¥h°£«Ü¤[¥H«eªº¡A¨Ò¦pA𝛽这样ªº¯f¦]¡A¬O难¥H°f转¯fµ{ªº¡C´¿经¦³个«D±`§Î¶Hªº¤ñ³ë¡A¤j脑¤¤¯«经¤¸¬O¤@个´ËªL¡AA𝛽´N¬O¤@®Ú¤õ®ã¡A当±wªÌ来¨ì医°|时¡A¤j脑¨½¤w经¬O¤@¤ù´ËªL¤j¤õ¡C这个时­Ô¦pªG¥u¥h灭±¼¤Þ°_¤õ灾ªº¤õ®ã¡A¬O无济¤_¨Æªº¡C

...

...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G´M³V10132258  µoªí®É¶¡:2019/6/12 ¤U¤È 10:45:00²Ä 1321 ½g¦^À³
ÁÂÁ¡I¬d¨ì¤F¡I·P®¦±z
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G°O°O10141673  µoªí®É¶¡:2019/6/12 ¤U¤È 10:39:24²Ä 1320 ½g¦^À³
mops.twse.com.tw/mops/web/t116sb01

¨p¶Ò±M°Ï...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/6/12 ¤U¤È 10:32:04²Ä 1319 ½g¦^À³
«ÒÄ_À°....¡K¯u¬O¦³·N«ä....¥à¬Û....§Ö°_­·¤F....
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G´M³V10132258  µoªí®É¶¡:2019/6/12 ¤U¤È 10:25:23²Ä 1318 ½g¦^À³
½Ð°Ý¤½§i¦b­þ¡H«ç»ò¨S¬Ý¨ì°T®§¡H

¥ýÁÂÁ±z©âªÅ§iª¾¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GJerry10148116  µoªí®É¶¡:2019/6/12 ¤U¤È 08:57:56²Ä 1317 ½g¦^À³
¨p¶Ò¦W³æ¤]¤½§i¤F

¡u¥»¦¸À³¶Ò¤H¬°³\¼y²»¡BªL«O¥Ð¡B¨H«H§»¤Î§õ³s±Ó¡C¡v

³o¦¸¨p¶Ò­nÀ°¤½¥q©ç©ç¤â

°õ¦æ®Ä²v°ª¡A­q»ù®Â½ÃªÑªFÅv¯q

¦W³æ¥D­n¬O¹L¥h¤@¦~¦h­·­·«B«B¤UÁÙ«ùÄò¤ä«ù¤½¥qªº¤jªÑªF

·PÁ¤½¥qªº§V¤O

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/6/12 ¤W¤È 10:01:43²Ä 1316 ½g¦^À³
¥H²{¦bªº¥«ªp¡A

¤½¥q¯à¥Î°ª©ó¥«»ùªºª¬ªp§ä¨ì¨p¶Ò¤H¡A

³oÂI¬O­È±oµ¹¤½¥qªÖ©wªº¡A

¦Ü¤Ö²Ä¤@µ§¨p¶Ò¶i¨Ó¡A¤]¬Oµ¹¤½¥q¥´¤F±j¤ß¾¯¡A

»¡¹ê¦bªº¡A¥xÆW¥Í§Þ·~¦³¨Ç¥D¨ÆªÌ¯uªº¬O«Ü¹ê¦b¡A

½²¸³¡B¤j±i¸³¡B¤p±i¸³³£¬O¤H«~¥¿¬£ªº¤H¡A

µL©`¯E­ô¨Æ¥ó«á¡A¬F©²¤fÀY¤W³Ûµo®i¥Í§Þ¡A¹ê»Ú¤W«o¤@ª½¥d¥Í§Þ¡A

§Æ±æ¥xÆW¥Í§Þ¥i¥H¦n¦n¨«¤U¥h¡A

²¦³º³o¬O²Ä¤@­Ó10¦~¡A

§Æ±æ¤U¤@­Ó10¦~¡A¥i¥HºCºC¶}ªáµ²ªG¡A´­¬Ü¦R®ð

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤s¥ý¥Í10024238  µoªí®É¶¡:2019/6/12 ¤W¤È 09:58:09²Ä 1315 ½g¦^À³
³o¦¸¥h°Ñ¥[¤µ¦~²Ä¤G¦¸ªÑªF·|,¤F¸Ñ¤½¥q¯uªº¦n¹³¥þ¤O§ë¤J¦b¤½¥qÀç¹B,¨Ã¤£·|µÛ¾¥¦bªÑ»ù°ª§C. ¤£¹L·í¤é·|«á¥æ¬y¦³¤@­Ó­«ÂI,¨p¶Ò®×¤@¦~¤º¤À¥|¦¸¶i¦æ,¥D­n²{¦æªÑ»ù§C¦ô¤½¥q»ù­È,©Ò¥H¤£·|¤@¦¸§¹¦¨¨p¶Ò; ­Ó¤H¤£­t责¥ô¸ÑŪ:¥¼¨Ó¶Ò¸ê»ù¤£´N¤@¦¸¤ñ¤@¦¸°ª,¤@¦~¤ºªÑ»ù«ùÄò©¹¤W¨«?
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2019/6/12 ¤W¤È 09:26:27²Ä 1314 ½g¦^À³
seniorbbs¤j,

¥H§Ú­Ó¤Hªº²L¨£, ±zªºÅU¼{À³¸Ó¾÷²v·L¥G¨ä·L

1. ¥H¥Ø«e¤é¦¨¥æ¶q¼Æ¤Q±iªºª¬ªp©³¤U,¡@­n¤j¶RªÑ²¼, «ÜÃø¤£¼@¯P¼vÅTªÑ»ù§a¡H

2. ¤½¥q¿ì²z¨p¶Òªº¥Øªº, Ѻª`¹êÅç¤ÎÀç¹Bµ¥¸g¶O, ªÑ¥Á¦b¥«³õ¤Wªº¥æ©ö, «ÜÃø¹ï¤½¥q¤è¦³ª½±µªºÑºª`

3.¡@³o¬O­«¤j°T®§¤½¥¬, ¤£¬O³y¯«¦¡ªº©I¤f¸¹¹B°Ê, §Ú·QÀ³¸ÓÁÙ¬O¦³©Ò¥»©Î¬O¦³¨Æ¥ý°Q½×³Wµe¥i¦æ©Ê, ¤~·|¦³¦¹­«°T¤½¥¬

°ò©ó¤W­zªº²z¥Ñ, §Ú·QÁÙ¬Oµ¹¤½¥q¹ªÀy§a¡I²¦³º¬O°ª©ó¥«³õ¤Wªº»ù®æ, ¬Ý¦b³o­Ó¥÷¤W, §Ú­Ó¤H¬Oı±o¤½¥q¬O¦³ÅU¼{¨ì©Ò¦³ªÑªFªºÅv¯q¤F

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªY½à¼Æ¦r¬ü10147157  µoªí®É¶¡:2019/6/12 ¤W¤È 02:00:26²Ä 1313 ½g¦^À³
¦M¨¹¤£¤J¡A¶Ã¨¹¤£©~ªº­ì«h¤U¡A¤p¤ßÁ׶}Á`¬O¹ïªº¡A¤½¥q¦b¸gÀç¤W­n§óÂÔ·V¡A¥¼¨Ó°ê»Ú±¡¶ÕµLªk¹w´ú°Ú¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªY½à¼Æ¦r¬ü10147157  µoªí®É¶¡:2019/6/12 ¤W¤È 01:10:30²Ä 1312 ½g¦^À³
¤£¹L¥¼¨Ó°Ó·~¸gÀç¦X§@¹ï¶H²{¦b§ë¸ê¥i¯à·|¦³¤º½u¥æ©ö°ÝÃD¡A¤]¤£¤Ó¥i¯à¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªY½à¼Æ¦r¬ü10147157  µoªí®É¶¡:2019/6/12 ¤W¤È 01:03:00²Ä 1311 ½g¦^À³
³oºØ¨p¶Ò»ù®æ¡A°²¦p¨p¶Ò¹ï¶H¥u¦³³æ¤@¦ì¡A§Ú²q´ú³oºØ»ù®æÁÙÄ@·N§ë¸êªº¦³¥i¯à¬O¥¼¨Ó°Ó·~¸gÀç¦X§@¹ï¶H¡H¬O©Ò¿×ªºµ¦²¤¹Ù¦ñ¡H¥¼¨Ó¥i¯à¦b¤½¥q¦³¤@®u¸³¨Æ®u¦ì©Î¥[¤J¸gÀç¹Î¶¤¡H

¥H¤W¬O­Ó¤H­J¶Ã²q´ú¡A«D©x¤èµo¥¬ªº°T®§¡A½Ð¤£­n¥H¦¹°µ§ë¸ê¨Ì¾Ú¡C

¸Ü»¡¡A¥h¦~ªÑªF°µµÛ­»´ä¤W¥«ªº¹Ú¡A¤½¥q®`©È³Q¬FÄÒ´c°«ªi¤Î¡A­n¨D°Q½×­n§C½Õ¡A¨º¤µ¦~­»´ä°k¥Ç±ø¨Ò¡A¥[¤W¤¤¬ü¶T©ö¾Ô¡A¦b­»´ä³]¥ß¤½¥q¡A¬O§_±q¬FÄÒ´c°«¸õ¶i¥t¥~¤@­Ó§ó²`ªº§|¡HÁöµM¥xªÑ±¡¶Õ¤]¤£¦n¡A¦ý¡AªÑªF­ÌÁÙ·|·Q¥h­»´ä¤W¥«¶Ü¡H

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/6/11 ¤U¤È 10:15:15²Ä 1310 ½g¦^À³
½T©w§ä¨ì¶R®a¤F¡H¥«³õ¶RÁÙ¤ñ¸û«K©y.......
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2019/6/11 ¤U¤È 09:24:05²Ä 1309 ½g¦^À³
­è­è¬Ý¨ì¤½¥q­«°T, ¨p¶Ò»ù­q¦b50¤¸, ı±o¦Û¤v¥²¶·¤W¨Óµ¹¤½¥q¥´¥´®ð! ³o¬O®a¥ú©ú½U¸¨ªº¤½¥q, ¦Ó½²±Ð±Â¤]ÅU¤Î©Ò¦³ªÑªFªºÅv¯q, §¹¥þ¤£¤¹³\¦ÑªÑ´«·sªÑªº±¡¨Æ

ªÑªF·|«á, ¤F¸Ñ¤½¥q¤À¨Éªº¸ê°T, ©Z¥Õ»¡, ·|«e¤ß¸ÌªººÃ´b, ®õ¥b®ø°£, ¥]¬A¦¬®×¶i«×´î½wªº­ì¦], ¸êª÷¶Ò¶°¤Wªº§xÃø, ³o¦¸½²±Ð±Â¤]«Ü±µ¦a®ðªº¤À¨É¤F¤½¥qÀç¹B¤W¥i¯àªº³W¹º

·íµM¶i«×½wºC, ¸êª÷¶Ò¶°¤£©ö, ¤´¬O«ùÄò¦s¦bªº¨Æ¹ê, ¦ý¬O¦b°í¹êªº¬ì¾Ç°ò¦»P½U¸¨ªº¸gÀ礧¤U, §Æ±æ¤½¥q¯à°÷¥[§Ö¸}¨B, í²Ïí¥´, ¤£­t²³¦hªÑªFªº´Á±æ, ¦­¤é¦¨¥\

·íµM¤]§Æ±æ¥i¹w¨£ªº´Á¤¤¤ÀªR, ¥i¥Hµ¹¤½¥q¤@­Ó¤½¹D, ´«¤H¨Ó·í¥Í§Þ»âÀY¦Ï!

½²±Ð±Â¥[ªo! ¦Ñ¥v¤j¥[ªo!

¤ß®®¥[ªo!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/11 ¤U¤È 08:57:35²Ä 1308 ½g¦^À³
¤½§i¥»¤½¥q¸³¨Æ·|¨Mij¿ì²z²{ª÷¼W¸ê¨p¶Ò´¶³qªÑ©w»ù¤Î ¬ÛÃö¨Æ©y

¨p¶ÒªÑ¼Æ©Î±i¼Æ:¥»¦¸¸³¨Æ·|¨Mijµo¦æ¨p¶Ò3,500¥aªÑ¡C

10.¹ê»Ú©w»ù¤é:108/06/11

11.°Ñ¦Ò»ù®æ:¨CªÑ·s¥x¹ô46.95¤¸¡C

12.¹ê»Ú¨p¶Ò»ù®æ¡BÂà´«©Î»{ÁÊ»ù®æ:¨CªÑ·s¥x¹ô50¤¸¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/9 ¤W¤È 09:05:27²Ä 1307 ½g¦^À³
°¸µM¶¡¬Ý¨ìªZ¥Ð»sÃĩ󤵦~¤­¤»¤ë¶¡¤W½uªºAMPA¨üÅé¼W®Ä¾¯TAK-137Á{§É«eªº°Êª«¸ÕÅç³ø§i , ¬O¤@­Ó¥i·qªº¹ï¤â

AMPA¨üÅé¼W®Ä¾¯TAK-137§@¬°ºë¯«¤Àµõ¯gªvÀøÃĪ«ªºÁ{§É«e¯S¼x

www.ncbi.nlm.nih.gov/pmc/articles/PMC6507438/

³ø§i¤º®e¤j­P¬° ( google ½Ķ )

. ºë¯«¤Àµõ¯g¬O¤@ºØºC©Êºë¯«¯e¯f¡A¨ã¦³¤@¨t¦C¯gª¬¡G¶§©Ê¡A³±©Ê©M»{ª¾¯gª¬¡C¤w¸g°ò©óÁ{§Éµo²{«ü¥X¤Fºë¯«¤Àµõ¯gªº¯f²z¥Í²z¾Çªº­Y¤z°²³]¡C°ª«×¦h¤ÚÓi°²»¡³Q»{¬°¬O¶§©Ê¯gª¬ªº¥D­n­ì¦]¡A¨Ã¥B§C¨¦®ò»Ä°²»¡¤£¶È°w¹ï¶§©Ê¯gª¬¦Ó¥B°w¹ï®ø·¥©M»{ª¾¯gª¬´£¥X

. ¨¦®ò»Ä¨t²Îªº¤U½Õ¥i¯à¯A¤Îºë¯«¤Àµõ¯gªº¶§©Ê¡A³±©Ê©M»{ª¾¯gª¬¡C³q¹L¼W±jªº¨¦®ò»Ä«H¸¹¶Ç¾É¡AAMPA¨üÅé¡]¤@ºØÂ÷¤l«¬¨¦®ò»Ä¨üÅé¡^ªº¬¡¤Æ¥i¯à¬Oºë¯«¤Àµõ¯gªº¤@ºØ·sªºªvÀøµ¦²¤¡CTAK -137¬O¤@ºØ¨ã¦³³Ì¤p¿E°Ê¬¡©Êªº·s«¬AMPA¨üÅé¼W®Ä¾¯; ¦b³o¶µ¬ã¨s¤¤¡A§Ú­Ì¨Ï¥Îø¥¾¦°Êª«©M«D¤HÆFªøÃþ°Êª«¨Óµû¦ô¨ä§@¬°ºë¯«¤Àµõ¯gÃĪ«ªº¼ç¤O¡C

. AMPA¨üÅ骺¿E¬¡¾É­PNMDA¨üÅé¥\¯à¼W¥[; ¦]¦¹¡AAMPA¨üÅé¼W®Ä¾¯¨ã¦³§@¬°ºë¯«¤Àµõ¯gªºªvÀøÃĪ«ªº¼ç¤O¡CµM¦Ó¡A¥ý«e³ø¾Éªº¤Æ¦Xª«¤w¸gªí©ú¤F½Ñ¦pÄÁ§Î¤ÏÀ³©M»¤µoÅöíwµo§@µ¥­·ÀI¡CLY451646©MLY404187ªºÅ餺¬ã¨sÅã¥Ü¨ä°~®kªºÄÁ§ÎÅTÀ³¡C§Ú­Ì³Ìªñµo²{¤F¤@ºØ·s«¬AMPA¨üÅé¼W®Ä¾¯-TAK-137¡]9-¡]4-­f®ñ°ò­f°ò¡^-3,4-¤G²BýmÔr¨Ã[2,1-c] [1,2,4]噻¤G嗪2,2-¤G®ñ¤Æª«¡^¡A¥Ñ©ó¨ä§C¿E°Ê¬¡©Ê¡A­°§C¤FÄÁ§Î¾¯¶q¤ÏÀ³©MÅöíwµo§@ªº­·ÀI¡C

. ¼Æ¾Úªí©ú¡A¨ã¦³§C¤º¦b¬¡©ÊªºTAK-137«¬AMPA¨üÅé¼W®Ä¾¯¥i¯à¬OªvÀøºë¯«¤Àµõ¯g¦hºØ¯gª¬ªº¦³§Æ±æªºªvÀø¤èªk¡A¤×¨ä¬O¹ï©ó®ø·¥©M»{ª¾¯gª¬¡C

. TAK‐137 significantly inhibited METH‐induced hyperlocomotion in rats to 33.6 ¡Ó 7.66% of that in the control ; §í¨î¦Ê¤À¤ñ§C©ó§Üºë¯«¯fÃĪ«¡A¨ä¦bD2R¦û¾Ú60¢H®Éªí²{¥X¤j©ó50¢Hªº§í¨î§@¥Î¡C¦]¦¹TAK-137¥i¥H¨ã¦³¦³­­ªº¹ïºë¯«¤Àµõ¯gªº¶§©Ê¯gª¬ªº¥\®Ä¡C»P³ø¾Éªº¨ã¦³¦h¤ÚÓiD2«ú§Ü§@¥Îªº§Üºë¯«¯fÃĤ£¦P¡ATAK-137¤£·|»¤¾ÉÅãµÛªº»ø¦í¤ÏÀ³©M¦å¼ß¤¤¶Ê¨Å¯À©M¸²µå¿}¤ô¥­ªº¼W¥[.

. ¥Ø«eªº§Üºë¯«¯fÃīܤ֯à§ïµ½³±©Ê¯gª¬¡CTAK-137¨ã¦³§ïµ½»PNMDA¨üÅé¥\¯à´î°h¬ÛÃöªºªÀ·|¦æ¬°ªº¼ç¤O¡C

. TAK-137¹ï»{ª¾¯gª¬¡A¯S§O¬Oª`·N¤O¡A¤u§@°O¾Ð©M°õ¦æ±±¨îªº¼vÅT¡A¦]¬°³o¨Ç³Q»{¬°¬Oºë¯«¤Àµõ¯g¤¤¨ü·lªºÃöÁä»{ª¾»â°ì¡A³q¹L§ïµ½ºë¯«¤Àµõ¯g¤¤ªº»{ª¾ªº´ú¶q©MªvÀø¬ã¨s¡C

. TAK-137ªº¯S¼x¦b©ó°w¹ï®ø·¥©M»{ª¾¯gª¬ªº¯S©w¥\®Ä¡C¦]¦¹¡A§Ú­Ì¬ã¨s¤F¦P®É¨Ï¥ÎTAK-137©M§Üºë¯«¯fÃĪ«ªº¼vÅT¡CTAK-137¤£·|¤zÂZ¶ø´á¥­¹ïMETH»¤¾Éªº¹L«×¹B°Êªº¼vÅT¡A¨Ã¥B¤£·|¥[¼@»ø¦í¤ÏÀ³©M¦å¼ß¶Ê¨Å¯À¤ô¥­¡C¦¹¥~¡A¶ø´á¥­ªºÁp¦XªvÀø¨Ã¥¼§ïÅÜTAK-137¹ï»{ª¾ªº¼vÅT¡C¦]¦¹¡ATAK-137»P¥Ø«e¥i¥Îªº§Üºë¯«¯fÃĪº²Õ¦X¥i¦³¯q©óªvÀøºë¯«¤Àµõ¯gªº¦hºØ¯gª¬¡C¦b¸Ó¬ã¨s¤¤¥¼ÀË´ú¨ì¥\®Äªº¨ó¦P¼W±j¡A³o¥i¯à¬O¶ø´á¥­¹ïD2R«ú§Ü§@¥Îªº¤£¦P§@¥Î¾÷¨î©MTAK-137¹ï¨¦®ò»Ä«H¸¹ªº¼W±j§@¥Îªºµ²ªG¡C

ÁöµM³ø§i«Ü¦³¬ÝÀY

¦ý¬OTAK-137«o¹L¤£¤F phase 1 ªºÃö¥d , ³QªZ¥Ð¤¤(²×)¤î¬ãµo¤F

clinicaltrials.gov/ct2/results?cond=&term=Tak-137&cntry=&state=&city=&dist=

www.pharmacodia.com/yaodu/html/v1/chemicals/6605cf6f932aa6510d637af51c820a6a.html

TAK-137 was developed by Takeda for the treatment of attention deficit hyperactivity disorder, neurological and psychiatric disorders.

Pharmacokinetic variability has led to a decrease in the compound¡¦s safety margin. So Takeda discontinued this studies in 2015.

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«°«°10148263  µoªí®É¶¡:2019/6/5 ¤U¤È 01:23:40²Ä 1306 ½g¦^À³
ÁÂÁ²q·Q¤jªº¸Ñµª
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/5 ¤W¤È 09:44:53²Ä 1305 ½g¦^À³
RF¤j

ÁÂÁ±z´£¨Ñªº¸Ñµª

¤p§Ì¨Ìµ}¤]¬OÅ¥¨ì¤ÏÀ³²v ©Ò¥H·Q¦A½T»{

­Y¬°¤ÏÀ³²v ´N¤Ó¦n°Õ! ÁöµM½²±Ð±Â¹ïÂùª¼¶¥¬qªº¦^µª¬O No comment

¦A¦¸ÁÂÁ±z!

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GRF10147837  µoªí®É¶¡:2019/6/5 ¤W¤È 09:26:31²Ä 1304 ½g¦^À³
²q·Q¤j:

SND-13Á{§Éªº¤T­Ó¶¥¬q ¡]run-in¡AÂùª¼¡A©µ¦ù ¡^ªº¡]¡H¡H¡H¡^¬O§_²Å¦X¤½¥q¹w´Á¡H

Å¥°_¨Ó¦n¹³¬O ¤ÏÀ³²v,¤£ª¾¹D¦³¨S¦³Å¥¿ù.ÁÂÁÂ

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/5 ¤W¤È 07:51:19²Ä 1303 ½g¦^À³
§Æ±æ¤ß®®½w½w¦a ºCºC¦a º¥º¥¦a¨B¤W¦¨¥\ªº©Z³~

±ÀºV½²±Ð±Âªº·Qªk

¤@¤Á¥HÁ{§É¦¨¥\¬°¨ÌÂk , ¦³°T¸¹´N¬O¦n±mÀY , §ó¦óªp¤jªº°T¸¹

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/5 ¤W¤È 05:15:27²Ä 1302 ½g¦^À³
«°«°¤j

sarcosine ¬OSNG-12ªº¥D¦¨¥÷

¯¬ºÖ¤j®a±q¦¹¨B¤W©Z³~

ÁÂÁ¤j®a¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«°«°10148263  µoªí®É¶¡:2019/6/5 ¤W¤È 01:18:16²Ä 1301 ½g¦^À³
½Ð°Ý²q·Q¤j¡Aµn¿ýªÑªF±`·|±K½X¬O¡H·P®¦
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/4 ¤U¤È 08:35:58²Ä 1300 ½g¦^À³
½Ð±Ð¬Q¤é°Ñ¥[ªÑªF±`·|ªº¦n¤Í­Ì

¬Q¤é¦³ªÑªF¸ß°Ý

SND-13Á{§Éªº¤T­Ó¶¥¬q ¡]run-in¡AÂùª¼¡A©µ¦ù ¡^ªº¡]¡H¡H¡H¡^¬O§_²Å¦X¤½¥q¹w´Á¡H

½²±Ð±Â¦^µª²Å¦X¹w´Á

½Ð°Ý»y¥y¤¤ªº ¡] ¡H¡H¡H¡^½²±Ð±Â¬O»¡¨º­Óµü¡H

½Ð¦³Å¥²M·¡ªº¦n¤Í­Ì¸ÑºÃ¦p¦ó¡H¥ý¦æÁÂÁ¤F

ÁÂÁ¤j®a¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/4 ¤W¤È 10:49:15²Ä 1299 ½g¦^À³
²ø³ì¦¼«ß®v ¼w¿²ªk«ß¨Æ°È©Ò«ß®v

¦@¦P¦X¹Ù¤H

§õ®Ëº_«ß®v

¦³Ãö«Y¶Ü?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GYOYO10140343  µoªí®É¶¡:2019/6/4 ¤W¤È 09:36:20²Ä 1298 ½g¦^À³
¥H¤U°T®§¨Ã«DªÑªF·|¤º®e,¶È­Ó¤H¬Ýªk.°ò¥»¤W°T®§¬O¦nªº,¥]¬A´Á¤¤¤ÀªR¥u®t20¦h¤H,¦~©³«e¥i°µ´Á¤¤¤ÀªR,¤w°µªºÁ{§É¤ÏÀ³²Å¦X¹w´Á;¼Ú¬w¼Æ­Ó°ê®a§t­^°ê¥[¤JÁ{§É´Nºü;·s¯Ç¤j¼Æ¾Ú¤Î¹q¤l¯f¾ú¦¬®×,¥¼¨Ó¦¬®×³t«×¥[§Ö,¥BÄY¿ïÁ{§É¯f¤H,¤£¶Ãºj¥´³¾,¬Ý°_¨Ó¬O¤½¥qÂÔ·V¬DÁ{§É¯f¤H,¤F¸Ñ¹L¥h¨ä¥¦¤½¥q¥¢±Ñ¸gÅç,´£°ª¹LÃö¾÷²v; ¨p¶Ò¤w¦³¼ç¦b§ë¸êªÌ,µu´ÁÁ{§É¸êª÷À³没°ÝÃD;

¦A¦hªº¸ê°T¤£Á¿¤F, Á¿¦h¤F¹ï¿Ë¦Û»P·|ªº¤H¤£¤½¥­,©¹¦~ªÑªF·|«e«áªÑ»ù³£¨«§C,³o¦¸ªÑªF·|«áªÑ»ù¤Ï¦Ó©¹¤W¨«,¦³°Ñ¥[ªº¤HÁÙ¤£Â²³æ,¤@¤Ñ³£¤£§\Án,¸Ó¤£·|ÀqÀq¦Y³f,µ¥º¦¤W¥h¤~­n§â¦n®ø®§¶K¥X¨Ó.

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/6/4 ¤W¤È 07:31:37²Ä 1297 ½g¦^À³
¥i¥H¤F..¡KÁÂÁ²q·Q¤j
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/6/4 ¤W¤È 07:06:51²Ä 1296 ½g¦^À³
²q·Q¤j

§ä¤F¤@¤Uµª®×....«ç»ò¸Õ³£¶i¤£¥h...¥i¥Hµy·L´£¥Ü¤@¤U¶Ü? ÁÂÁÂ

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/6/3 ¤U¤È 09:14:56²Ä 1295 ½g¦^À³
ÁÂÁ¹ù¥SªºªÑªF·|¤ß±o

108ªÑªF·|´XÂI¤ß±o

liawbf.pixnet.net/blog/post/48956484

­Ó¤H¥H¬°

½²±Ð±Â³o¦¸ªÑªF·|Á¿±o¤ñ¸û¶KªÑªFªº¤ß

½²±Ð±Â³Ì«á¤]½ÐªÑªF­Ì¬Û«H¥L , Ä~Äò¤ä«ù¤ß®®

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/6/3 ¤W¤È 10:49:50²Ä 1294 ½g¦^À³
¤µ¤ÑªÑªF·|¡A¦³°Ñ¥[ªºªB¤Í¤À¨É¤@¤U³Ì·sªº¤½¥q°T®§§a
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p½T©Ê10148065  µoªí®É¶¡:2019/6/2 ¤W¤È 12:12:40²Ä 1293 ½g¦^À³
§Ú­Ìªº¤ß¤ß¡A¥i¥H¸ò¹j¾À´×ªº¬P¬P

¤â²o¤â¤@°_¬ÝµVµV¡C

¯uªº¬OÃø¥SÃø§Ì°Ú¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/5/31 ¤U¤È 02:19:22²Ä 1292 ½g¦^À³
°·±d·s»D

³Ü¯à¶q¶¼®Æ¥i¯à·l¶Ë¤ß¦åºÞJAHA¬ã¨sµo²{¤ß¹q¬¡°Ê²§±`

¨Ó·½¡GÂå¾Ç·sµøÂI ¡@2019-05-31

med.sina.com/article_detail_103_1_66644.html

»P¹ï·Ó²Õ¬Û¤ñ¡A¶¼¥Î¯à¶q¶¼®Æ«á¡A¨ü¸ÕªÌªº¤ß¹q¬¡°Ê²§±`¡AQT¶¡´Á©µªø¡A¦Ó³o¬O¤wª¾ªºÖ`¦º­·ÀI¦]¯À¡C

¬°¤F´£¯«¡B½w¸Ñ¯h³Ò¡A¯à¶q¶¼®Æ¹ï©ó«C¤Ö¦~©M¦~»´¤H¨Ó»¡¨Ã¤£­¯¥Í¡CµM¦Ó­I«áªº°·±d­·ÀI«o¤@ª½¬°¤j²³©Ò©¿µø¡C¬ü°ê¤ßŦ¨ó·|ºX¤U´Á¥ZJournal of the American Heart Association³Ì·sµoªíªº¤@¶µ¬ã¨s´£¥Ü¡A¯à¶q¶¼®Æ¥i¯à·|¤zÂZ¤ßŦ¸`«ß¡A¤É°ª¦åÀ£¡C

¬ã¨s¹Î¶¤ªí¥Ü¡A¤j¶q«C¤Ö¦~¡B¤j¾Ç¥Í©M¦~»´¤H³£¦b³Ü¯à¶q¶¼®Æ¡A¤F¸Ñ³o¨Ç¶¼®Æ¹ï¤ßŦ¥H¤Î¨ä¥L¨­Åé¾÷¯àªº¼vÅT«D±`­«­n¡CShah³Õ¤h´£¿ô¡A¡§¦³¨ä¥L¼ç¦bªº°·±d°ÝÃDªº¤H¸s¡A¦p±w¦³QT¶¡´Á©µªøºî¦X¼x©Î°ª¦åÀ£ªº¤H¸s¤×¨ä»Ý­nª`·N¡C¡¨¦b¦P´Á¥ZµoªºªÀ½×¤¤¡A±K¦è¦è¤ñ¤j¾ÇÂå¾Ç¤¤¤ßMichael D. Winniford¤]«ü¥X¡A¹ï¯à¶q¶¼®Æªºµu´Á©Mªø´Á°·±d­·ÀI¡A§Ú­Ìªº¾á¼~»·»·¤£¤î¬O¤ß«ß¤è­±ªº¼vÅT¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/5/28 ¤W¤È 08:58:37²Ä 1291 ½g¦^À³
¹ï¤£°_! §ï­Ó¦r

¬ð¯}©ÊªvÀø«ü©w ( BTD ) :

en.wikipedia.org/wiki/Breakthrough_therapy

If the designation is no longer supported by subsequent data, FDA may rescind the designation.

¦pªG«áÄò¼Æ¾Ú¤£¦A¤ä«ù¸Ó«ü©w¡AFDA¥i¥HºM¾P¸Ó«ü©w¡C

108/05/07 ¤½¥q¤½§iªº­«¤j°T®§

´£¤Î

[

SND13§í¨î¥k±ÛÓi°ò»Ä®ñ¤Æ»Ã¯À(D-amino acid oxidase)¡A¥H´£°ª¥k±Ûµ·Ói»Ä¿@«×¡A¬¡¤Æ¤j¸£NMDA¨t²Îªº¥\¯à¡A¬O·s¾÷Âà·sÃÄ¡A¥i°t·f¥Ø«eªº§Üºë¯«¯fÃĪ«¬°¦X¨ÖªvÀø¡A¤HÅéÁ{§É¸ÕÅçµo²{¥i¥H¦³®ÄªvÀø¥¿¦V¯gª¬¡B­t¦V¯gª¬¡B»{ª¾¥\¯à´î·l¤T¤j¯gª¬»â°ì¡A

³o¶µ¬ã¨s¤wÀò¥þ²y°ß¤@¬ü°êFDA¬ð¯}©ÊªvÀøªº»{©w¡C

]

SND-13 ¥[ªo!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/5/28 ¤W¤È 08:53:46²Ä 1290 ½g¦^À³
¬ð¯}©ÊªvÀø«ü©w ( BTD ) :

en.wikipedia.org/wiki/Breakthrough_therapy

If the designation is no longer supported by subsequent data, FDA may rescind the designation.

¦pªG«áÄò¼Æ¾Ú¤£¦A¤ä«ù¸Ó«ü©w¡AFDA¥i¥H·|ºM¾P«ü©w¡C

108/05/07 ¤½¥q¤½§iªº­«¤j°T®§

´£¤Î

[

SND13§í¨î¥k±ÛÓi°ò»Ä®ñ¤Æ»Ã¯À(D-amino acid oxidase)¡A¥H´£°ª¥k±Ûµ·Ói»Ä¿@«×¡A¬¡¤Æ¤j¸£NMDA¨t²Îªº¥\¯à¡A¬O·s¾÷Âà·sÃÄ¡A¥i°t·f¥Ø«eªº§Üºë¯«¯fÃĪ«¬°¦X¨ÖªvÀø¡A¤HÅéÁ{§É¸ÕÅçµo²{¥i¥H¦³®ÄªvÀø¥¿¦V¯gª¬¡B­t¦V¯gª¬¡B»{ª¾¥\¯à´î·l¤T¤j¯gª¬»â°ì¡A

³o¶µ¬ã¨s¤wÀò¥þ²y°ß¤@¬ü°êFDA¬ð¯}©ÊªvÀøªº»{©w¡C

]

SND-13 ¥[ªo!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/5/28 ¤W¤È 08:27:25²Ä 1289 ½g¦^À³
¬ð¯}©ÊªvÀø«ü©w ( BTD ) :

en.wikipedia.org/wiki/Breakthrough_therapy

Drugs that have been granted breakthrough status are given priority review. The FDA works with the sponsor of the drug application to expedite the approval process. This expedited process can include rolling reviews, smaller clinical trials, and alternative trial designs.

¤wÀò±o¬ð¯}©Ê¦a¦ìªºÃĪ«±NÀò±oÀu¥ý¼f¬d¡CFDA»PÃÄ«~¥Ó½ÐªºÆg§U°Ó¦X§@¡A¥H¥[§Ö¼f§åµ{§Ç¡C³oºØ§Ö³t¬yµ{¥i¥H¥]¬Aºu°Ê¼f¬d¡A¸û¤pªºÁ{§É¸ÕÅç©M´À¥N¸ÕÅç³]­p¡C

SND-13¥[ªo

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/5/27 ¤U¤È 09:07:39²Ä 1288 ½g¦^À³
¤µ¤Ñ§â¦~³ø¦A¬Ý¤@¦¸

p.48 ¼gµÛ

[

3.¤½¥q¥Ø«e¤§°Ó«~¶µ¥Ø

§Ú­Ìªº¶}µo¹Î¶¤°w¹ï³o¨Ç¤¤¼Ï¯«¸g¯e¯f»â°ìÂåÀø»Ý¨D©|¥¼³Qº¡¨¬ªº³¡¥÷¶i¦æ¬ãµo¡A¦Ó¸Ó³Ð·sªvÀø¥ç±N´£¨Ñ¤F¥b¥@¬ö¥H¨Ó³o¨Ç¯e±w¥¼´¿¦³ªº§ó¦nªº¿ï¾Ü¡C§Ú­ÌÃĪ«ªº¯S¦â¥]§t¡G·sÃÄ¡B·s¾÷Â઺¬ð¯}©ÊªvÀø¡A¥i¥H¥Ó½Ð¨u¨£ÃĪ«¡]©t¨àÃÄ¡^¡B¬ð¯}©ÊªvÀøªº¸ê®æ¡B§Ö±¶ÃĪ«µo®i¡BÃĪ«­«·s©w¦ì¡B7 ¨ì7.5 ¦~´Á¿W¦ûÅv¡B¨Ó¹F¨ì·¥¤p­·ÀI¥H¤Î°ªÀò§Qµ¥¡C

¥»¤½¥qªº¹Î¶¤¦¨­û³£¬O¦U»â°ìªº±M®a¡A¥i¥Hºë·Ç¦a¹F¦¨ÃĪ«µo®i¤¤ªº¯S©w¼Ðªº¡C¨Ò¦p¡A°w¹ïºë¯«¤Àµõ¯f§ïµ½¨ä»{ª¾¥\¯à»P­t©Ê¯gª¬¡A¤ñ°_¥Ø«e¤W¥«ªºÃĪ«¡A§Ú­Ìªº²£«~¤w¸g¦³³\¦h­«­nªº¤HÅé¹êÅçµ²ªG¡A¦³¿W¤@µL¤GªºÀø®Ä¤Î¨S¦³¤£¨}ªº°Æ§@¥Î¡A³o¨Ç³£»¡©ú§Ú­Ìªº²£«~¦b¥«³õ¤W¦³±j¤jªº¾P°â¼ç¤O¡C]

]

ÁöµM¦h¦~¨Óªº¦~³ø³£¬O³o¼Ë¼g

¤×¨ä°w¹ïSND-13ªº³¡¤À---[°w¹ïºë¯«¤Àµõ¯f§ïµ½¨ä»{ª¾¥\¯à»P­t©Ê¯gª¬¡A¤ñ°_¥Ø«e¤W¥«ªºÃĪ«¡A§Ú­Ìªº²£«~¤w¸g¦³³\¦h­«­nªº¤HÅé¹êÅçµ²ªG¡A¦³¿W¤@µL¤GªºÀø®Ä¤Î¨S¦³¤£¨}ªº°Æ§@¥Î¡A³o¨Ç³£»¡©ú§Ú­Ìªº²£«~¦b¥«³õ¤W¦³±j¤jªº¾P°â¼ç¤O¡C]

µMSND-13¤]§Y±N´Á¤¤¤ÀªR , ¦U¶µ¼Æ¾Ú©Î³\¤½¥q°ª¼h¦h¦³´x´¤ , ¤×¨ä¬O«á­±©µ¦ù¤@¦~ªº¶}©ñªvÀø

©Ò¥H³o¨Ç¦r¥y , ¬O§_¤]¬O¤½¥q¦b¿Å¶qSND-13²Ä2b´Á¥i´x´¤ªº¼Æ¾Ú«á , ¤´»{¬°¥i°µ¦p¬OÆ[¶Ü?

§_«h , «ç»ò¤£°µ¤@¨Ç»y·N¤Wªº­×¥¿?

«¢«¢! ·Q¤Ó¦h¤F? ¤£¹L , ¤pªº¨Ì¦³©Ò´Á«Ý!

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/5/25 ¤U¤È 07:42:11²Ä 1287 ½g¦^À³
¥@¤W¿ç®g³Ì±jªº¦a¤è«D®Ö¹q¼t ³º¦b¦³³oºØÃa²ßºDªº¤HÅ餺¡I

2019-05-25 16:18¤¸®ðºô ¤B­»Âå¥Í

health.udn.com/health/story/10561/3833934

¨ü¨ì¹qÂ÷¿ç®g³Ì¦hªº¡AÁÙ¤£¬O¥L­Ì¡K¡K¦Ó¬O¡K¡K·Ï¥Á¡I

¦]¬°­»·Ï¤º¨ã¦³©ñ®g©Êªº°z©M¹]¡A¦]¦¹¡A¨C¤@¦ì·Ï¥ÁªºªÍ³¡¥­§¡¨C¦~·|¨ü¨ì160000·L¦è¥±ªº¿ç®g¡I¤@¦¸CT±½´y·|±µ¨ü7000·L¦è¥±ªº¿ç®g±j«×

¦pªGÁÙ¬O¥Î­»¿¼¨Ó°µ¤ñ¸û¡A¤W¹Ï¸Ì­±³Ì¤pªº®Ø®Ø¬O§Ú­Ì¥­§¡¨C¤H¨ü¨ì¿ç®g¥»©³¼Æ¾Ú¡A¨º·Ï¥Á¨C¦~¦Û¤º¦Ó¥~¨ü¨ìªº¿ç®g¶q´N¬O³Ì¥~ªº¨º­Ó®Ø®Ø®@¡C

¦n¤F¡A¤U¦¸¦pªG¦³¤H°Ý°_§A¡A°µ©ñ®g©ÊÀˬdªº¦M®`ªº®É­Ô¡A½Ð§A§i¶D¥L­Ìªº¦P®É¡A¤]§i¶D¥L­Ì³o¥ó¨Æ¡G§l·ÏªÌªºªÍ¨ü¨ìªº¿ç®g¦p¦¹¤§¤j¡I¯uªº¾á¤ß¿ç®g¡A½Ð¥ý§ÙµÒ§a¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/5/24 ¤W¤È 11:01:00²Ä 1286 ½g¦^À³
°Ñ¦Ò

JNJ ªº Spravato ªºµP»ù(?) (ÁÙ¬O³o»ò¶Q?)

Known as esketamine and marketed as Spravato, the nasal spray was developed by Johnson & Johnson (JNJ).

The initial month of therapy can cost from $4,720 to $6,785, while subsequent treatment can cost $2,360 to $3,540.

The annual tab might run from $33,000 to about $49,200.

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a !

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªN­ô10148223  µoªí®É¶¡:2019/5/23 ¤W¤È 11:24:26²Ä 1285 ½g¦^À³
ok ©ú¥Õ¡C¤£·|¦b¦¹¯d¤UÁpµ¸¸ê°T¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GªN­ô10148223  µoªí®É¶¡:2019/5/23 ¤W¤È 09:36:55²Ä 1284 ½g¦^À³
¦³¤H­n¤@°_¥h°Ñ¥[ªÑªF·|¶Ü??

­nªº¥´+1

¨Ó¶}¹ÎÅo!!

¶}ªÑªF·|¦ÛµM¬O¨S°ÝÃD¡A¦ý½Ðª`·N¥»ºôª©³W¡A

½Ð¤Å¦b¦¹¯d¤U¥ô¦ó§Î¦¡¤§Ápµ¸¤è¦¡¡A·q½Ð°t¦X¡AÁÂÁ¡IBY¥²´Iºôª©¥D

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/5/21 ¤U¤È 09:09:39²Ä 1283 ½g¦^À³
«i©¹ª½«e¤j©Ò¨¥¬Æ¬O¡A

´N¬O¿úªº°ÝÃD¦Ó¤w¡A¯E­ô±b¤W¸êª÷©|¨¬¡A

¤µ¦~¤´¼W¸ê¹w­p¶Ò20»õ¤¸¡A

§Æ±æ¤ß®®¦b¨p¶Ò¤W¤]¯à¶¶§Q¡A

¤ß®®¥[ªo¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2019/5/21 ¤U¤È 07:18:22²Ä 1282 ½g¦^À³
§Ú·Q, ²{¦b¨Ó°Q½×¯u°²®®°g©Î¬O¥Î¥´¸¨¤ôª¯¨Ó§Î®e, ·N¸q¨ä¹ê¤£¤j

¥H²{¦b³o¼Ëªº»ù¦ì©M¨«¶Õ, ·|¨ÓÃöª`¥»ª©ªº, ´X¥G³£¬O®³¥X¯uª÷¥Õ»ÈªºªÑªF

¦ó¤£¥­¤ßÀR®ð¦a¨Ó¬Ý«Ý¦U¤è«Ø¨¥?

¤p·ç¤j´£ªº¦~³ø¤¤ªº¶i«×, ªº½T¤]¬O²³¦hªÑªFÃö¤ßªº³¡¤À, ¦Anarrow down ¨Ó¬Ý°ÝÃDªº®Ö¤ß, ¤£¹L´N¬O¿ú!

¸êª÷¦³¤F, ·íµM©Ò¦³¨ú±oINDªºpipeline³£¬O·Q·íµMº¸ªº¥i¥H¶}©l¦¬®×, ©Ò¥H¦³°Ñ»PªÑªF·|ªºªB¤Í­Ì, ­Ë¬O¥i¥H¦n¦n¤F¸Ñ¨ì©³³o³¡¤À¤½¥qªº³W¹º¦p¦ó? ·íµMÁ{ªÑ·|¤W½²±Ð±Â¦³´£¨ì²³¦h¿ï¶µªº¥i¯à©Ê, ¥i¬O²´¬Ý®É¶¡¶i¹G,(¤£ºÞ¬O¤½¥q²{ª÷¬y©Î¬O°ê»ÚÄvª§¹ï¤â³°Äò¶}ªáµ²ªG), ¤½¥q¬O¤£¬O¥i¥H¤À¨Éµu¤¤ªø´Áªº­pµe? ¦Ó¤£¬OÅýªÑªFµL¤îºÉªºµ¥«Ý

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/5/21 ¤U¤È 04:16:45²Ä 1281 ½g¦^À³
­Y­n±´°Q¤½¥q³o´X¦~ªº¶i«×¡A

¨ä¹êÅu¶}¦~³ø³Ì¹ê¦b¡A

³o´X¦~¦~³ø¸Ì­±¹ïÃĪ«Á{§Éªº³W¹º¥J²Ó¬Ý¹L¡A

¥i¥Hµo²{¨ä¹ê¨C¦~³£¬Odelay¡ASND-14¦b105¦~¦~³ø·í®É³W¹º106¦~¤U¥b¦~±Ò°Ê¦¬®×

SNG-12¦b106¦~¦~³ø·í®É³W¹º107¦~¤U¥b¦~±Ò°Ê¦¬®×

³Ìªñµo¥¬ªº107¦~³ø¤S¦A«×¼gSND-14¹w­p107¦~¤U¥b¦~¨ì108¦~¤W¥b¦~±Ò°Ê¦¬®×¡ASNG-12¹w­p108¦~¤U¥b¦~±Ò°Ê¦¬®×¡A

¤µ¦~©³¥i¥H¦A¨ÓÀËÅ礽¥qªº¶i«×¬O¤£¬O¦p¹w´Á¶}®i¡A

¦pªG¤S¦A«×¸¨ªÅ¡A¤]³\¬O§ë¸ê¤H¤£°÷¤O®¼¤½¥q¡A¾É­P¦¬®×µLªk®i¶}??

¤ß®®µo¤j°]!

¤ß®®µo¤j°]!

¤ß®®µo¤j°]!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GGPF10138950  µoªí®É¶¡:2019/5/21 ¤U¤È 04:04:55²Ä 1280 ½g¦^À³
¡u¥Ê¥Ð¤£¯Ç¼i¡A§õ¤U¤£¾ã«a¡C¡v

¥H¥´¸¨¤ôª¯ªº¤è¦¡¨Ó¤ä«ù¤½¥q¡K¡K¤]½}¡I

¥uÄ@¤ß®®ªºÄ@´º¯à¹ê²{¡C¡u¡K¡K§Ú­Ì¤@°_§V¤O¡AÅý¥¢¸¨¼~Æ{ªº«C¤Ö¦~¡A¥H¤Î¥¢¾Ð©t±Iªº¦Ñ¦~¤H¡A­«¬B¤ßÆFªº°·±d¡C¡v

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/5/21 ¤U¤È 02:01:08²Ä 1279 ½g¦^À³
¯E­ô¬O¤p§Ì²Ä¤@®a§ëªº¥Í§Þ·sÃÄ¡A¤ß®®¬O¤p§Ì§ëªº²Ä¥|®a¤F¡A

ÁöµM±b¤W¥u¦³·l¡A¨S¦³¯q¡A¦ý¤p§Ì¤º¤ßÁÙ¬O«Ü»{¦P¥xÆW¥Í§Þ²£·~ªº¡A

ÁöµM¨­Ã䪺Âå®vªB¤Í³£¤£»{¦P¥xÆW¥Í§Þ·sÃĤ½¥q(¥]§t¯E­ô©M¤ß®®)¡A

¬Æ¦ÜÁÙ¦³±q¨Æ¨ÖÁʪº«ß®vªB¤Í¸ò¤p§Ì»¡¥L­Ó¤H¹ï°ê¤º³¡¥÷·sÃĤ½¥qªº¬Ýªk(°¾¦V­t­±©~¦h)¡A

¦ý¤p§Ì¨ÌµM¹ï¥xÆW¥Í§Þ·sÃĤ½¥q©ê«ù»{¦P»P¤ä«ù¡A

²{¦b¤p§Ì¤]¬O·|±`¨ì¯E­ôª©¤W¬Ý½Ñ¦ì«e½úªºµo¨¥¡A

¯E­ôª©¤WÁöµMªñ¨Ó§N²M³\¦h¡A¦ý¦Ü¤Ö¦U¤è¬Ýªk¤]¬O¯àÀò±o´L­«¡A

¤ÏÆ[¥»ª©²{¦b¥u­n¦³§Æ±æ¤½¥q¶i¨B©M§ï¶iªº¦a¤è¡A´N­n³Q½èºÃ¡A

¹ê¦b¬O¥O¤H·P¹Ä¡A

³Ìªñ¤£¸T¦^·Q°_¯E­ô¤@­±¬Ý¦n¤§®É¡A¤Ö¼Æ«Øij¤j®aÂÔ·Vªº¨¥½×°¨¤W³Q¸s°_§ðÀ»¡A

¦ý¦^ÀY¨Ó¬Ý¡A·í®É³Ì¾ÖÅ@¯E­ô¡A§¹¥þ¤£®e³\¤£¦PÁn­µªº±b¸¹²{¦b³£¾PÁn°Î¸ñ¤F¡A¹ê¦b¥O¤H¤£³Ó®D¼N!

¯E­ô©M¤ß®®¬O¦³§Þ³Nªº¦n¤½¥q¶Ü? ¤p§Ì§¹¥þ«H¥ô¯E­ô©M¤ß®®ªº§Þ³N¡A¤]«H¥ô±i¸³©M½²¸³ªº¤H«~¡A

²{¦b¬Ý¯E­ô¡Aı±o¯E­ô¸g¾ú¹L¸Ñª¼­·¼É¤§«á¡A

¤½¥q¤w¸g¦³¤j´Tªº½Õ¾ã¡A²£«~½u§ó¦h¤¸¡A¤@ª½Ã­¨B«e¶i¡A³o¤]¬OÅý¯E­ô§ë¸ê¤H«ÜªY¼¢ªº¦a¤è¡A

¤ÏÆ[¤ß®®¯Ê¥F¯E­ô³o¼Ë¦³¤Oªº¤jªÑªF¡A¦h¶µÃĪ«µLªk¶i¤JÁ{§É¡A

§ë¸ê¤H¦pªG¹ï¤½¥qªº²{ªp·P¨ìº¡·N¡A¤]¬O®¼¯«©_ªº¡A

¤p§Ì¹ê¦bµLªk®e§Ô³oºØ¥u­ã¤@¨¥°óªº¨¥½×¡A¦b³o©M²q·Q¤j»¡Án©êºp¡C

¤ß®®µo¤j°]!

¤ß®®µo¤j°]!

¤ß®®µo¤j°]!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GGPF10138950  µoªí®É¶¡:2019/5/21 ¤W¤È 11:46:57²Ä 1278 ½g¦^À³
¡§¥q°¨¬L¤§¤ß¡¨

µLX°g¡I

¦óÂç²M¡H

265¦Ü43.4¤~¹îı¡A«áª¾«áı¦Ü·¥¡I

·PÁÂ ²q·Q ¤j¤j

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G§õ©ú¼w10148198  µoªí®É¶¡:2019/5/20 ¤U¤È 02:42:07²Ä 1277 ½g¦^À³
¤jªÑªF¦­´Nµo¤j°]°Õ¡I¤p´²¤á´N¨Ä¨Ä

·í­´µæ§a¡I

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GJerry10148116  µoªí®É¶¡:2019/5/20 ¤U¤È 02:34:52²Ä 1276 ½g¦^À³
¤ß®®µo¤j°]¡I

¤ß®®µo¤j°]¡I

¤ß®®µo¤j°]¡I

³¯ÀRµo¤j°]¡I

³¯ÀRµo¤j°]¡I

³¯ÀRµo¤j°]¡I

³o¼Ëºâ¬O¯u®®°g¡H°²®®°g¡HÁÙ¬O»Ä¥Á¡H

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/5/20 ¤U¤È 02:23:06²Ä 1275 ½g¦^À³
·PÁªáªá¤j¡B«i©¹ª½«e¤j¡Bseniorbbs¤j,

ÁÙ¬O§Æ±æ¤ß®®¦n¦n¥[ªo¡A°£¤F§Þ³N­±ªº§V¤O¥~¡A°]°È©M¸gÀ給²¤¤]­nÄ~Äò§V¤O¡A

³Ìªñ¬Ý¤Ó¶§¯à²£·~ªººGª¬¡A

Åý§Ú·Q°_2008¦~¤W¥b¦~°Ñ¥[³Ð§ë·~ªº»E·|¡A

®u¶¡¤@¦ì¬ï±ô¨â©¤§ë¸êªº³Ð§ë¦Ñ¸³¦V¤j®a¥Üĵ¥xÆW¤Ó¶§¯à²£·~«e´º¤£§®(¥D¦]¤j³°±U°_)¡A

³o¦ì¦Ñ¸³ªº¹w¨¥¦¨¯u¡A¥xÆW¤Ó¶§¯à²£·~³£±¾¤F¡A³s¥x¿n¹qªº§ë¸ê¤]»{½ß¥X³õ¡A

¦^ÀY¨Ó¬Ý¡A¤Ó¶§¯à²£·~¯uªººÙ±o¤W¬¡¤U¨Ó¡A¦Ó¥BÄ~ÄòÁÈ¿úªº¡A

¥u³Ñ¤¤¬ü´¹(ÁöµM¥L¬O¾a¤Á³Î¥X¥hªº¤l¤½¥qÀò§Q¡A¦ý¤]ºâ¬O¬¡¤U¨ÓÄ~ÄòÁÈ¿ú)¡A

¤¤¬ü´¹¯à¬¡¤U¨Ó¡A´N¬O¾a¿c¸³ªº¸gÀ給²¤¦¨¥\¡A

ÁöµM¨C­Ó²£·~®t²§«Ü¤j¡A¦ý¸gÀ給²¤ÁÙ¬O¥ø·~¯à§_§§¤jªºÃöÁä~

§Æ±æ¤ß®®¦U¤è­±³£¶V¨Ó¶V¦n¡C

¤ß®®µo¤j°]~~

¤ß®®µo¤j°]~~

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/5/20 ¤U¤È 12:49:09²Ä 1274 ½g¦^À³
¤ß®®µo¤j°]!!!!

¤ß®®µo¤j°]!!!!

¤ß®®µo¤j°]!!!!

¤ß®®µo¤j°]!!!!

¤ß®®µo¤j°]!!!!

¤ß®®µo¤j°]!!!!

¤ß®®µo¤j°]!!!!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GYendis10145808  µoªí®É¶¡:2019/5/20 ¤W¤È 09:36:06²Ä 1273 ½g¦^À³
¬Ý°_¨Ó¤@¤â¦nµP¥i¥H¥´¦¨³o¼Ë¤]¯uªº¬O¨ØªA½²¸³¤£¹L¸Ü»¡¦^¨Ó½²¸³¯uªº¬O¤£À´±o¸gÀ礽¥q´Nºâ¦³¦nªF¦è¤]«Ü¦³¥i¯à§â¤½¥q°µ­Ë
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gªáªá10145954  µoªí®É¶¡:2019/5/20 ¤W¤È 05:47:43²Ä 1272 ½g¦^À³
³¯ÀR¤j

§A¤£´N¦n´Î´Î,§A³Ì§Q®`

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G³¯ÀR10141886  µoªí®É¶¡:2019/5/19 ¤U¤È 11:36:28²Ä 1271 ½g¦^À³
¦³°²Áú¯»´N¦³°²®®°g¡AÂ礣²Mªº¡CµL½×¯u°²¡A¨ü®`ªº¬OÁú¡B®®¡A
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2019/5/19 ¤U¤È 10:33:46²Ä 1270 ½g¦^À³
¤p·ç¤jªº¦^ÂÐ¬Û·í¤¤ªÖ +1

¤jÁp·ùªº·í¬õ¬µ¤lÂû, ©Î¦h©Î¤Ö³£«Ý¹L¤pÁp·ù, ª½¨ì¥i¥H®³¥X¹³¼Ëªº¦¨ÁZ, ¤~¯à¤@ÅD¦Ó¦¨¥Ø¥úµJÂI

ºîÆ[ª©¤W¥ý¶i¹ï¤ß®®´£¥Xªº·Qªk©MºÃ´b, ³£¬O§Æ±æ¤ß®®§ó¦n, ¦³¥ô¦ó´c·N§ð°P¤§³B¶Ü? ³¯ÀR¤j©Ò´£ªº°ê»Ú¬×, ¦pªG¤ß®®¥i¥H¨«¨ì¦¨¥\ªº¨º¤@¨B, ¥¼¹Á¤£¬O¥xÆW¤§¥ú, ¬Û«Hª©¤Wªº¦U¦ì¤@©w¤]»P¦³ºa²j

¥u¬O¦b¨«¨ì°ê»Ú¬×¤§«e, ¦³¦h¤ÖÃö¥d­n§JªA? ¥ú¬O¿ð¿ðµLªk¶}®iªºÁ{§É©MÁ{§É©Ò»ÝªºÃe¤j¸êª÷, ´N¤w¸gÅý¤ß®®»q¨¬¤£«e

ªÑ»ùªº§C°g¤w¸g¥H¦~­p¤F, µL¶·¦A©ì±Àµ¹¥ô¦óªÑªF, ¨C­ÓªÑªF¹ï©ó§ë¸êªº·Qªk¤£¦P, §Ô¨üªÑ»ù¾_Àúªº½d³ò¤]¤£¦P, ¬Æ¦Ü¤H¥ÍÁ`·|¹J¨ì»Ý­n¸êª÷ªº®É­Ô, Ãø¹D¥s¤H®a¤£­n½æ¶Ü? ¬JµM¶i¤F¼p©Ð, ´N¤£­n³Û¼ö, ¦³¤H¶i¦³¤H¥X, ¬O¦A¦ÛµM¤£¹Lªº, ¥u¬O³o¼Ëªºª^³ò³y¦¨·Q¥Xªº¤j©ó´±¶iªº¤H, Ãø¹DÁÙ­n©ÇªÑªF½æªÑ¶Ü? §Ú·Q¤j®aÃö¤ßªº³£¬O¸gÀç¼h­±ªº°ÝÃD, ¦pªG¨ä¥L¨ú±oINDªº trials ¥i¥H¶¶§Q¶}®i, ¤£ºÞ¬O¸êª÷©Î¬O¹êÅç«ùÄò¦³¶i«×, Ãø¹DÁ٩ȨS¦³¶R½L?

·Q¥´°ê»Ú¬×, ¤j®a³£·Q§a! ²{¹ê¬OªÑ»ù¦p¦¹, °ê»Ú½Í§P? ¶Ò¸ê? »ù®æ·|¦n¶Ü? ¤â¤W¤T´ÁªºSND-13 ³£­n¾a¶Ò¸êÄ~Äò³Ý®§, §Ú·Q³o¤~¬OÅýª©¤W¤j¤j¶Ø¹Äªº¥D¦]§a

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gªáªá10145954  µoªí®É¶¡:2019/5/19 ¤U¤È 07:58:09²Ä 1269 ½g¦^À³
¤p·ç¤j

±z¹ï³¯ÀR¤jªº¦^ÂЧڵ¹±z100¤À

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/5/19 ¤W¤È 11:09:20²Ä 1268 ½g¦^À³
ªZ¥Ð»sÃÄ ( TAKEDA )2019/05/14 °]³ø FORM 6-K

last10k.com/sec-filings/tak

´¦ÅS

TAK-831 ¦b ¾AÀ³¯g Friedreich¡¦s ataxia ªº II(a) ´ÁÁ{§É¤¤¤î (P.6)

²z¥Ñ :

Efficacy data from the proof-of-concept study of TAK-831 in Friedreich¡¦s ataxia did not meet prespecified criteria to justify further development in this indication.

¦ý¬O

TAK-831 °w¹ï Negative symptoms and/or cognitive impairment associated with schizophrenia

ªº Phase-II(a) Á{§É¤´Ä~Äò¶i¦æ¤¤ ( P.4 )

¶È¨Ñ°Ñ¦Ò

ÁÂÁ¤j®a!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/5/18 ¤U¤È 07:16:19²Ä 1267 ½g¦^À³
³¯ÀR¤j¡A

Å¥±z½Í¦R¤]¬O»á¦³¨£ÃÑ¡A¤]¥²©w¬O¹¡Åª¸Ö®Ñ¤§¤H¡A

³o¸Ìªºª©¤Í«ùªÑ¤£½×¦h¤Ö¡A¤]³£¤@ª½¤ä«ù¤½¥q¡A

´N¹³®a¤H¦n¤Í¦P¨Æ¤§¶¡¡AÁa¨Ï¦b¿Ë±K¡A¤]Ãø§K·|¦³§Æ±æ¹ï¤è§ï¶i¤§³B¡A§ó¦óªp¬O§ë¸êªº¤½¥q¡A

³¯ÀR¤j¤S¦ó­W¥Î»Ä¥Á¤G¦r«õ­Wª©¤Í¡A

­Y³¯ÀR¤j¤£³ß³o¨Ç¨¥½×¡Aª½±µ¤Ï»é©Î¬O´£¥X­Ó¤H¬Ýªk¤]«Ü¦n¡A°£«D³¯ÀR¤j§Æ±æ³o­Óª©¥u¯àºq¥\¹|¼w¡A¤½¥q©Ò§@µL¾Ó¥iÀ»¡A¨º¤p§Ì¤]µL¸Ü¥i»¡¤F

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G³¯ÀR10141886  µoªí®É¶¡:2019/5/18 ¤U¤È 02:22:34²Ä 1266 ½g¦^À³
¥xÆW¥Í§Þ²£·~¨S§Þ³N¨S¸ê¥»¸g¯E¹©¤w¸g¥´¦^­ì§Î¡C¤ß®®°ß¤@¥X¸ô´N¬O§ï¥´°ê»ÚªM¡C°·¨È°÷¤£¤W¬O°ê»Ú¥ë¦ñ¡B¥u¦³½æªÑµoªÑ§Q¤@³~¡A³Ìªñ¯ÉÊðªÑ»ùªi°Ê´N³o»ò¤@¦^¨Æ¡A³o»ò¦h»Ä¥Á°_¨­§ðÀ»¤ß®®¡A説±e¤H¦ÛÊð¤]ÁÙ®¥ºû¤F¡BÃø¤£¦¨¶Ò¸ê¥Ñ»Ä¥Á¥D¾É¡H¨º´N§¹¤F
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/5/17 ¤U¤È 10:11:46²Ä 1265 ½g¦^À³
¬Ý§¹¤Q¤jªÑªFµ²ºc¡Aı±o¶V¨Ó¶V¦³½ì¤F........¬O¼~¬O³ß....Åý§Ú­ÌÄ~Äò¬Ý¤U¥h
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2019/5/17 ¤U¤È 09:25:24²Ä 1264 ½g¦^À³
¦~³øÀ³ÃÒ¤F5/13´£¨ìªº...­ì©lªÑªFXX¤½¥q¤@ª½¥X...­Ó¤H¤j©@¤@ª½±µ...

·s¼WªºªL©m¤jªÑªF¨S°O¿ùªº¸Ü¤]¬O«ÒÄ_¤j¤á...

­Ó¤H¤j¤á­Ì³o¤@¦~¨Ó¤j¼W«ùªÑ...¦³­@¤ßªºªø´Á§ë¸ê¾Ô¤Í­Ì...«ùÄò¬Ý¤U¥h§a...

·|­û¡G¤p©¯¹B10141538 µoªí®É¶¡:2019/5/13 ¤W¤È 10:20:54²Ä 1237 ½g¦^À³

3/08¶g¤é 50±i«ùªÑ¥H¤W¦û82.707%

5/10¶g¤é 50±i«ùªÑ¥H¤W¦û82.938%

­ì©lªÑªF°·X¤@ª½¥X..³£³Q½Ö±µ¨«¤F?

ÀR¤U¤ß¦n¦n«ä¦Ò...¬°¤°»ò¦³¤j©@´±¤@ª½±µ...

¦³¨Ç¨Æ¤£¤@©w¬O§Ú­Ì¬Ý¨ìªº...¬Ý¤U¥h...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/5/17 ¤U¤È 07:09:35²Ä 1263 ½g¦^À³
¦~³ø¥X¨Ó¤F ¬Ý¤F¤@¤U10¤jªÑªF, ¤pS®a±Ú¦³¤»¤d¦h±i, ÁÙ¦³¤@­ÓªL©m¦ÛµM¤H, «ùªÑ¤]ÆZ¦hªº
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/5/17 ¤U¤È 02:37:35²Ä 1262 ½g¦^À³
¤j¤á¤j&¤p´²¤á¤j§¹¥þ»¡¥X¤p§Ìªº¤ßÁn¡A

¦³¹ê½èªº§Q¦h©M¶i®i¡A¤~¦³¿ìªk¤ä¼µªÑ»ù¨«¥X¤@­ÓÁͶաA

§_«hµu¼Èªº¤Ï¼u¥u¬O§l¤Þ¤j®a¶VÅu¶V¥­¡A

¤ß®®ªº§Þ³N¬O¨S°ÝÃDªº¡A

ÃöÁäÁÙ¬O¦b¹êÅç¶i«×¡B¸êª÷¶Ò¶°¡B°Ó·~¦X§@¡A

³o¤T­Ó­±¦V¦³¨S¦³¹ê½è¶i®i¡A

¦b¨S¦³©úÅã¶i®i¤§«e¡AªÑ»ù¬OÃø¨«¥X¦V¤WÁͶժº¡A

·Q­n¥[½Xªº¤ß¤Í¡A­n¦Ò¶q¦Û¨­¸ê²£²Õ¦X°t¸m¡A

¦b­·ÀI©Ó¨ü½d³ò¤º§ë¸ê¡A

¤Á¤Å¦]¬°¥[½X¦Ó¾É­PºÎ¤£µÛ¡B¦Y¤£¤U¡A¼vÅT¤ß±¡©M¥Í¬¡¡A

ÁÙ¬O¦^Âk¤@¥y¸Ü¡A³o¬O¤@³õ«ù¤[¾Ô¡A­n¥Î¥´8¦~§Ü¾Ôªº¤ß±¡­±¹ï¡A

¤Á¤Å¬Ý¨ì¤Ï¼u´N¥H¬°­n­¸¤Ñ¤F¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤j¤á¤H®a10140174  µoªí®É¶¡:2019/5/17 ¤U¤È 01:11:08²Ä 1261 ½g¦^À³
¬Ý¬Ý¹j¾Àªº¬P¬P´Nª¾¹D¦h¤Ö¦¸ªº¤@¨â¤é¤jº¦«á,Åܦ¨²{¦bªº¼Ë¤l.¨S¦³¦ñÀH¯u¹ê§Q¦hªº¤Wº¦,¤§«á±`³£¬O¦ñÀHÄ~Äòªº¯}§C.
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p´²¤á10147972  µoªí®É¶¡:2019/5/17 ¤U¤È 12:12:32²Ä 1260 ½g¦^À³
¤@¤éªº¤jº¦ ¥u¬O¬°¤FÄF§ó¦h´²¤á¶i³õ¡AÅý¤j®aı±oÁÙ¦³§Æ±æ¡C¤×¨ä¬O¤@¸ô¤£Â÷¤£±óªº¤pªÑªF¡A§ó·|±Ç¤f³U¯{¿ú¥h¶R¡C³Ì«á¶VÅu¶V¥­¡C¦pªG¤ß®®¥¼¨Ó³o»ò¼ÖÆ[¡A¤£·|²_¸¨¨ì³o¼Ë¡C°ê»Ú¤jÃļt¤]¤£¬O²Â³J¡A¯uªº¦³¼ç¤O¦³¥¼¨Ó¡A¦­´N±·µÛ´X»õ¬üª÷¤Wªù­n¨D¦X§@©Î¬O¨ÖÁÊ¡C³o­Ó°Q½×ª©¥Rº¡¤F¼ÖÆ[µo¨¥ªº¤H¡A¦ý¨Æ«á¨Ó¬Ý¨C¦¸(Á{®É)ªÑªF·|ªº®ø®§¡A³£¬OÃa®ø®§¡C§O¦A³QÄF¤F¦U¦ì¡A§Ú¨¥ºÉ©ó¦¹¡C¥¼¨Ó§Ú¤]¤£·|¦Aµo¨¥¡A¯¬ºÖ¦U¦ì¡C
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2019/5/17 ¤W¤È 11:34:20²Ä 1259 ½g¦^À³
ªñ´Á104¤H¤Oºô¬Ý¨ì¤½¥q¤jÁ|¼x¤H10¶µÂ¾¦ì...

¨ä¤¤ªk°È¤H¨Æ¸g²z¦L¶H¤¤¦n¹³¨S¦³³]¸m¹L...

«e°}¤l¦Ë¬ì¯²¦a®×¤]¤£ª¾³Ì·s¶i®i¦p¦ó...

ªÑªF·|§Ö¨ì¤F...¤½¥q¨ì©³·Q·F¹À?

ª©¤W¦U¤j¤j...¿ãÅD¥X®uªÑªF·|§a!

©Î³\ªÑªF·|Ãz´×...¤½¥qª¾¦W«×¤]¯à¤j´T¼W¥[...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤j¤á¤H®a10140174  µoªí®É¶¡:2019/5/17 ¤W¤È 10:46:44²Ä 1258 ½g¦^À³
¤jº¦¤@¤Ñ,¥Nªí¤°»ò? ¬O¤î¶^ÁÙ¬O·Ç³Æ¦A¯}©³? ºCºC¬Ý¤U¥h.
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GYOYO10140343  µoªí®É¶¡:2019/5/17 ¤W¤È 09:43:58²Ä 1257 ½g¦^À³
¤µ¤éÁ`ºâ¦³¶R½L,³o®É³{§C¥[½X,¦n³B¦h¦h,²Ä¤@:­×²z§âªÑ»ù¥´¤U¥hªºªÅÀY,·íªÑ»ù¤Ï¼u,´N¬O½æ¦b§CÂIªº¤H¶Ì²´ªº®É­Ô,¦ó§«Åý¥L­Ì¶Ì²´¤@¤U; ²Ä¤G:¥Ø«eªÑ»ù¦bªø½u§CÂI,³o»ù¦ì,¥i¥H§â¦Û¤v¦¨¥»擹¥­; ²Ä¤T:¤»¤ëªÑªF·|«á,¦p¦³±ÂÅv©Î¨p¶Ò§Q¦h,ªÑ»ù´N¤£®e©ö¦A¤U¨Ó; ¤ß¤Í­Ì²{¦b³Ì·Qªº¨Æ±¡À³¸Ó¬O§â°·Xªº«ùªÑ¥Î§C»ù¬~¥ú, ¬~§¹¤F,¥»ÀÉ´Á±æ¦Û¤v¯à¨«¥X¤@¤ù¤Ñ,©Ò¥H¤@±i¤£¶û¤Ö,¤G±i¤£¶û¦h,¹sªÑ¤]¥i¶R,¤½¥qªº»ù­È¦Û¤v±Ï.
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/5/16 ¤W¤È 11:05:56²Ä 1256 ½g¦^À³
°ê¹©¢±¢¯¢°¢¯¦~¢´¤ë¤W¿³Âd¦Ü¤µº¡¢¸¦~¡A¤W¿³Âd»ù®æ¢²¢¯¦h¡A¤j³¡¤À®É¶¡ªÑ»ù³£¦b¢±¢¯¡ã¢³¢¯¶¡¨Ó¦^¡A

¤µ¤Ñ¯¸¦^¢´¢¯¤¸¡C

¤ß®®¢±¢¯¢°¢µ¦~¢°¤ë¤W¿³Âd¦Ü¤µ¢²¦~¢³­Ó¤ë¡AªÑ»ù¤µ¤Ñ«ùÄò³Ð·s§C¡A

¹ï·Ó°ê¹©«ùÄò¦hºØÃĪ««ùÄò¶i¦æÁ{§É¡A¶Ò¸ê¤]¶¶§Qªº±¡§Î¤U¡AªÑ»ù¤´µM¥²¶·îh¥ñ¦h¦~¡A

¤ß®®Á{§É¶i«×«D±`ÈнwºCÈСA¥¼¨Ó¤´¦³«Üº©ªøªº¤@¬q¸ô­n¨«¡A

¤ß¤Í­Ì¥[ªo¡A¤j®a­n°í«ù¦í¡A³o¦¸ªÑªF·|¤]­n½Ð¤½¥q­n¥[ªo¡A

·íª¾¹D¤ß®®¦³¬ãµo¥¢´¼ÃĪ«®É¡AÁÙ«Ü°ª¿³¸ò¿Ë¤Í»¡ªø½ú­Ìªº¥¢´¼¦³ÃĤF¡A

¦ýµ¥¨ì²{¦b¨ÌµM¨S¦³¼v¡A¥u¦³µL©`¤G¦r¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/5/16 ¤W¤È 10:53:16²Ä 1255 ½g¦^À³
²q·Q¤jªº¤ß±¡¡A´N¬O²³¦h¤ß¤Í­Ìªº¼g·Ó¡A

¤p§Ì¹ï°ê¹©¹L¥h¨S¬ã¨s¡A

­è­èªáÂI®É¶¡¥h¤F¸Ñ°ê¹©ªºµo®i¹Lµ{¡A

­ì¨Ó°ê¹©¤jªÑªF°£¤F»·¶¯¤§¥~¡A¨p¶Ò¹Lµ{¤]¤Þ¶i·s´¶¡]6121¡^¸³¨Æªø§ººÖ²»¡B´¹µØ¡]2707¡^¤jªÑªF®a±Ú¦¨­û¼ï«ä·½¡B¥ßÀB¡]6286¡^Á`¸g²zÁ¨û«G¡A°ê¹©¤µ¦~¤]«ùÄò¨p¶Ò¤Þ¶i¸êª÷¡A

°ê¹©ªº¬ãµo¦h¸ô¨Ö¶i¡Aªü¯÷®üÀq·sÃÄÁÙ©M¼b¥ÍÄâ¤â¶i¦æ°Êª«¹êÅç¡A

¥Ñ°ê¹©ªºµo®i¾úµ{¨Ó¬Ý¤ß®®¥i¥H§ï¶i¤§³B :

1.¤µ¦~©³¸êª÷´N­n¿N¥ú¤F¡A¬°¦ó¤õ¿N§¾ªÑ¤~­n¨p¶Ò¡A°ê¤º¤£¥F¦³·N§ë¸ê¥Í§Þ·sÃĪº¤j¤á¡A

¹L¥hªÑ»ù¦n®É¡A¬°¦ó¤£¦­ÂI´N°µ·Ç³Æ¡A¤µ¦~ªÑ»ù«ùÄò¯}©³¤~­n¥Î§C»ù¶Ò¸ê¡C

2.¤â¤W¦nµP¤@°ï¡AÃö°_ªù¨Ó¦Û¤v¬ãµo¡A¬°¦ó¤£¦Ò¼{©M¨ä¥L¤j¼t¦X§@¡A

°ê¹©©M¼b¥Í¦X§@¡A¦ý¼b¥Í¤]¥u¬OÀu¥ý±ÂÅv¹ï¶H¡A¤]¨Ã«Dµ´¹ï¥i¥H®³¨ì±ÂÅv¡A

¦ý©M°ê»Ú¤j¼t¦X§@¡AÁ`¤ñ¦Û¤vÃö°_ªù¨Ó°µ¦n§a! SND-13¦¬®×¦¬¨ì²{¦b´X¥G°±º¢!!

¤ß®®ªº¤½¥q³¡ªù¦pªG¦³¦b¬ÝªO¡A½Ð§âªÑªF·N¨£¤Ï¬Mµ¹°ª¼h¡AÁÂÁ¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/5/16 ¤W¤È 10:08:52²Ä 1254 ½g¦^À³
¤W¤F¸é²î

³o¬O¶R°ê¹©·íªìªºªº·Pı , ÁÙ¦³²{¦b¤ß®®ªº·P¨ü

µM¦Ó¸é²î¤WºÉ¬O¶Àª÷¯]Ä_ÁÙ¦³¬üª÷§r , ³o¬O²{¦b«ù¦³°ê¹©ªºÂà´«¤ß±¡

¦ý¤ß®®¦ó®É¤~¯àÅý¤H¦³³oºØÅw©I?

½²±Ð±Â§r!¦³¦nªF¦è¦Ü¤Ö­n©MªÑªF¤À¨É¤~¹ï§r!

½Ð¤£­nÅýªÑªF­Ì±æªÑ»ù¤Ñ¤Ñ¤Ñ¶Â¿³¹Ä!

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G²q·Q10136148  µoªí®É¶¡:2019/5/16 ¤W¤È 07:41:00²Ä 1253 ½g¦^À³
¨ä¥L¾ÇªÌªº¬ã¨s

Neuron¡G¦Û³¬¯g©Îºë¯«¤Àµõ¥i¯à¬O¤j¸£³s±µ¤£¨¬©Ò­P

¨Ó·½¡G ¥Íª«±´¯Á ¡@§@ªÌ¡G¬ö¤j¤A¡@2019-05-15

med.sina.com/article_detail_103_1_65800.html

¸Ó¶µ¬ã¨s­º¦¸ÅçÃÒ¤F¤j¸£³s±µ¤£¨¬¬O³oÃþ¯«¸g¯e¯fªº°ò¦°²»¡¡C¥Ñ©ó°ò¦]©M½u²ÉÅé¥\¯à»Ùê¡A¤j¸£¥Ö¼hªºÃöÁ䯫¸g²Ó­M¦b¦­´Áµo¨|¹Lµ{¤¤¥Íªø¨ü­­¡A©Ò¥H³æ­Ó¯«¸g²Ó­MµLªk«Ø¥ß¥¿½T¼Æ¶qªº³s±µ¡A±q¦Ó¾É­Pºë¯«¯e¯fªºµo¥Í¡C

³ìªvµØ²±¹y¤j¾Çªº¬ã¨s¹Î¶¤¨Ï¥ÎDiGeorge/22q11¯Ê¥¢ºî¦X¼x¤p¹«¼Ò«¬§@¬°¬ã¨s¹ï¶H(¤@ºØ¤wª¾»Pºë¯«¤Àµõ¯g©M¦Û³¬¯gµ¥¯e¯f¦³³Ì°ª¿ò¶ÇÃöÁpªº±`¨£¯e¯f)¡C¬ã¨sµ²ªG­º¦¸½T»{¡A³s±µ¤£¨¬¬O¦æ¬°¯Ê³´ªº®Ú·½¡A¦Ó¤£¬O¹L«×³s±µ¡C

¨s¤p²ÕÀH«á¹ï¦¹²z½×¶i¦æ¤FÅçÃÒ¡X¡X§Y³o¨Ç²Ó­M¤¤ªº½u²ÉÅé¥i¯à¥Ñ©ó¬¡©Ê®ñºØÃþªº¼W¥[¦Ó¥\¯à¥¢½Õ¡A¬¡©Ê®ñ¤À¤l¦b²Ó­M¤¤¦Û¥Ñ¹C¿º¨Ã³y¦¨¼sªxªº·l¶Ë¡C³Ì«á¡A¬ã¨s¤p²Õ¨Ï¥Î§Ü®ñ¤ÆÀøªk¨Ó¤¤©M³o¨Ç¦MÀIªº®ñ¡§¦Û¥Ñ°ò¡¨¡A¥HÀ°§U«ì´_½u²ÉÅé¥\¯à¡C¬ã¨sµo²{¡A³oºØÀøªk¤£¶È©T©w¤F³s±µ¡AÁ٪ȥ¿¤F¦æ¬°¯Ê³´¡C

*********

ºë¯«¤Àµõ¯g©M¦Û³¬¯gµ¥¯e¯f , ¯«¸g²Ó­M³s±µ¤£¨¬¬O¦æ¬°¯Ê³´ªº®Ú·½¡A¦Ó¤£¬O¹L«×³s±µ¡C

ÁÙ¦³ ½u²ÉÅé¥\¯à»Ùê , ¬¡©Ê®ñ¤À¤l( ROS ) , ³o¨Ç¤j®a³£¬O§_¦ü´¿¬ÛÃÑ©O?

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡GEmelianenk10143395  µoªí®É¶¡:2019/5/15 ¤U¤È 07:49:58²Ä 1252 ½g¦^À³
¤p§Ì·R¤§²` ³d¤§¤Á ®¤ª½¨¥

¥ý«e¦³BTD¥úÀô

¤½¥q¥i¥HºCºC°µ §C½Õ°µ ·R«ç»ò°µ´N«ç»ò°µ

¦ý®É¶¡¨ì¤F ÁÙ¬O±o§â¦¨ªG®i²{¥X¨Ó

¤£¯à¥u¦bÁ{ªÑ·|¤W ­nªÑªF¦h¦h¤ä«ù´£®×

Á{ªÑ·|«á Ä~Äò¯«Áô

¤p§Ì²`ª¾¨C­Ó¤Hªº¨C¤@ªÑ¦³¤£¦P·N¸q

­n¬ÕÁ«¦Û­t

¦ý ¤½¥q¬O§_ÀË°Q¹L

ªÑ»ù¤Ñ¤Ñ¯}©³

¬O§C¦ô?¬O­è¦n?ÁÙ¬O¤´µM¹L«×°ª¦ô?

½Ð¦³°Ñ¥[ªÑªF·|ªº¥ý¶i

¥Î¤Oªº·þ«P¤@¤U¤½¥q

§j¤F¦n´X¦~

¬O¸Ó®³¥X¹êÁZ¤F

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«i©¹ª½«e10141841  µoªí®É¶¡:2019/5/14 ¤U¤È 08:09:13²Ä 1251 ½g¦^À³
¬Ý¨ìªáªá¤jªº§i§O, ¤ß¤¤·P¨ì«ÜÃø¹L, ¹ï©ó¤½¥qªº¬ì¾Ç©Ê, ³o³¡¤À§Ú²q¤j³¡¤ÀªºªB¤Í³£¤£·|ÃhºÃ, ²¦³º¦³¨â±iBTD¦b¤â¤F, ¦ý¬O¦b¤½¥q¸gÀ窺¤è¦V¥H¤ÎÀç¹B®i±æ¤W­±, ¬O¬Û¹ï¼Ò½kªº³¡¤À, §Ú·Q¬O¤£¬O¤j®a¤@°_·J¾ã¤@¨Ç°ÝÃD, ³Â·Ðª©¤W±N·|¥X®uªÑªF·|ªºªB¤Í­Ì, À°¦£´£¥X?

¥H¤U¤pªº¥ý©ß¿j¤Þ¥É:

Ãö©óSND-13 ¦¬®×ªº³¡¤À:

1. ³t«×©ñ½wªº¥D¦]? ¬O§_ÁÙ¬O¯à¦p¹w´Á¦b2019 Q3´Á¤¤¤ÀªR? ¦pªG»¼©µ, ½Ð°Ý¹w´Áªº®É¶¡ÂI?

2. ½Ð°Ý´Á¤¤¤ÀªRªºµ²ªG·|§_¤½¥¬?

3. ­^°êMHRA¤]¤w¸g®Ö­ãSND-13 ªº¦¬®×, ½Ð°Ý¦ó®É¶}©l¦¬®×?

Ãö©ó¤½¥qÀç¹B¸êª÷ªº³¡¤À:

1. 2¤ë¥÷Á{®ÉªÑªF·|³q¹Lªº®ü¥~±ÂÅv¤@®×, ·Q½Ð°Ý¬O§_¦³¨ãÅ骺¹ï¶H¬¢½Í¤¤? ¶i«×¬°¦ó?

2. °w¹ïSND-13¦¬®×§¹¦¨©Ò»Ýªº¸êª÷¯Ê¤f, ½Ð°Ý¤½¥q¨ãÅ骺°µªk¬°¦ó? ¥i§_¨ãÅé§iª¾ªÑªF®Éµ{»P­pµe?

3. ¦pªG¨p¶Òªºª÷ÃB¤£¨¬¥HÀ³¥ISND-13¦¬®×§¹¦¨, ½Ð°Ý¤½¥q¤U¤@¨Bªº­pµe¬°¦ó? ®É¶¡ÂI?

Ãö©ó¨ä¥L¥¼¶}®i¦ý¤w¨ú±oINDªº²£«~½u:

³o³¡¤À§Ú·Q¬O¸ò¦³µL¸êª÷¨Ó¶}®i¦³«Ü¤jªºÃö³s©Ê, ©Ò¥H·Qª¾¹D¤½¥qªºÄw±¹¸êª÷­p¹º¦p¦ó? ¨s³º¨ãÅé®Éµ{³Wµe¦p¦ó?

ÁöµM§Ú­Ì¥u¬O¤½¥q¨S¦³ª½±µ¸ò§Ú­Ì®³¿úªº¤pªÑªF, ¦ý¬O§Ú»{¬°¥u­n¬OªÑªF, ¤½¥q³£¦³¸q°È»P³d¥ôÁ¿²M·¡»¡©ú¥Õ¥¼¨ÓÀç¹Bªº¤è¦V, §Ú·Q¦b¦¹®É¦¹¨è, ªÅªxªº¤f¸¹©Î¬O·§¬A¦¡ªº¦^µª¨ÃµLªk½w¸Ñ±Y¼ìªº«H¤ß, §Æ±æªÑªF­Ì¶°«ä¼s¯q, ´£¥X°ÝÃD, ¦P®É¤]¬O¤½¥qÅýªÑªF¦w¤ßªº¤j¦n¾÷·|

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gsw5432110144762  µoªí®É¶¡:2019/5/14 ¤U¤È 02:13:40²Ä 1250 ½g¦^À³
§Ú·Q°Ý¤@¤U ·íªì¤@¨Ç¤G´Á¤T´ÁªºÁ{§É ¨ì²{¦b¤]¤w¸g¦n´X¦~¤F

³£¨S¦³¸Ñª¼ªº®ø®§¥X²{? ¦b®É¶¡¤W¦n¹³¤Ó¤[¤F ÁÙ¬O¦³¨Ç¤w¸g¦³µ²ªG¤F?

¦³¤H¥i¥H¦C¥X¨Ó ¤ß®®¦U´ÁÁ{§Éªº¹w¦ô¸Ñª¼®É¶¡? ·PÁÂ

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G«ÜµL©`10148167  µoªí®É¶¡:2019/5/14 ¤W¤È 11:36:02²Ä 1249 ½g¦^À³
³o¥»¤é°O¥Rº¡¦å²\´³´³ªºµL©`...

¹ê¦b«ÜÃø¼g¤U¥h

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gªáªá10145954  µoªí®É¶¡:2019/5/14 ¤W¤È 09:33:50²Ä 1248 ½g¦^À³
¦A¯}©³
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/5/14 ¤W¤È 09:27:20²Ä 1247 ½g¦^À³
¤p§Ì´X¦~«e´N¶}©l©M¤½¥qµ¡¤fÁpµ¸¹L¦h¦¸¡A

¦ý³q±`±o¨ìªºµªÂдN¬O1.µo¨¥¤H¦b¶}·|(¨C¦¸³£¬O¦b¶}·|) 2.¥N²zµo¨¥¤H¤£¦b¦ì¸m¤W

¨C¦¸¯d¸Ü¤§«á¤]³£¨S¦^ÂСA

¥u¦¬¨ì¦^¹q¹L¤@¦¸¡A

¤p§Ì¤]¤£¬O²Ä¤@¦¸©M§ë¸êªº¤½¥qÁpµ¸¤F¡A

¦ý»¡¹ê¦bªº¡A¤ß®®¦b©M§ë¸ê¤H¤¬°Ê³o¶ô¹ê¦b«D±`¤£¤Î®æ¡A

¤p§Ì¦b³o¦¸ªÑªF·|¤]·|¤Ï¬M¡A

¦]¬°¸ê°T¹ê¦b¤Ó¤£³z©ú¤F¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤s¥ý¥Í10024238  µoªí®É¶¡:2019/5/14 ¤W¤È 09:09:40²Ä 1246 ½g¦^À³
¦pªG¦¹¤½¥q¦b¨p¶Ò®×­n¥ÎÀ£§CªÑ»ù·d°­,¤j®a´N¿ãÅD¦bªÑªF·|µo¨¥¸ß°Ý,¤£µM´N没¾÷·|¦V¤½¥q°Q±Ð¤F.
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G§õ©ú¼w10148198  µoªí®É¶¡:2019/5/13 ¤U¤È 10:28:28²Ä 1245 ½g¦^À³
ªÑ»ù¨«ªk§â¤pªÑªF³£·d¦¨ºë¯«¤Àµõ¤F¡AÃħ@¥X¨Ó«á¡A¦³¨S¦³ªÑªFÀu´f»ù¡AªÖ©w¦³«Ü¦h¤H»Ý­n¡A°¶«v±Ð±Â
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p½T©Ê10148065  µoªí®É¶¡:2019/5/13 ¤U¤È 09:47:49²Ä 1244 ½g¦^À³
·ÓµÛ¼@¥»¨«¡A¨p¶ÒÀ£§CªÑ»ù¡A¬¢¯S©w¤H¡A

¯}©³¦A¯}©³¡A¦LªÑ²¼´«¶r²¼¡C

®É¾÷¤@¨ì©Ô°ª°ª¦b¥X³f¡AµL­­½ü°j¡A

³Ì¥i¼¦ªºÁÙ¬O­ì©lªÑªF°Ú¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gªáªá10145954  µoªí®É¶¡:2019/5/13 ¤U¤È 04:34:08²Ä 1243 ½g¦^À³
¦U¦ì¤ß¤Í­Ì¡A­n¸ò¤j®a»¡¦A¨£¤F¡A³o¦¸¯uªº·l¥¢ºG­«¡C²{¦b¤£ºÞ±q¤°»ò­±¦V¡A°ò¥»­±¡B§Þ³N­±¡BÄw½X­±¡A§Ú¹ê¦b¬Ý¤£¥X¤ß®®ÁÙ¦³¤°»ò¥i¥H´Á«Ýªº¡A·PÁ²q·Q¤j¤@ª½ªº§V¤OÅý§Ú¾Ç¨ì«Ü¦hª¾ÃÑ¡A§Ú¤£¬O¬ãµoÃĪ«ªº§Ú¥u¬O¤@­Ó¤p¨ì¤£¯à¦A¤pªºªÑ¥Á¡Aª¾ÃѦA¦h¡AÃĨS¦³¥X¨Ó¡A¹ï§Ú¨Ó»¡·N¸q¤£¤j¡C¦A¨£¤F¡A¯¬ºÖ¦U¦ì¤ß¤Í­Ì.
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gªáªá10145954  µoªí®É¶¡:2019/5/13 ¤U¤È 02:09:59²Ä 1242 ½g¦^À³
¯}©³
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤j¤á¤H®a10140174  µoªí®É¶¡:2019/5/13 ¤U¤È 01:59:48²Ä 1241 ½g¦^À³
¬°¦ó¤£²{¼WÅý­ìªÑªF»{ÁÊ, »{Áʤ£¨¬ªº³¡¤À¦A¬¢¯S©w¤H? ¤½¥q¤@­Pªº»¡ªk³£¬O¨p¶Òªº¶Ò¸ê¤ñ¸û§Ö...., ³o¨ä¹ê³£¬OÂǤf.¤j³¡¤Àªº¤½¥q¨ä¹ê³£¬O·|¹Ï§Q¯S©w¤Hªº.³o¸ÌªÑ»ùªº¤U¶^¥u¬OÅý¯S©w¤H¥i¥H»{§ó§C¨p¶Ò, ©Ò¦³ªº¼@¥»±q¨Ó³£¬OÄ묹¤pªÑªFªº§Q¯q.
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p·ç10140606  µoªí®É¶¡:2019/5/13 ¤U¤È 01:40:42²Ä 1240 ½g¦^À³
²q·Q¤j¡B¦U¦ì¤ß¤Í¤È¦w,

¶ZÂ÷2¤ëªÑªF·|¤]¹L¤F2­Ó¤ë¤F¡A

³o°}¤l¤p§Ì¦b«ä¦Ò¬JµM¤w¸g±ÂÅvµ¹­»´äªº¥S§Ì¤½¥q¡A

¬°¦ó³o¦¸ªÑªF·|¤S­nªí¨M¨p¶Ò®×¡A

­Ó¤H±À´ú³o¨ä¹ê¤j·§´N¬O¤½¥q¤w¸g¨M©w¨«¨p¶Ò¤F¡A

¥Ø«e¤â¤Wªº¹êÅç³Ì§Ö¤]­n110¦~©³¤~¦³µ²ªG¡A

¦Ü¤ÖÁÙ¦³¨â¦~¥bªºªÅµ¡´Á¡A

­Ó¤Hı±o¤ß®®³o¼Ë½L¶^ªº¨«ªk¡A

¥[¤Wµu´Á¤º¤S¨S¦³±ÂÅv®ø®§¡A

³o¤@¸ô½L¶^ªº¨«ªk©M¬P¬P¨S¨â¼Ë¡A

¬P¬P¦Ü¤ÖÁÙ¦³³\¦h­ì©lªÑªFÄ@·N¤@ª½®³¿ú¥X¨Ó¡A

¤ß®®³s­ì©lªÑªF³£¶]¥ú¤F¡A

­Ó¤Hı±o¥¼¨Ó¨â¦~¡A¤ß®®·|­±Á{§ó´H§Nªº´H¥V¡A

ªÑ»ù3¦rÀY¬O¦³¥i¯à¨£¨ìªº¡A

¥u¯à«ùÄò¥V¯v¡AÀR«Ý2¦~«áªº¬K¤Ñ¤F¡C

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p½T©Ê10148065  µoªí®É¶¡:2019/5/13 ¤W¤È 11:40:10²Ä 1239 ½g¦^À³
«Ü§Ö´N¥i¥H¬Ý¨ì3¦rÀY¤F¡C§O«æµÛ¥[½X
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2019/5/13 ¤W¤È 10:55:30²Ä 1238 ½g¦^À³
¤@­Ó°ê®aªº¸gÀÙ¦nÃa...¬Ý³o­Ó°ê®aªºªÑ¥««ü¼ÆÁͶեH¤Î¦ì¸m...

¤@¶¡¤½¥qªº¸gÀç¦nÃa...¬Ý³o¶¡¤½¥qªºªÑ»ùÁͶդΦì¸m...

ª©¤Wªø´Á¤ä«ùªº¤j¤j...¿ãÅD°Ñ¥[¤U­Ó¤ëªìªºªÑªF·|°Ý²M·¡¦UºØ¤ß¤¤ºÃ°Ý§a...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤p©¯¹B10141538  µoªí®É¶¡:2019/5/13 ¤W¤È 10:20:54²Ä 1237 ½g¦^À³
3/08¶g¤é 50±i«ùªÑ¥H¤W¦û82.707%

5/10¶g¤é 50±i«ùªÑ¥H¤W¦û82.938%

­ì©lªÑªF°·X¤@ª½¥X..³£³Q½Ö±µ¨«¤F?

ÀR¤U¤ß¦n¦n«ä¦Ò...¬°¤°»ò¦³¤j©@´±¤@ª½±µ...

¦³¨Ç¨Æ¤£¤@©w¬O§Ú­Ì¬Ý¨ìªº...¬Ý¤U¥h...

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡Gseniorbbs10144999  µoªí®É¶¡:2019/5/13 ¤W¤È 10:15:07²Ä 1236 ½g¦^À³
­«ÂIÁÙ¬O·sÃĪѳo­Ó²£·~¤£¦n§a...¤¤¸Î¡B¯E¹©¡BÃĵØÃÄ.....µ¥«ÜºG....
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤s¥ý¥Í10024238  µoªí®É¶¡:2019/5/13 ¤W¤È 09:44:09²Ä 1235 ½g¦^À³
¥t¥~¤@­ÓÆ[¹î,·í¤½¥q»P¤jªÑªF²z©À¤£¦X®É,ªÑ»ù©¹¤U¨«,¤]Åã¥Ü¤½¥q¨ÃµL¥i¾aªºª÷¥D©Îªk¤H¨Ó¤ä«ù,­Ó¤H¤]ı±o¤ß®®¤½¥q¥D¬FªÌ«Ü©_©Ç,¦Û¤v°]¤O¤£¨¬,¤S»Ý­n¥~³¡ªÑªF¸êª÷¤ä«ù,·F¹ÀÀY´ß¨º»òµw,§â¦Û¤vªÑ»ù·dÄê;¿³Âd»ù«ùÄò¯}©³,¥Nªí´²¤á¤]¥þ½ß,¤jªÑªF¤Î¤pªÑªF³£½ß,¥u¯à»¡µL©`
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤s¥ý¥Í10024238  µoªí®É¶¡:2019/5/13 ¤W¤È 09:34:56²Ä 1234 ½g¦^À³
­Ó¤HÆ[¹î¤¸¤jX©M³o¦ìªk¤H¬O¦]²z©À©Î·Qªk¤£¦P,¤~·|¤@ª½¥X²M,¨p¶Ò¹ï¶H°ò¥»¤W¤£¬O³o¦ì, ¤j®a¥u¯à¦bªÑªF·|­n¨D¤½¥q§â¦¬®×¶i«×Á¿§ó©ú¥Õ,­Ó¤H»{¬°³o­Ó½L¬O¤½¥q¸gÀçªÌ»P¤jªÑªF²z©À¤£¦X³y¦¨ªºµ²ªG,¦ý½æ¤è¤@©w½æªº¹ï¶Ü?®É¶¡·|ÃÒ©ú,¬Ý°_¨Ó½æ¤è¥u¬O·Q¥X²M,»ù®æ´NÀH«K½æ,ªÑ»ù¤Ï¼u¦A«á®¬¤]¬O¥i¹wª¾ªº
¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
·|­û¡G¤j¤á¤H®a10140174  µoªí®É¶¡:2019/5/13 ¤W¤È 09:32:31²Ä 1233 ½g¦^À³
¨p¶Ò´Nª¾¹D¬O¹ï´²¤á¤£§Qªº, ¤j³¡¤Àªº¨p¶Ò´N¬OÀ£§C»ù®æÅý¦³¤ß¤H¶i¨Ó. ³o­Ó»ù¦ì¦A¥´¤E§é,¤j¬ù´N¬O40¤¸ªþªñ.

¦^ÂÐ¥»¤å ¦^°Q½×°Ï1­¶
¤W¤@­¶12345678910¤U¤@­¶³Ì«á¤@­¶

         

¡@

§Ú¡@¡@­n¡@¡@¦^¡@¡@À³¡@¡@¥»¡@¡@¸Ü¡@¡@ÃD

·| ¡@­û¡G

  

§@ ªÌ ¡G

 

¬ÛÃöªÑ²¼¤½¥q¦WºÙ ¡G

¤ß®®¥ÍÂå

¤º¡@ ®e¡G

¡@
½Ð¥ýµn¤J ­Y±z©|µL·|­û¨­¤À¡A½Ð¥ý¥Ó½Ð±b¸¹ ¡@
¡@

°Q½×°Ï¬ÛÃö³W©w¡G
    1.­Y±b¸¹¶¢¸m¹L¤[¨t²Î·|¦Û°Êµn¥X¡A«Øij¦b¼g¦n¤å³¹¨Ã¥B©|¥¼µo°e¤§«e¥ý¦æ½Æ»s¡A¥H§Kµo°e¥¢±Ñ«á¾É­P¤º¤å®ø¥¢¡I
    2.½Ð¤Å°Q½×ªÑ²¼¶R½æ©Î´£¤Î¦¨¥æ»ù¦ìµ¥¨Æ©y¡A¤Z¬O¯d¤U¬ÛÃö¥æ©ö°T®§¡A¥»ºô±N¦Û°Ê§R°£¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    3.ÄY¸T¯d¤UÁpµ¸¤è¦¡¡A½Ñ¦pLINE¡BFB¡BE-mail¡B¹q¸Ü..µ¥¡A©Î¥H¥ô¦ó©ú¥Ü¡B·t¥Üµ¥¤âªk¶i¦æÁpµ¸¡A¹HªÌ±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    4.¬°ÁקK®ö¶Oºô¸ô¸ê·½¡A½Ð¤Å±N¬Û¦P¤º®e³sÄòµo¦b¦h­Ó¤£¦P¥DÃD¤º¡A©ÎªÌ³sÄòµo°e¦h­Ó·s¥DÃD¡A­Y¦³¦¹Ãþ¬~ª©¤§¦æ¬°±NµLªkÄ~Äò°Ñ»P°Q½×¡I
    5.ÄY¸T·N¹ÏÂǥΥ»ºô¥­¥x¤½µM´²¥¬¤å¦r©ó²³¡A¦Ó«üÂÖ¡B«V°d©Î¶Ç­z¨¬¥H·´·l¥L¤H¦WÅA¤§¨ÆªÌ¡A­Y¦]¦Ó¯A¤Îªk«ß°ÝÃD¡A·§»P¥»¤½¥qµLÃö¡A·q½Ð¿í¦u¡C

·q½Ð´L­«¥»ºô¤§¸gÀç²z©À¨Ã¿í¦uª©³W¡AÁÂÁ¡C


¼s§i¦X§@ ¥¼¤W¥«ÂdªÑ²¼¬d¸ß ¥¼¤W¥«ºô¯¸¾ÉÄý ¥¼¤W¥«ÂdªÑ²¼±MÃD ¿³ÂdªÑ²¼±MÃD ¥¼¤W¥«ªÑ²¼-¶°¹Î¤ÀÃþ ²§·~Âà§ë¸ê¥Í§Þ·~ ¤U³æ±Ð¾Ç
¥¼¤W¥«|¥¼¤W¥«ªÑ²¼|³Ì±M·~ªº  ¥xÆW¥¼¤W¥«ªÑ²¼  °]¸gºô¯¸-Copyright©2022¡£¥²´Iºô¡¤ §K¥I¶OªA°È±M½u:0800-035-178   ªA°È«H½c:postmaster@berich.com.tw
¥»ºô¯¸¬° ¥¼¤W¥«ÂdªÑ²¼¬d¸ß,¥¼¤W¥«ªÑ²¼§Y®É·s»D,¥¼¤W¥«¤½¥q¤½§i,¿³ÂdªÑ²¼¶R½æ,·Ç¤W¥«ªÑ²¼,¤¤ÅҪѠ ¬ÛÃö¸ê°T¤À¨É¥æ¬yªÀ¸sºô¯¸,¸ê®Æ¶È¨Ñ°Ñ¦Ò,¨Ï¥ÎªÌ½Ð¦Û¦æ·r°u!
¥»ºô¯¸¤£¤¶¤J·|­û¶¡¤§¥¼¤W¥«ªÑ²¼¶R½æ,³æ¯Â´£¨Ñ  ¥¼¤W¥«ªÑ²¼¦æ±¡,«ùªÑÂàÅý,¥¼¤W¥«ªÑ²¼¹L¤á¿Ô¸ß  ¶È´£¨Ñ¥¼¤W¥«ªÑ²¼¥æ©ö¥­¥xµ¹·|­û¨Ï¥Î,¨Ì¥»¸ê®Æ¥æ©ö«á¬ÕÁ«¦Û­t!